Catalog Home Page

Publications: Institute for Immunology and Infectious Diseases

Export as [feed] RSS
Group by: Publication Type | Year
Number of items at this level: 741.

Journal Article

Abana, C.O., Pilkinton, M.A., Gaudieri, S., Chopra, A., McDonnell, W.J., Wanjalla, C., Barnett, L., Gangula, R., Hager, C., Jung, D.K., Engelhardt, B.G., Jagasia, M.H., Klenerman, P., Phillips, E.J., Koelle, D.M., Kalams, S.A. and Mallal, S.A. (2017) Cytomegalovirus (CMV) Epitope–Specific CD4 + T Cells Are Inflated in HIV + CMV + Subjects. The Journal of Immunology, 199 (9). pp. 3187-3201.

Abraham, M.B., Carpenter, K., Baynam, G.S., Mackay, D.J.G., Price, G. and Choong, C.S. (2015) Report and review of described associations of Mayer-Rokitansky-Küster-Hauser syndrome and Silver-Russell syndrome. Journal of Paediatrics and Child Health, 51 (5). pp. 555-560.

Acikyol, B., Graham, R.M., Trinder, D., House, M.J., Olynyk, J.K., Scott, R.J., Milward, E.A. and Johnstone, D.M. (2013) Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience, 235 . pp. 119-128.

Adams, L.A., Crawford, D.H., St Pierre, T.G. and Olynyk, J.K. (2015) Reply: Does the Death Knell Toll for Phlebotomy in NAFLD? Hepatology, 62 (6). pp. 1921-1922.

Adams, L.A., Crawford, D.H., Stuart, K., House, M.J., St Pierre, T.G., Webb, M., Ching, H.L.I., Kava, J., Bynevelt, M., MacQuillan, G.C., Garas, G., Ayonrinde, O.T., Mori, T.A., Croft, K.D., Niu, X., Jeffrey, G.P. and Olynyk, J.K. (2015) The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. Hepatology, 61 (5). pp. 1555-1564.

Adams, L.A., White, S.W., Marsh, J.A., Lye, S.J., Connor, K.L., Maganga, R., Ayonrinde, O.T., Olynyk, J.K., Mori, T.A., Beilin, L.J., Palmer, L.J., Hamdorf, J.M. and Pennell, C.E. (2013) Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology, 57 (2). pp. 590-600.

Adler, N.R., Aung, A.K., Ergen, E.N., Trubiano, J., Goh, M.S.Y. and Phillips, E.J. (2017) Recent advances in the understanding of severe cutaneous adverse reactions. British Journal of Dermatology . In Press.

Affandi, J.S., Montgomery, J., Brunt, S.J., Nolan, D. and Price, P. (2015) The immunological footprint of CMV in HIV-1 patients stable on long-term ART. Immunity & Ageing, 12 (1).

Allcock, R.J.N., Martin, A.M. and Price, P. (2000) The mouse as a model for the effects of MHC genes on human disease. Immunology Today, 21 (7). pp. 328-332.

Almeida, C., van Miert, P., O'Driscoll, K., Zoet, Y.M., Chopra, A., Watson, M., de Santis, D., Witt, C., John, M., Claas, F.H.J. and D'Orsogna, L.J. (2017) Stimulation of HIV-specific T cell clonotypes using allogeneic HLA. Cellular Immunology, 316 . pp. 32-40.

Almeida, C.M., Bronke, C., Roberts, S.G., McKinnon, E., Keane, N.M., Chopra, A., Kadie, C., Carlson, J., Haas, D. W., Riddler, S. A., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2011) Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes. The Journal of Immunology, 187 (5). pp. 2502-2513.

Altmüller, F., Lissewski, C., Bertola, D., Flex, E., Stark, Z., Spranger, S., Baynam, G., Buscarilli, M., Dyack, S., Gillis, J., Yntema, H.G., Pantaleoni, F., van Loon, R.L.E., MacKay, S., Mina, K., Schanze, I., Tan, T.Y., Walsh, M., White, S.M., Niewisch, M.R., García-Miñaúr, S., Plaza, D., Ahmadian, M.R., Cavé, H., Tartaglia, M. and Zenker, M. (2017) Genotype and phenotype spectrum of NRAS germline variants. European Journal of Human Genetics, 25 (7). pp. 823-831.

Alvarez Palomo, A.B., McLenachan, S., Chen, F.K., Da Cruz, L., Dilley, R.J., Requena, J., Lucas, M., Lucas, A., Drukker, M. and Edel, M.J. (2015) Prospects for clinical use of reprogrammed cells for autologous treatment of macular degeneration. Fibrogenesis & Tissue Repair, 8 (1).

Anderton, R., Meloni, B., Mastaglia, F. and Boulos, S. (2014) Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy. Translational Neuroscience, 5 (1). pp. 8-16.

Anderton, R.S. and Mastaglia, F.L. (2015) Advances and challenges in developing a therapy for spinal muscular atrophy. Expert Review of Neurotherapeutics, 15 (8). pp. 895-908.

Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., Peters, B., De Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and Frueh, K. (2016) Human CD4 + T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity. Journal of Virology, 91 (5).

Apetrei, C., Borges, Á.H., O’Connor, J.L., Phillips, A.N., Baker, J.V., Vjecha, M.J., Losso, M.H., Klinker, H., Lopardo, G., Williams, I., Lundgren, J.D. and John, M. (2014) Factors associated with D-Dimer levels in HIV-Infected individuals. PLoS ONE, 9 (3).

Applegate, T.L., Gaudieri, S., Plauzolles, A., Chopra, A., Grebely, J., Lucas, M., Hellard, M., Luciani, F., Dore, G.J. and Matthews, G.V. (2014) Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C. Antiviral Therapy, 20 (2). pp. 199-208.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G., Bosch, R., Heckerman, D., Stein, J.L., Soderberg, K.A., Moody, M.A., Denny, T.N., Zeng, X., Fang, J., Moffett, A., Lifson, J.D., Goedert, J.J., Buchbinder, S., Kirk, G.D., Fellay, J., McLaren, P., Deeks, S.G., Pereyra, F., Walker, B., Michael, N.L., Weintrob, A., Wolinsky, S., Liao, W. and Carrington, M. (2013) Influence of HLA-C expression level on HIV control. Science, 340 (6128). pp. 87-91.

Arlehamn, C.S.L., Copin, R., Leary, S., Mack, S.J., Phillips, E., Mallal, S., Sette, A., Blatner, G., Siefers, H. and Ernst, J.D. (2017) Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 100 Luo infants from the Boro area of Nyanza Province, Kenya. Human Immunology, 78 (4). pp. 325-326.

Armstrong, A.R., Herrmann, S.E., Chassany, O., Lalanne, C., Da Silva, M.H., Galano, E., Carrieri, P.M., Estellon, V., Sogni, P. and Duracinsky, M. (2016) The International development of PROQOL-HCV: An instrument to assess the health-related quality of life of patients treated for Hepatitis C virus. BMC Infectious Diseases, 16 (1).

Au, P.Y.B., Huang, L., Broley, S., Gallagher, L., Creede, E., Lahey, D., Ordorica, S., Mina, K., Boycott, K.M., Baynam, G. and Dyment, D.A. (2017) Two females with mutations in USP9X highlight the variable expressivity of the intellectual disability syndrome. European Journal of Medical Genetics, 60 (7). pp. 359-364.

Aung, A.K., Haas, D.W., Hulgan, T. and Phillips, E.J. (2014) Pharmacogenomics of antimicrobial agents. Pharmacogenomics, 15 (15). pp. 1903-1930.

Awadalla, P., Carlson, J., Kadie, C., Mallal, S. and Heckerman, D. (2007) Leveraging hierarchical population structure in discrete association studies. PloS one, 2 (7). pp. 1-13.

Ayonrinde, O.T., Olynyk, J.K., Marsh, J.A., Beilin, Lawrence J., Mori, Trevor A., Oddy, Wendy H. and Adams, Leon A. (2014) Childhood adiposity trajectories and risk of nonalcoholic fatty liver disease in adolescents. Journal of Gastroenterology and Hepatology, 30 (1). pp. 163-171.

Ayonrinde, O.T., Subramaniam, K., Latchmiah, F., Helenius, J.P., Ng, K., Kan, M, Spilsbury, K., Semmens, J., Mukhtar, A., Leahy, M.F. and Olynyk, J.K. (2014) Patterns of aspirin use in the Australian community. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 57.

Baker, R. and McGregor, S.R. (2014) Does preoperative laboratory monitoring of antithrombotic therapy avoid adverse outcomes in patients undergoing surgery or regional anaesthesia? Anaesthesia and Intensive Care, 42 (5). pp. 555-557.

Baker, R.I., Harper, P. and McLintock, C. (2012) Avoiding adverse events with dabigatran by careful selection of eligible patients. The Medical Journal of Australia, 196 (7). pp. 431-432.

Balakrishnan, K., Verdile, G., Mehta, P.D., Beilby, J., Nolan, D., Galvão, D.A., Newton, R., Gandy, S.E. and Martins, R.N. (2005) Plasma Aβ42 correlates positively with increased body fat in healthy individuals. Journal of Alzheimer's disease : JAD, 8 (3). pp. 269-282.

Balloux, F., McLaren, P.J., Coulonges, C., Ripke, S., van den Berg, L., Buchbinder, S., Carrington, M., Cossarizza, A., Dalmau, J., Deeks, S.G., Delaneau, O., De Luca, A., Goedert, J.J., Haas, D., Herbeck, J.T., Kathiresan, S., Kirk, G.D., Lambotte, O., Luo, M., Mallal, S., van Manen, D., Martinez-Picado, J., Meyer, L., Miro, J.M., Mullins, J.I., Obel, N., O'Brien, S.J., Pereyra, F., Plummer, F.A., Poli, G., Qi, Y., Rucart, P., Sandhu, M.S., Shea, P.R., Schuitemaker, H., Theodorou, I., Vannberg, F., Veldink, J., Walker, B.D., Weintrob, A., Winkler, C.A., Wolinsky, S., Telenti, A., Goldstein, D.B., de Bakker, P.I.W., Zagury, J-F and Fellay, J. (2013) Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls. PLoS Pathogens, 9 (7). e1003515.

Barnard, R., Chopra, A., James, I., Blinco, J., Watson, M.W., Jabara, C.B., Hazuda, D., Lemon, S.M., Mallal, S. and Gaudieri, S. (2016) Primer ID ultra-deep sequencing reveals dynamics of drug resistance-associated variants in breakthrough hepatitis C viruses: Relevance to treatment outcome and resistance screening. Antiviral Therapy, 21 . pp. 567-577.

Barnes, E., Ward, S.M., Kasprowicz, V.O., Dusheiko, G., Klenerman, P. and Lucas, M. (2004) Ultra-sensitive class I tetramer analysis reveals previously undetectable populations of antiviral CD8+ T cells. European Journal of Immunology, 34 (6). pp. 1570-1577.

Barrett, J.C., Clayton, D.G., Concannon, P., Akolkar, B., Cooper, J.D., Erlich, H.A., Julier, C., Morahan, G., Nerup, J., Nierras, C., Plagnol, V., Pociot, F., Schuilenburg, H., Smyth, D.J., Stevens, H., Todd, J.A., Walker, N.M., Rich, S.S., Gaudieri, S., James, I., McKinnon, E. and Nolan, D. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics, 41 (6). pp. 703-707.

Bartha, I., Carlson, J.M., Brumme, C.J., McLaren, P.J., Brumme, Z.L., John, M., Haas, D.W., Martinez-Picado, J., Dalmau, J., Lopez-Galindez, C., Casado, C., Rauch, A., Günthard, H.F., Bernasconi, E., Vernazza, P., Klimkait, T., Yerly, S., O'Brien, S.J., Listgarten, J., Pfeifer, N., Lippert, C., Fusi, N., Kutalik, Z., Allen, T.M., Muller, V., Harrigan, P.R., Heckerman, D., Telenti, A. and Fellay, J. (2013) A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control. eLife, 2 . e01123-e01123.

Bartlett, J., Mocroft, A., Lundgren, J.D., Ross, M., Law, M., Reiss, P., Kirk, O., Smith, C., Wentworth, D., Neuhaus, J., Fux, C.A., Moranne, O., Morlat, P., Johnson, M.A., Ryom, L. and Nolan, D. (2015) Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study. PLoS Medicine, 12 (3).

Bates, K.A., Sohrabi, H.R., Rainey-Smith, S.R., Weinborn, M., Bucks, R.S., Rodrigues, M., Beilby, J., Howard, M., Taddei, K., Martins, G., Paton, A., Shah, T., Dhaliwal, S.S., Foster, J.K., Martins, I.J., Lautenschlager, N.T., Mastaglia, F.L., Gandy, S.E. and Martins, R.N. (2016) Serum high-density lipoprotein is associated with better cognitive function in a cross-sectional study of aging women. International Journal of Neuroscience, 127 (3). pp. 243-252.

Bauersachs, R. and Baker, R.I. (2010) Oral Rivaroxaban for Symptomatic Venous Thromboembolism. New England Journal of Medicine, 363 (26). pp. 2499-2510.

Baynam, G., Broley, S., Bauskis, A., Pachter, N., McKenzie, F., Townshend, S., Slee, J., Kiraly-Borri, C., Vasudevan, A., Hawkins, A., Schofield, L., Helmholz, P., Palmer, R., Kung, S., Walker, C.E., Molster, C., Lewis, B., Mina, K., Beilby, J., Pathak, G., Poulton, C., Groza, T., Zankl, A., Roscioli, T., Dinger, M.E., Mattick, J.S., Gahl, W., Groft, S., Tifft, C., Taruscio, D., Lasko, P., Kosaki, K., Wilhelm, H., Melegh, B., Carapetis, J., Jana, S., Chaney, G., Johns, A., Owen, P.W., Daly, F., Weeramanthri, T., Dawkins, H. and Goldblatt, J. (2017) Initiating an undiagnosed diseases program in the Western Australian public health system. Orphanet Journal of Rare Diseases, 12 (1).

Baynam, G., Pachter, N., McKenzie, F., Townshend, S., Slee, J., Kiraly-Borri, C., Vasudevan, A., Hawkins, A., Broley, S., Schofield, L., Verhoef, H., Walker, C.E., Molster, C., Blackwell, J.M., Jamieson, S., Tang, D., Lassmann, T., Mina, K., Beilby, J., Davis, M., Laing, N., Murphy, L., Weeramanthri, T., Dawkins, H. and Goldblatt, J. (2016) The rare and undiagnosed diseases diagnostic service – Application of massively parallel sequencing in a state-wide clinical service. Orphanet Journal of Rare Diseases, 11 (1).

Baynam, G., Walters, M., Claes, P., Kung, S., LeSouef, P., Dawkins, H., Bellgard, M., Girdea, M., Brudno, M., Robinson, P., Zanki, A., Groza, T., Gillet, D. and Goldblatt, J. (2015) Phenotyping: Targeting genotype's rich cousin for diagnosis. Journal of Paediatrics and Child Health, 51 (4). pp. 381-386.

Baynam, G.S., González, C. and Temtamy, S.A. (2013) A boy with hand anomalies similar to those documented with prenatal misoprostol exposure. Middle East Journal of Medical Genetics, 2 (2). pp. 58-62.

Beecham, A.H., Patsopoulos, N.A., Xifara, D.K., Davis, M.F., Kemppinen, A., Cotsapas, C., Shah, T.S., Spencer, C., Booth, D., Goris, A., Oturai, A., Saarela, J., Fontaine, B., Hemmer, B., Martin, C., Zipp, F., D'Alfonso, S., Martinelli-Boneschi, F., Taylor, B., Harbo, H.F., Kockum, I., Hillert, J., Olsson, T., Ban, M., Oksenberg, J.R., Hintzen, R., Barcellos, L.F., Agliardi, C., Alfredsson, L., Alizadeh, M., Anderson, C., Andrews, R., Søndergaard, H.B., Baker, A., Band, G., Baranzini, S.E., Barizzone, N., Barrett, J., Bellenguez, C., Bergamaschi, L., Bernardinelli, L., Berthele, A., Biberacher, V., Binder, T.M.C., Blackburn, H., Bomfim, I.L., Brambilla, P., Broadley, S., Brochet, B., Brundin, L., Buck, D., Butzkueven, H., Caillier, S.J., Camu, W., Carpentier, W., Cavalla, P., Celius, E.G., Coman, I., Comi, G., Corrado, L., Cosemans, L., Cournu-Rebeix, I., Cree, B.A.C., Cusi, D., Damotte, V., Defer, G., Delgado, S.R., Deloukas, P., di Sapio, A., Dilthey, A.T., Donnelly, P., Dubois, B., Duddy, M., Edkins, S., Elovaara, I., Esposito, F., Evangelou, N., Fiddes, B., Field, J., Franke, A., Freeman, C., Frohlich, I.Y., Galimberti, D., Gieger, C., Gourraud, P-A, Graetz, C., Graham, A., Grummel, V., Guaschino, C., Hadjixenofontos, A., Hakonarson, H., Halfpenny, C., Hall, G., Hall, P., Hamsten, A., Harley, J., Harrower, T., Hawkins, C., Hellenthal, G., Hillier, C., Hobart, J., Hoshi, M., Hunt, S.E., Jagodic, M., Jelčić, I., Jochim, A., Kendall, B., Kermode, A., Kilpatrick, T., Koivisto, K., Konidari, I., Korn, T., Kronsbein, H., Langford, C., Larsson, M., Lathrop, M., Lebrun-Frenay, C., Lechner-Scott, J., Lee, M.H., Leone, M.A., Leppä, V., Liberatore, G., Lie, B.A., Lill, C.M., Linden, M., Link, J., Luessi, F., Lycke, J., Macciardi, F., Männistö, S., Manrique, C.P., Martin, R., Martinelli, V., Mason, D., Mazibrada, G., McCabe, C., Mero, I-L, Mescheriakova, J., Moutsianas, L., Myhr, K-M, Nagels, G., Nicholas, R., Nilsson, P., Piehl, F., Pirinen, M., Price, S.E., Quach, H., Reunanen, M., Robberecht, W., Robertson, N.P., Rodegher, M., Rog, D., Salvetti, M., Schnetz-Boutaud, N.C., Sellebjerg, F., Selter, R.C., Schaefer, C., Shaunak, S., Shen, L., Shields, S., Siffrin, V., Slee, M., Sorensen, P.S., Sorosina, M., Sospedra, M., Spurkland, A., Strange, A., Sundqvist, E., Thijs, V., Thorpe, J., Ticca, A., Tienari, P., van Duijn, C., Visser, E.M., Vucic, S., Westerlind, H., Wiley, J.S., Wilkins, A., Wilson, J.F., Winkelmann, J., Zajicek, J., Zindler, E., Haines, J.L., Pericak-Vance, M.A., Ivinson, A.J., Stewart, G., Hafler, D., Hauser, S.L., Compston, A., McVean, G., De Jager, P., Sawcer, S.J. and McCauley, J.L. (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45 (11). pp. 1353-1360.

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2014) Correction: Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 9 (1).

Bellgard, M., Beroud, C., Parkinson, K., Harris, T., Ayme, S., Baynam, G., Weeramanthri, T., Dawkins, H. and Hunter, A. (2013) Dispelling myths about rare disease registry system development. Source Code for Biology and Medicine, 8 (1). p. 21.

Bellgard, M.I., Sleeman, M.W., Guerrero, F.D., Fletcher, S., Baynam, G., Goldblatt, J., Rubinstein, Y., Bell, C., Groft, S., Barrero, R., Bittles, A.H., Wilton, S.D., Mason, C.E. and Weeramanthri, T. (2014) Rare disease research roadmap: Navigating the bioinformatics and translational challenges for improved patient health outcomes. Health Policy and Technology, 3 (4). pp. 325-335.

Bhattacharya, T., Daniels, M., Heckerman, D., Foley, B., Frahm, N., Kadie, C., Carlson, J., Yusim, K., McMahon, B., Gaschen, B., Mallal, S., Mullins, J.I., Nickle, D.C., Herbeck, J., Rousseau, C, Learn, G.H., Miura, T., Brander, C., Walker, B. and Korber, B. (2007) Founder effects in the assessment of HIV polymorphisms and HLA allele associations. Science, 315 (5818). pp. 1583-1586.

Bihl, F., Frahm, N., Di Giammarino, L., Sidney, J., John, M., Yusim, K., Woodberry, T., Sango, K., Hewitt, H.S., Henry, L., Linde, C.H., Chisholm, J.V., Zaman, T.M., Pae, E., Mallal, S., Walker, B.D., Sette, A., Korber, B.T., Heckerman, D. and Brander, C. (2006) Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses. Journal of Immunology, 176 (7). pp. 4094-101.

Black, L.J., Jacoby, P., She Ping-Delfos, W.C., Mori, T.A., Beilin, L.J., Olynyk, J.K., Ayonrinde, O.T., Huang, R.C., Holt, P.G., Hart, P.H., Oddy, W.H. and Adams, L.A. (2014) Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. Journal of Gastroenterology and Hepatology, 29 (6). pp. 1215-1222.

Bourke, J., Pavlos, R., James, I. and Phillips, E. (2015) Improving the effectiveness of penicillin allergy De-labeling. The Journal of Allergy and Clinical Immunology: In Practice, 3 (3). pp. 365-374.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies. Journal of Clinical Neuroscience, 21 (11). pp. 1835-1846.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy. Journal of Clinical Neuroscience, 21 (11). pp. 1847-1856.

Broadley, S.A., Barnett, M.H., Boggild, M., Brew, B.J., Butzkueven, H., Heard, R., Hodgkinson, S., Kermode, A.G., Lechner-Scott, J., Macdonell, R.A.L., Marriott, M., Mason, D.F., Parratt, J., Reddel, S.W., Shaw, C.P., Slee, M., Spies, J.M., Taylor, B.V., Carroll, W.M., Kilpatrick, T.J., King, J., McCombe, P.A., Pollard, J.D. and Willoughby, E. (2015) A new era in the treatment of multiple sclerosis. The Medical Journal of Australia, 203 (3). pp. 139-141.

Brockman, M.A., Chopera, D.R., Olvera, A., Brumme, C.J., Sela, J., Markle, T.J., Martin, E., Carlson, J.M., Le, A.Q., McGovern, R., Cheung, P.K., Kelleher, A.D., Jessen, H., Markowitz, M., Rosenberg, E., Frahm, N., Sanchez, J., Mallal, S., John, M., Harrigan, P.R., Heckerman, D., Brander, C., Walker, B.D. and Brumme, Z.L. (2012) Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity. Journal of Virology, 86 (12). pp. 6913-6923.

Bronke, C., Almeida, C.M., McKinnon, E., Roberts, S.G., Keane, N.M., Chopra, A., Carlson, J.M., Heckerman, D., Mallal, S. and John, M. (2013) HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes. AIDS, 27 (6). pp. 899-905.

Brusch, A.M., Clarke, R.C., Platt, P.R. and Phillips, E.J. (2014) Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis. British Journal of Clinical Pharmacology, 78 (7). pp. 14-23.

Bruyand, M., Ryom, L., Shepherd, L., Fatkenheuer, G., Grulich, A., Reiss, P., De Wit, S., d´Arminio Monforte, A., Furrer, H., Pradier, C., Lundgren, J., Sabin, C. and Nolan, D. (2015) Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor–based combination antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68 (5). pp. 568-577.

Bull, R.A., Leung, P., Gaudieri, S., Deshpande, P., Cameron, B., Walker, M., Chopra, A., Lloyd, A.R. and Luciani, F. (2015) Transmitted/founder viruses rapidly escape from CD8+T cell responses in acute hepatitis C virus infection. Journal of Virology, 89 (10). pp. 5478-5490.

Bull, R.A., Luciani, F., McElroy, K., Gaudieri, S., Pham, S.T., Chopra, A., Cameron, B., Maher, L., Dore, G.J., White, P.A. and Lloyd, A.R. (2011) Sequential bottlenecks drive viral evolution in early acute Hepatitis C virus infection. PLoS Pathogens, 7 (9). e1002243.

Buller, H., Deitchman, D., Prins, M., Segers, A. and Baker, R.I. (2008) Efficacy and safety of the oral direct factorXa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. Journal of Thrombosis and Haemostasis, 6 (8). pp. 1313-1318.

Bundell, C., Rojana-udomsart, A., Mastaglia, F., Hollingsworth, P. and McLean-Tooke, A. (2016) Diagnostic performance of a commercial immunoblot assay for myositis antibody testing. Pathology, 48 (4). pp. 363-366.

Carey, D., Puls, R., Amin, J., Losso, M., Phanupak, P., Foulkes, S., Mohapi, L., Crabtree-Ramirez, B., Jessen, H., Kumar, S., Winston, A., Lee, M.P., Belloso, W., Cooper, D.A., Emery, S. and Nolan, D. (2015) Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study. The Lancet Infectious Diseases, 15 (7). pp. 793-802.

Carlson, J.M., Brumme, C.J., Martin, E., Listgarten, J., Brockman, M.A., Le, A.Q., Chui, C.K.S., Cotton, L.A., Knapp, D.J.H.F., Riddler, S.A., Haubrich, R., Nelson, G., Pfeifer, N., DeZiel, C.E., Heckerman, D., Apps, R., Carrington, M., Mallal, S., Harrigan, P.R., John, M. and Brumme, Z.L. (2012) Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1. Journal of Virology, 86 (24). pp. 13202-13216.

Carlson, J.M., Du, V.Y., Pfeifer, N., Bansal, A., Tan, V.Y.F., Power, K., Brumme, C.J., Kreimer, A., DeZiel, C.E, Fusi, N., Schaefer, M., Brockman, M.A., Gilmour, J., Price, M.A., Kilembe, W., Haubrich, R., John, M., Mallal, S., Shapiro, R., Frater, J., Harrigan, P.R., Ndung'u, T., Allen, S., Heckerman, D., Sidney, J., Allen, T.M., Goulder, P.J.R., Brumme, Z.L., Hunter, E. and Goepfert, P.A. (2016) Impact of pre-adapted HIV transmission. Nature Medicine, 22 (6). pp. 606-613.

Carlson, J.M., Schaefer, M., Brumme, C., Pfeifer, N., Shapiro, R., Ndung'u, T., Frater, J., Mallal, S., John, M., Heckerman, D., Goulder, P., Brumme, Z. and Hunter, E. (2014) Transmitted escape mutations lead to accelerated HIV-1 disease progression and largely define the relative contribution of HLA Alleles to control. AIDS Research and Human Retroviruses, 30 (S1). A40.

Carroll, G.J., Makin, K., Garnsey, M., Bulsara, M., Carroll, B.V., Curtin, S.M., Allan, E.M., McLean-Tooke, A., Bundell, C., Kemp, M.L., Deshpande, P., Ihdayhid, D., Coleman, S., Easter, T., Triplett, J., Disteldorf, T., Marsden, C.H. and Lucas, M. (2017) Undetectable Mannose Binding Lectin and Corticosteroids Increase Serious Infection Risk in Rheumatoid Arthritis. The Journal of Allergy and Clinical Immunology: In Practice, In Press .

Castley, A., Berry, C.M., French, M., Fernandez, S., Krueger, R. and Nolan, D. (2014) Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: A changing paradigm for routine HIV laboratory monitoring? PLoS ONE, 9 (12). e115226.

Castley, A., Williams, L., James, I., Guelfi, G., Berry, C. and Nolan, D. (2016) Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PloS one, 11 (6). e0158169.

Castley, A.S.L., Gaudieri, S., James, I., Gizzarelli, L.S., Guelfi, G., John, M. and Nolan, D. (2016) Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000–2014. AIDS Research and Human Retroviruses, 32 (3). pp. 211-219.

Chakera, A., Lucas, A. and Lucas, M. (2011) Surrogate markers of infection: interrogation of the immune system. Biomarkers in Medicine, 5 (2). pp. 131-148.

Chalmers, K.A., Knuiman, M.W., Divitini, M.L., Bruce, D.G., Olynyk, J.K. and Milward, E.A. (2012) Long-term mortality risks associated with mild anaemia in older persons: the Busselton Health Study. Age and Ageing, 41 (6). pp. 759-764.

Chatterjee, P., Lim, W.L.F., Shui, G., Gupta, V.B., James, I., Fagan, A.M., Xiong, C., Sohrabi, H.R., Taddei, K., Brown, B.M., Benzinger, T., Masters, C., Snowden, S.G., Wenk, M.R., Bateman, R.J., Morris, J.C. and Martins, R.N. (2016) Plasma phospholipid and sphingolipid alterations in presenilin1 mutation carriers: A pilot study. Journal of Alzheimer's Disease, 50 (3). pp. 887-894.

Chaubey, S.K., Sinha, A.K., Phillips, E., Russell, D.B. and Falhammar, H. (2009) Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sexual Health, 6 (3). pp. 254-257.

Cheng, Y.-C., Anderson, C.D., Bione, S., Keene, K., Maguire, J.M., Nalls, M., Rasheed, A., Zeginigg, M., Attia, J., Baker, R., Barlera, S., Biffi, A., Bookman, E., Brott, T.G., Brown, R. D., Chen, F., Chen, W.-M., Ciusani, E., Cole, J.W., Cortellini, L., Danesh, J., Doheny, K., Ferrucci, L., Grazia Franzosi, M., Frossard, P., Furie, K.L., Golledge, J., Hankey, G.J., Hernandez, D., Holliday, E.G., Hsu, F.-C., Jannes, J., Kamal, A., Khan, M.S., Kittner, S.J., Koblar, S.A., Lewis, M., Lincz, L., Lisa, A., Matarin, M., Moscato, P., Mychaleckyj, J.C., Parati, E.A., Parolo, S., Pugh, E., Rost, N.S., Schallert, M., Schmidt, H., Scott, R.J., Sturm, J.W., Yadav, S., Zaidi, M., Boncoraglio, G.B., Levi, C.R., Meschia, J.F., Rosand, J., Sale, M., Saleheen, D., Schmidt, R., Sharma, P., Worrall, B. and Mitchell, B.D. (2012) Are myocardial infarction-associated single-nucleotide polymorphisms associated with ischemic stroke? Stroke, 43 (4). pp. 980-986.

Cherry, C.L., Nolan, D., James, I.R., McKinnon, E.J., Mallal, S.A., Gahan, M.E., Lal, L., McArthur, J.C. and Wesselingh, S.L. (2006) Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-Infected individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes, 42 (4). pp. 435-440.

Chikata, T., Carlson, J.M., Tamura, Y., Borghan, M.A., Naruto, T., Hashimoto, M., Murakoshi, H., Le, A.Q., Mallal, S., John, M., Gatanaga, H., Oka, S., Brumme, Z.L. and Takiguchi, M. (2014) Host-Specific adaptation of HIV-1 Subtype B in the Japanese population. Journal of Virology, 88 (9). pp. 4764-4775.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Yakiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-infected Japanese cohort: analysis of four-digit HLA allele level. Retrovirology, 9 (Suppl 2).

Chopra, A. and Nanjundiah, V. (2013) The precision with which single cells of Dictyostelium discoideum can locate a source of cyclic AMP. Chaos, Solitons & Fractals, 50 . pp. 3-12.

Christiansen, F., Moore, C.B., De Santis, D., Gaudieri, S., Witt, C.S., James, I.R. and Mallal, S.A. (2003) HLA and NK receptor genes in HIV progression. Genes and Immunity, 4 (S1). S6.

Chua, A.C.G., Divitini, M.L., Trinder, D., Knuiman, M.W. and Olynyk, J.K. (2014) High iron and transferrin saturation levels are associated with increased risks of non-skin cancers in women. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 147.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-present). Retrovirology, 9 (Suppl 2). P157.

Coutinho, C.M.L.M., Coutinho-Silva, R., Zinkevich, V., Pearce, C.B., Ojcius, D.M. and Beech, I. (2017) Sulphate-reducing bacteria from ulcerative colitis patients induce apoptosis of gastrointestinal epithelial cells. Microbial Pathogenesis, 112 . pp. 126-134.

Creaney, J., Ma, S., Sneddon, S.A., Tourigny, M.R., Dick, I.M., Leon, J.S., Khong, A., Fisher, S.A., Lake, R.A., Lesterhuis, W.J., Nowak, A.K., Leary, S., Watson, M.W. and Robinson, B.W. (2015) Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen. OncoImmunology, 4 (7). e1011492.

Cromer, D., Schlub, T., Smyth, R., Grimm, A., Chopra, A., Mallal, S., Davenport, M. and Mak, J. (2016) HIV-1 Mutation and recombination rates are different in Macrophages and T-cells. Viruses, 8 (4). p. 118.

Cull, G., Hall, D., Fabis-Pedrini, M.J., Carroll, W.M., Forster, L., Robins, F., Ghassemifar, R., Crosbie, C., Walters, S., James, I., Augustson, B. and Kermode, A.G. (2017) Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 3 (1). pp. 1-9.

Côté, H.C.F., Gerschenson, M., Walker, U.A., Miro, O., Garrabou, G., Hammond, E.L., Villarroya, J., Giralt, M., Villarroya, F., Cinque, P., Garcia-Arumi, E., Andreu, A.L., Pinti, M. and Cossarizza, A. (2011) Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion, 11 (3). pp. 520-527.

D'Arminio Monforte, A., Abrams, D., Pradier, C., Weber, R., Reiss, P., Bonnet, F., Kirk, O., Law, M., De Wit, S., Friis-Moller, N., Phillips, A., Sabin, C., Lundgren, J. and Mallal, S. (2008) HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS, 22 (16). pp. 2143-2153.

D'Orsogna, L.J., Nguyen, T.H.O., Claas, F.H.J., Witt, C. and Mifsud, N.A. (2013) Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. Tissue Antigens, 81 (6). pp. 399-407.

D'Orsogna, L.J., van den Heuvel, H., van der Meer-Prins, E.M.W., Roelen, D.L., Doxiadis, I.I.N. and Claas, F.H.J. (2012) Stimulation of human EBV-and CMV-specific cytolytic effector function using allogeneic HLA molecules. The Journal of Immunology, 189 (10). pp. 4825-4831.

Dai, Y., Lu, T., Wang, Y., Fang, L., Li, R., Kermode, A.G. and Qiu, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Journal of Clinical Neuroscience, 26 . pp. 168-170.

Delatycki, M.B., Gurrin, L.C., Ong, S.Y., Ramm, G.A., Anderson, G.J., Olynyk, J.K., Allen, K.J., Nicoll, A.J. and Powell, L.W. (2015) Reduced mortality due to phlebotomy in moderately iron-loaded HFE haemochromatosis? The need for clinical trials. Journal of Hepatology, 63 (1). pp. 282-283.

Derrick, M.I.P., Williams, K.B., Shade, L.M and Phillips, E.J. (2017) A survey of drug allergy training opportunities in the United States. The Journal of Allergy and Clinical Immunology: In Practice, In press .

Deshpande, P., Lucas, M., Brunt, S., Lucas, A., Hollingsworth, P. and Bundell, C. (2016) Low level autoantibodies can be frequently detected in the general Australian population. Pathology, 48 (5). pp. 483-490.

Desmond, C.P., Bartholomeusz, A., Gaudieri, S., Revill, P.A. and Lewin, S.R. (2007) A systematic review of T-cell epitopes in hepatitis B virus: Identification, genotypic variation and relevance to antiviral therapeutics. Antiviral Therapy, 13 (2). pp. 161-175.

Desmond, C.P., Gaudieri, S., James, I.R., Pfafferott, K., Chopra, A., Lau, G.K., Audsley, J., Day, C., Chivers, S., Gordon, A., Revill, P.A., Bowden, S., Ayres, A., Desmond, P.V., Thompson, A.J., Roberts, S. K., Locarnini, S.A., Mallal, S.A. and Lewin, S.R. (2012) Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative disease. Journal of Virology, 86 (2). pp. 1181-1192.

Dong, T., Zhang, Y., Xu, K. Y., Yan, H., James, I., Peng, Y., Blais, M.-E., Gaudieri, S., Chen, X., Lun, W., Wu, H., Qu, W. Y., Rostron, T., Li, N., Mao, Y., Mallal, S., Xu, X., McMichael, A., John, M. and Rowland-Jones, S. L. (2011) Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. Blood, 118 (1). pp. 98-106.

Dunkley, S.M., Russell, S.J., Rowell, J.A., Barnes, C.D., Baker, R.I., Sarson, M.I. and Street, A.M. (2009) A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disorders. The Medical journal of Australia, 191 (8). pp. 460-3.

Duracinsky, M., Armstrong, A., Herrmann, S., Lalanne, C., Galano, E., Da Silva, M.H., Carrieri, P.M. and Chassany, O. (2015) Psychometric Validation of the New International Questionnaire to Assess Health-Related Quality of Life (Hrql) Specific to Viral Hepatitis C: Proqol-Hcv. Value in Health, 18 (7). A591-A592.

Duracinsky, M., Herrmann, S., Berzins, B., Armstrong, A.R., Kohli, R., Le Coeur, S., Diouf, A., Fournier, I., Schechter, M. and Chassany, O. (2012) The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 498-505.

Duracinsky, M., Lalanne, C., Goujard, C., Herrmann, S., Cheung-Lung, C., Brosseau, J -P, Schwartz, Y. and Chassany, O. (2014) Electronic versus paper-based assessment of health-related quality of life specific to HIV disease: Reliability study of the PROQOL-HIV questionnaire. Journal of Medical Internet Research, 16 (4).

Duracinsky, M., Lalanne, C., Le Coeur, S., Herrmann, S., Berzins, B., Armstrong, A.R., Fai Lau, J.T., Fournier, I. and Chassany, O. (2012) Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument–specific to HIV disease. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59 (5). pp. 506-515.

Duracinsky, M., Leclercq, P., Herrmann, S., Christen, M-O, Dolivo, M., Goujard, C. and Chassany, O. (2014) Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients. BMC Infectious Diseases, 14 (1). p. 474.

Dwyer, B.J., Olynyk, J.K., Ramm, G.A. and Tirnitz-Parker, J.E.E. (2014) TWEAK and LTβ signaling during chronic liver disease. Frontiers in Immunology, 5 .

Edwards, D.J., Dipietro, L., Demirtas-Tatlidede, A., Medeiros, A.H., Thickbroom, G.W., Mastaglia, F.L., Krebs, H.I. and Pascual-Leone, A. (2014) Movement-generated afference paired with transcranial magnetic stimulation: An associative stimulation paradigm. Journal of NeuroEngineering and Rehabilitation, 11 (1).

Elera, J.D., Boteanu, C., Blanco, M.A.J., Gonzalez-Mendiola, R., García, I.C., Alvarez, A., Martinez, J.J.L., Garrido, J.M., Barona, C.T., Chorda, C.P., Salgueiro, R.L., Palacios, M.D., De Rojas, D.H.F., Acar, E.A., Aktas, A., Ermertcan, A.T., Temiz, C., Lin, C-Y, Hui, C-Y.R., Chang, Y-C, Yang, C-H, Chung, W-H, Carolino, F., Silva, D., De Castro, E.D., Cernadas, J.R., Ensina, L.F., Aranda, C., Nunes, I.C., Lacerda, A., Martins, A.M., Goudouris, E., Ribeiro, M., Da Silva Franco, J.F., Queiroz, L., Solé, D., Dalgiç, C.T., Sin, A.Z., Günsen, F.D., Bulut, G., Ardeniz, F.Ö., Gülbahar, O., Gökmen, E.N.M., Kokuludag, A., De Francisco, A.M.M., De Vicente Jiménez, T.M., Mendoza Parra, A.M., Burgos Pimentel, A.M., Luque, A.G., Amaral, L., Leão, L.C., Pinto, N., Belo, J., Marques, J., Carreiro-Martins, P., Leiria-Pinto, P., Chaabane, A., Romdhane, H.B., Fredj, N.B., Chadly, Z., Boughattas, N.A., Aouam, K., Uyttebroek, A.P., Bridts, C.H., Romano, A., Ebo, D.G., Sabato, V., Lopes, A., Cosme, J., Aguiar, R., Lourenço, T., Paes, M-J, Spínola-Santos, A., Pereira-Barbosa, M., Cruz, C.R., Dos Reis, R.P., Tomaz, E., Pires, A.P., Inácio, F., Benito-Garcia, F., Mota, I., Correia, M., Gaspar, Â., Chambel, M., Piedade, S., Morais-Almeida, M., Nakonechna, A., Antipkin, Y., Umanets, T., Pineda, F., Arribas, F., Lapshyn, V., Miranda, P.A., De La Cruz Hoyos, B., Blanco, A.J., Del Pozo, M., Vultaggio, A., Nencini, F., Pratesi, S., Matucci, A., Maggi, E., Cegec, I., Nahal, D.J., Turk, V.E., Aumiler, M.R., Ausperger, K.M., Kraljickovic, I., Simic, I., Yamaguchi, Y., Watanabe, T., Satoh, M., Tanegashima, T., Oda, K., Wada, H., Aihara, M., Lee, J.J., Choi, J.C., Lee, H.Y., Fernandes, R-A.R., Faria, E., Pita, J., Sousa, N., Ribeiro, C., Carrapatoso, I., Bom, A.T., Rodolfo, A., Dias-Castro, E., Voronova, M., Valle, D.K., Coronel, V.P., Chordá, C.P., Madamba, R.C.Y., Ferrer, M., Goikoetxea, M.J., D’Amelio, C., Bernad, A., Vega, O., Gastaminza, G., Bibián, B.L., Salazar, M.L., Vilà-Nadal, G., Roman, A.M.F., Ortega, J.D., Muñoz, M.G., Gancedo, S.Q., Moreno, M.R.C., Hofmeier, K.S., Barzylovych, V., Pola, B., Lluncor, M., Fiandor, A., Bellón, T., Domínguez, J., Quirce, S., Yang, M-S, Kim, S-S, Kim, S-H, Kang, H-R, Park, H-W, Cho, S-H, Min, K-U, Chang, Y-S, Delahaye, C., Flabbee, J., Waton, J., Bauvin, O., Barbaud, A., Fadhel, N.B., Gulin, S.J., Chiriac, A., Cardoso, B.K., Viseu, R., Moreira, A., Cadinha, S., Neves, A.C., Barreira, P., Malheiro, D., Da Silva, J.P., Jurakic-Toncic, R., Ljubojevic, S., Turcic, P., Gilissen, L., Huygens, S., Goossens, A., Andreu, I., Romero, A.M., Cabezas, P.G., Parejo, P.A., Del Carmen Plaza-Serón, M., Doña, I., Blanca-López, N., Flores, C., Galindo, M.L., Molina, A., Perkins, J.R., Cornejo-García, J.A., García-Agúndez, J.A., García-Martín, E., Campo, P., Canto, M.G., Blanca, M., Guéant-Rodríguez, R.M., Jurado-Escobar, R., Barrionuevo, E., Salas, M., Canto, G., Guéant, J-L, Usui, T., Tailor, A., Faulkner, L., Farrell, J., Alfirevic, A., Kevin Park, B., Naisbitt, D.J., Trelles, O., Guerrero, M.A., Upton, A., Ueta, M., Sawai, H., Sotozono, C., Tokunaga, K., Kinoshita, S., Sukasem, C., Satapornpong, P., Tempark, T., Rerknimitr, P., Pairayayutakul, K., Klaewsongkram, J., Koomdee, N., Jantararoungtong, T., Santon, S., Puangpetch, A., Intusoma, U., Tassaneeyakul, W., Theeramoke, V., Ramirez, E., Borobia, A.M., Tong, H., Castañer, J.L., De Abajo, F.J., Galvao, V.R., Pavlos, R., McKinnon, E., Williams, K., Beeghly-Fadiel, A., Phillips, E., Castells, M., Boni, E., Russello, M., Mauro, M., Ue, K.L., Rutkowski, K., Gomis, V.S., Ferre, J.F., Rodriguez, A.E., Reig, V.C., Sanchez, J.F., Breynaert, C., Van Hoeyveld, E., Schrijvers, R., Blanco, A.J., Irigoyen, R.F., Collado, D., Vida, Y., Najera, F., Perez-Inestrosa, E., Mesa-Antunez, P., Mayorga, C., Torres, M.J., Tannert, L.K., Mortz, C.G., Skov, P.S., Bindslev-Jensen, C., Pfützner, W., Dörnbach, H., Visse, J., Rauber, M., Möbs, C., Elzagallaai, A.A., Chow, L., Abuzgaia, A.M., Rieder, M.J., Trubiano, J., Woolnough, E., Cheng, C., Kato, K., Azukizawa, H., Hanafusa, T., Katayama, I., Fujiyama, T., Hashizume, H., Umayahara, T., Ito, T., Tokura, Y., Silar, M., Zidarn, M., Rupnik, H., Korosec, P., Redwood, A.J., Strautins, K., White, K., Chopra, A., Konvinse, K., Leary, S., Mallal, S., Cabañas, R., Fiandor, A.M., Sullivan, A., Whitaker, P., Peckham, D., Haw, W.Y., Polak, M.E., Mcguire, C., Ardern-Jones, M.R., Aoyama, Y., Shiohara, T., Correia, S., Gelincik, A., Demir, S., Sen, F., Bozbey, H.U., Olgac, M., Unal, D., Coskun, R., Colakoglu, B., Buyuozturk, S., Çatin-Aktas, E., Deniz, G., Laguna, J.J., Dionicio, J., Fernandez, T., Olazabal, I., Ruiz, M.D., Torres, M.J., Lafuente, A., Núñez, J., Fernández, T.D., Palomares, F., Fernández, R., Sanchez, M.I., Fernandez, T., Ruiz, A., Ariza, A., Alonso, A.B., Garófalo, C.D., Matute, O.V., Puga, M.F., Lapresa, M.J.G., Lasarte, G.G., Thinnes, A., Merk, H.F., Baron, J.M., Leverkus, M., Balakirski, G., Gibson, A., Ogese, M., Al-Attar, Z., Yaseen, F., Meng, X., Jenkins, R., Farrel, J., Alhilali, K., Xue, Y., Illing, P., Mifsud, N., Fettke, H., Lai, J., Ho, R., Kwan, P., Purcell, A., Ogese, M.O., Betts, C., Thomson, P., Alhaidari, M., Berry, N., O’Neill, P.M., Alzahrani, A., Azoury, M.E., Fili, L., Bechara, R., Scornet, N., Nhim, C., Weaver, R., Claude, N., Joseph, D., Maillere, B., Parronchi, P., Pallardy, M., Villani, A.P., Rozières, A., Bensaïd, B., Tardieu, M., Albert, F., Mutez, V., Baysal, T., Maryanski, J., Nicolas, J-F, Kanagawa, O., Vocanson, M., Hung, S-L, Harrison, C.J., Jenkins, R.E., French, N.S., Montañez, M.I., Fernandez, T.D., Martin-Serrano, A., Torres, M.J., Molina, N., Wood, S., Pirmohamed, M., Montañez, M.I., Martín-Serrano, Á., Pérez-Inestrosa, E., Pérez-Sala, D., Guzmán, A.E., Ko, T-M, Chen, Y-T, Wu, J-Y, Sánchez-Gómez, F.J., González-Morena, J.M., Torres, M.J., Arreola, A.M., Corona, J.A.B., Flores, S.M., Cherit, J.D., Figueroa, N.V.D., Flores, J.L.C., Perkins, J., Pérez-Alzate, D., Bogas, G., Torres, M.J., Marti, L.M.T., De La Losa, F.P., Poves, F.A., Lopez, J.T. and Santiago, T.L. (2016) 7th Drug hypersensitivity meeting: part two. Clinical and Translational Allergy, 6 (S3).

Elsegood, C.L., Chan, C.W., Degli-Esposti, M.A., Wikstrom, M.E., Domenichini, A., Lazarus, K., van Rooijen, N., Ganss, R., Olynyk, J.K. and Yeoh, G.C.T. (2015) Kupffer cell-monocyte communication is essential for initiating murine liver progenitor cell-mediated liver regeneration. Hepatology, 62 (4). pp. 1272-1284.

Evans, T., Jefferson, A., Byrnes, M., Walters, S., Ghosh, S., Mastaglia, F.L., Power, B. and Anderton, R.S. (2017) Extended “Timed Up and Go” assessment as a clinical indicator of cognitive state in Parkinson's disease. Journal of the Neurological Sciences, 375 . pp. 86-91.

Fabis-Pedrini, M.J., Xu, W., Burton, J., Carroll, W.M. and Kermode, A.G. (2016) Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment. Journal of Clinical Neuroscience, 25 . pp. 145-147.

Falster, K., Petoumenos, K., Chuah, J., Mijch, A., Mulhall, B., Kelly, M., Cooper, D.A. and Mallal, S. (2009) Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes, 50 (3). pp. 307-313.

Favaloro, E.J., Thom, J., Patterson, D., Just, S., Dixon, T., Koutts, J., Baccala, M., Rowell, J. and Baker, R. (2009) Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: Differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Thrombosis Research, 123 (6). pp. 862-868.

Fellay, J., Ge, D., Shianna, K.V., Colombo, S., Ledergerber, B., Cirulli, E.T., Urban, T.J., Zhang, K., Gumbs, C.E., Smith, J. P., Castagna, A., Cozzi-Lepri, A., De Luca, A., Easterbrook, P., Günthard, H.F., Mallal, S., Mussini, C., Dalmau, J., Martinez-Picado, J., Miro, J.M., Obel, N., Wolinsky, S.M., Martinson, J.J., Detels, R., Margolick, J.B., Jacobson, L.P., Descombes, P., Antonarakis, S.E., Beckmann, J.S., O'Brien, S.J., Letvin, N.L., McMichael, A.J., Haynes, B.F., Carrington, M., Feng, S., Telenti, A., Goldstein, D.B. and McCarthy, M.I. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genetics, 5 (12). e1000791.

Fewings, N., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis. Data in Brief, 11 . pp. 364-370.

Fewings, N.L., Gatt, P.N., McKay, F.C., Parnell, G.P., Schibeci, S.D., Edwards, J., Basuki, M.A., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Manrique, C.P., McCauley, J.L., Nickles, D., Baranzini, S.E., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2017) The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis. Journal of Autoimmunity, 78 . pp. 57-69.

Fiches, G.N., Eyre, N.S., Aloia, A.L., Van Der Hoek, K., Betz-Stablein, B., Luciani, F., Chopra, A. and Beard, M.R. (2016) HCV RNA traffic and association with NS5A in living cells. Virology, 493 . pp. 60-74.

Fiessinger, J. N., Bounameaux, H., Cairols, M. A., Clement, D. L., Coccheri, S., Fletcher, J. P., Hoffmann, U., Turpie, A. G. G. and Baker, R.I. (2010) Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study. Journal of Thrombosis and Haemostasis, 8 (11). pp. 2369-2376.

Flanagan, D., MacLellan, D., Gibbs, H., Baker, R. and Fletcher, J. (2008) The insidious hazard of hospitalisation: Venous thromboembolism. Medicine Today, 9 (9). pp. 16-26.

Fonceca, A.M., Chopra, A., Levy, A., Noakes, P.S., Poh, M.W.-P., Bear, N.L., Prescott, S. and Everard, M.L. (2017) Infective respiratory syncytial virus is present in human cord blood samples and most prevalent during winter months. PLOS ONE, 12 (4). e0173738.

Frater, A.J., Edwards, C.T.T., McCarthy, N., Fox, J., Brown, H., Milicic, A., Mackie, N., Pillay, T., Drijfhout, J.W., Dustan, S., Clarke, J.R., Holmes, E.C., Zhang, H.T., Pfafferott, K., Goulder, P.J.R., McClure, M.O., Weber, J., Phillips, R.E. and Fidler, S. (2006) Passive Sexual Transmission of Human Immunodeficiency Virus Type 1 Variants and Adaptation in New Hosts. Journal of Virology, 80 (14). pp. 7226-7234.

Fritzius, T., Turecek, R., Seddik, R., Kobayashi, H., Tiao, J., Rem, P.D., Metz, M., Kralikova, M., Bouvier, M., Gassmann, M. and Bettler, B. (2016) KCTD Hetero-oligomers confer unique kinetic properties on Hippocampal GABA B Receptor-Induced K + Currents. The Journal of Neuroscience, 37 (5). pp. 1162-1175.

Gabutero, E., Moore, C., Mallal, S., Stewart, G. and Williamson, P. (2007) Interaction between allelic variation in IL12B and CCR5 affects the development of AIDS: IL12B/CCR5 interaction and HIV/AIDS. AIDS, 21 (1). pp. 65-69.

Gaido, C.M., Stone, S., Chopra, A., Thomas, W.R., Le Souëf, P.N., Hales, B.J. and Williams, B. (2016) Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C. Journal of Virology, 90 (23). pp. 10459-10471.

Galvão, V.R., Phillips, E., Giavina-Bianchi, P. and Castells, M.C. (2016) Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 816-818.

Gang, Q., Bettencourt, C., Machado, P.M., Fox, Z., Brady, S., Healy, E., Parton, M., Holton, J.L., Hilton-Jones, D., Shieh, P.B., Zanoteli, E., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Hanna, M.G., Houlden, H., Needham, M. and Mastaglia, F. (2015) The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiology of Aging, 36 (4). 1766.e1-1766.e3.

Gardiner, E.E., Al-Tamimi, M., Mu, F.-T., Karunakaran, D., Thom, J.Y., Moroi, M., Andrews, R.K., Berndt, M.C. and Baker, R.I. (2008) Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. Journal of Thrombosis and Haemostasis, 6 (7). pp. 1175-1182.

Gardiner, E.E., Karunakaran, D., Arthur, J.F., Mu, F.-T., Powell, M.S., Baker, R.I., Hogarth, P.M., Kahn, M.L., Andrews, R.K. and Berndt, M.C. (2008) Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing Fc RIIa. Blood, 111 (1). pp. 165-174.

Garon, S.L., Pavlos, R.K., White, K.D., Brown, N.J., Stone, C.A. and Phillips, E.J. (2017) Pharmacogenomics of off-target adverse drug reactions. British Journal of Clinical Pharmacology, 83 (9). pp. 1896-1911.

Gatanaga, H., Brumme, Z.L., Adland, E., Reyes-Teran, G., Avila-Rios, S., Mejía-Villatoro, C.R., Hayashida, T., Chikata, T., Van Tran, G., Van Nguyen, K., Meza, R.I., Palou, E.Y., Valenzuela-Ponce, H., Pascale, J.M., Porras-Cortés, G., Manzanero, M., Lee, G.Q., Martin, J.N., Carrington, M.N., John, M., Mallal, S., Poon, A.F.Y., Goulder, P., Takiguchi, M. and Oka, S. (2017) Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection. AIDS, 31 (14). pp. 1935-1943.

Gaudieri, S. (2011) Biomarkers that reflect immune activation or dysfunction will be important in the management of infectious diseases. Biomarkers in Medicine, 5 (2). pp. 109-112.

Gaudieri, S. and Lucas, M. (2017) Innate and adaptive immunity shape circulating HCV strains. Nature Genetics, 49 (5). pp. 657-658.

Gaudieri, S., Lucas, M., Lucas, A., McKinnon, E., Albloushi, H., Rauch, A., di Iulio, J., Martino, D., Prescott, S.L. and Tulic, M.K. (2012) Genetic variations in IL28B and allergic disease in children. PLoS ONE, 7 (1). e30607.

Gaudieri, S., Tulic, M.K., Lucas, A. and Lucas, M. (2012) IFN-λ and IgE-mediated allergic disease: A potential future role? Biomarkers in Medicine, 6 (2). pp. 151-157.

Gerace, K.S., Karlin, E., McKinnon, E. and Phillips, E. (2015) Varying penicillin allergy testing practices in the United States: A time for consensus. The Journal of Allergy and Clinical Immunology: In Practice, 3 (5). pp. 791-793.

Gillieatt, S.J. and Mallal, S.A. (2000) Uptake of HIV Testing and Treatment in an Isolated Population with Access to Free and Universal Healthcare. International Journal of STD & AIDS, 11 (5). pp. 303-312.

Gimeno Brias, S., Stack, G., Stacey, M.A., Redwood, A.J. and Humphreys, I.R. (2016) The role of IL-22 in viral infections: Paradigms and paradoxes. Frontiers in Immunology, 7 .

Gitschlag, B.L., Kirby, C.S., Samuels, D.C., Gangula, R.D., Mallal, S.A. and Patel, M.R. (2016) Homeostatic Responses Regulate Selfish Mitochondrial Genome Dynamics in C. elegans. Cell Metabolism, 24 (1). pp. 91-103.

Goot, K., Hazeldine, S., Bentley, P., Olynyk, J. and Crawford, D. (2012) Elevated serum ferriti: What should GPs know? Australian Family Physician, 41 (12). pp. 945-949.

Goozee, K., Chatterjee, P., James, I., Shen, K., Sohrabi, H.R., Asih, P.R., Dave, P., Ball, B., ManYan, C., Taddei, K., Chung, R., Garg, M.L. and Martins, R.N. (2017) Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease. Scientific Reports, 7 (1).

Goris, A., Pauwels, I., Gustavsen, M.W., van Son, B., Hilven, K., Bos, S.D., Celius, E.G., Berg-Hansen, P., Aarseth, J., Myhr, K-M, D'Alfonso, S., Barizzone, N., Leone, M.A., Martinelli Boneschi, F., Sorosina, M., Liberatore, G., Kockum, I., Olsson, T., Hillert, J., Alfredsson, L., Bedri, S.K., Hemmer, B., Buck, D., Berthele, A., Knier, B., Biberacher, V., van Pesch, V., Sindic, C., Bang Oturai, A., Sondergaard, H.B., Sellebjerg, F., Jensen, P.E.H., Comabella, M., Montalban, X., Perez-Boza, J., Malhotra, S., Lechner-Scott, J., Broadley, S., Slee, M., Taylor, B., Kermode, A.G., Gourraud, P-A, Sawcer, S.J., Andreassen, B.K., Dubois, B. and Harbo, H.F. (2015) Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain, 138 (3). pp. 632-643.

Graeme, J. and Baker, R.I. (2010) B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. The Lancet Neurology, 9 (9). pp. 855-865.

Gratte, F.D., Olynyk, J.K., Yeoh, G.C.T., Tosh, D., Coombe, D.R. and Tirnitz-Parker, J.E.E. (2014) Serum-free hepatocytic transdifferentiation of pancreatic progenitor cells facilitated by extracellular matrix proteins. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). pp. 6-7.

Greene, I.D., Mastaglia, F., Meloni, B.P., West, K.A., Chieng, J., Mitchell, C.J., Gai, W-P and Boulos, S. (2013) Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation. Journal of Neuroscience Research, 92 (4). pp. 506-516.

Grifoni, A., Angelo, M., Sidney, J., Paul, S., Peters, Bjoern, de Silva, A.D., Phillips, E., Mallal, S., Diehl, S.A., Botten, J., Boyson, J., Kirkpatrick, B.D., Whitehead, S.S., Durbin, A.P., Sette, A., Weiskopf, D. and García-Sastre, A. (2017) Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Journal of Virology, 91 (8).

Grifoni, A., Angelo, M.A., Lopez, B., O’Rourke, P.H., Sidney, J., Cerpas, C., Balmaseda, A., Silveira, C.G.T., Maestri, A., Costa, P.R., Durbin, A.P., Diehl, S.A., Phillips, E., Mallal, S., De Silva, A.D., Nchinda, G., Nkenfou, C., Collins, M.H., de Silva, A.M., Lim, M.Q., Macary, P.A., Tatullo, F., Solomon, T., Satchidanandam, V., Desai, A., Ravi, V., Coloma, J., Turtle, L., Rivino, L., Kallas, E.G., Peters, B., Harris, E., Sette, A. and Weiskopf, D. (2017) Global assessment of dengue Virus-Specific CD4+ T cell responses in Dengue-Endemic areas. Frontiers in Immunology, 8 .

Groza, T., Kohler, S., Doelken, S., Collier, N., Oellrich, A., Smedley, D., Couto, F.M., Baynam, G., Zankl, A. and Robinson, P.N. (2015) Automatic concept recognition using the Human Phenotype Ontology reference and test suite corpora. Database, 2015 . pp. 1-13.

Gupta, V.B., Hone, E., Pedrini, S., Doecke, J., O'Bryant, S., James, I., Bush, A.I., Rowe, C.C., Villemagne, V.L., Ames, D, Masters, C.L. and Martins, R.N. (2017) Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 8 . pp. 60-72.

Gutteridge, D.H. and Mastaglia, F.L. (2017) Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: A cautionary tale. Internal Medicine Journal, 47 (10). pp. 1199-1201.

Haas, D.W., Kuritzkes, D.R., Ritchie, M.D., Amur, S., Gage, B.F., Maartens, G., Masys, D., Fellay, J., Phillips, E., Ribaudo, H.J., Freedberg, K.A., Petropoulos, C., Manolio, T.A., Gulick, R.M., Haubrich, R., Kim, P., Dehlinger, M., Abebe, R. and Telenti, A. (2011) Pharmacogenomics of HIV therapy: Summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases. HIV Clinical Trials, 12 (5). pp. 277-285.

Ham, S., Meachem, S.J., Choong, C.S., Charles, A.K., Baynam, G.S., Jones, T.W., Samarajeewa, N.U., Simpson, E.R. and Brown, K.A. (2013) Overexpression of aromatase associated with loss of heterozygosity of the STK11 gene accounts for prepubertal gynecomastia in boys with Peutz-Jeghers Syndrome. Journal of Clinical Endocrinology & Metabolism, 98 (12). E1979-E1987.

Hammond, E., Lucas, A., Lucas, M., Phillips, E. and Gaudieri, S. (2010) Vaniprevir: HCV NS3/4A protease inhibitor treatment of hepatitis C. Drugs of the Future, 35 (10). pp. 803-813.

Hammond, E., McKinnon, E., Glendenning, P., Williams, R., Mallal, S. and Phillips, E. (2012) Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clinical Endocrinology, 76 (2). pp. 201-206.

Harcourt, G.C., Lucas, M., Sheridan, I., Barnes, E., Phillips, R. and Klenerman, P. (2004) Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA-DR11 restricted epitopes. Journal of Viral Hepatitis, 11 (4). pp. 324-331.

Hart, P.H., Lucas, R.M., Booth, D.R., Carroll, W.M., Nolan, D., Cole, J.M., Jones, A.P. and Kermode, A.G. (2017) Narrowband UVB phototherapy for clinically isolated syndrome: A trial to deliver the benefits of Vitamin D and other UVB-Induced molecules. Frontiers in Immunology, 8 .

Harutyunyan, A.S., Giambruno, R., Krendl, C., Stukalov, A., Klampfl, T., Berg, T., Chen, D., Milosevic Feenstra, J.D., Jager, R., Gisslinger, B., Gisslinger, H., Rumi, E., Passamonti, F., Pietra, D., Muller, A.C., Parapatics, K., Breitwieser, F.P., Herrmann, R., Colinge, J., Bennett, K.L., Superti-Furga, G., Cazzola, M., Hammond, E. and Kralovics, R. (2016) Germline RBBP6 mutations in familial myeloproliferative neoplasm. Blood, 127 (3). pp. 362-365.

Harvey, M.L., Dadour, I.R. and Gaudieri, S. (2003) Mitochondrial DNA cytochrome oxidase I gene: potential for distinction between immature stages of some forensically important fly species (Diptera) in western Australia. Forensic Science International: Genetics, 131 (2-3). pp. 134-139.

Hazeldine, S., Trinder, D. and Olynyk, J.K. (2013) Non-Hfe iron overload: Is Phlebotomy the answer? Current Hepatitis Reports, 12 (1). pp. 20-27.

Hemler, J.A., Phillips, E.J., Mallal, S.A. and Kendall, P.L. (2015) The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. Annals of Allergy, Asthma & Immunology, 115 (6). pp. 471-476.

Herrmann, R., Thom, J., Wood, A., Phillips, M, Muhammad, S. and Baker, R. (2013) Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and Haemostasis, 111 (5). pp. 989-995.

Herrmann, S., McKinnon, E., Hyland, N.B., Lalanne, C., Mallal, S., Nolan, D., Chassany, O. and Duracinsky, M. (2013) HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection. Health and Quality of Life Outcomes, 11 (1).

Herrmann, S., Wardrop, J., John, M., Gaudieri, S., Lucas, M., Mallal, S. and Nolan, D. (2012) The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report. Sexual Health, 9 (5). pp. 407-413.

Herrmann, S.E., McKinnon, E.J., Williams, L.J., John, M., Mallal, S., Lucas, M. and Nolan, D.A. (2010) Use of alcohol, nicotine and other drugs in the Western Australian HIV Cohort study. Sexual Health, 9 (2). pp. 199-201.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E.J., Huang, J.C., Riadi, G., Mallal, S. and Jojic, N. (2011) Mapping the Landscape of Host-Pathogen Coevolution: HLA Class I Binding and Its Relationship with Evolutionary Conservation in Human and Viral Proteins. Journal of Virology, 85 (3). pp. 1310-1321.

Hertz, T., Oshansky, C., Roddam, P., DeVincenzo, J., Caniza, M., Jojic, N., Mallal, S., Phillips, E., James, I., Thomas, P., Halloran, M. and Corey, L. (2013) HLA targeting efficiency correlates with human T cell response magnitude and with mortality from influenza A infection. The Journal of Immunology, 190 (Supp. 1). 49.21.

Hertz, T., Oshansky, C.M., Roddam, P.L., DeVincenzo, J.P., Caniza, M.A., Jojic, N., Mallal, S., Phillips, E., James, I., Halloran, M.E., Thomas, P.G. and Corey, L. (2013) HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection. Proceedings of the National Academy of Sciences, 110 (33). pp. 13492-13497.

Hew, M., McKinnon, E.J., Kirwin, B., Martinez, O.P. and Lucas, M. (2015) Systemic lupus erythematosus patients and tertiary specialist care - simple considerations dropping through the cracks: Osteoporosis monitoring as an example. Internal Medicine Journal, 45 (5). p. 596.

Hew, M., O'Connor, K., Edel, M. and Lucas, M. (2015) The possible future roles for iPSC-Derived therapy for autoimmune diseases. Journal of Clinical Medicine, 4 (6). pp. 1193-1206.

Hilner, J. E., Perdue, L. H., Sides, E. G., Pierce, J. J., Wagner, A. M., Aldrich, A., Loth, A., Albret, L., Wagenknecht, L. E., Nierras, C., Akolkar, B., Gaudieri, S., James, I., McKinnon, E. and Nolan, D. (2010) Designing and implementing sample and data collection for an international genetics study: the Type 1 Diabetes Genetics Consortium (T1DGC). Clinical Trials, 7 (1 Suppl). S5-S32.

Holm, M. (2014) Interview administered versus self-administered PROQOL-HIV scale in India. Quality of Life Research, 23 (Supp. 1). pp. 84-85.

Hooper, A.J.., Robertson, K., Ng, L., Kattampallil, J.S., Latchem, D., Willsher, P.C., Thom, J., Baker, R.I. and Burnett, J.R. (2009) A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendency. Clinica Chimica Acta, 409 (1-2). pp. 136-139.

House, M.J., Bangma, S.J., Thomas, M., Gan, E.K., Ayonrinde, O.T., Adams, L.A., Olynyk, J.K. and St Pierre, T.G. (2015) Texture-based classification of liver fibrosis using MRI. Journal of Magnetic Resonance Imaging, 41 (2). pp. 322-328.

House, M.J., Gan, E.K., Adams, L.A., Ayonrinde, O.T., Bangma, S.J., Bhathal, P.S., Olynyk, J.K. and St Pierre, T.G. (2013) Diagnostic performance of a rapid magnetic resonance imaging method of measuring hepatic steatosis. PLoS ONE, 8 (3). e59287.

Hu, H., Haas, S.A., Chelly, J., Van Esch, H., Raynaud, M., de Brouwer, A.P.M., Weinert, S., Froyen, G., Frints, S.G M, Laumonnier, F., Zemojtel, T., Love, M.I., Richard, H., Emde, A-K, Bienek, M., Jensen, C., Hambrock, M., Fischer, U., Langnick, C., Feldkamp, M., Wissink-Lindhout, W., Lebrun, N., Castelnau, L., Rucci, J., Montjean, R., Dorseuil, O., Billuart, P., Stuhlmann, T., Shaw, M., Corbett, M.A., Gardner, A., Willis-Owen, S., Tan, C., Friend, K.L., Belet, S., van Roozendaal, K.E.P., Jimenez-Pocquet, M., Moizard, M-P, Ronce, N., Sun, R., O'Keeffe, S., Chenna, R., van Bömmel, A., Göke, J., Hackett, A., Field, M., Christie, L., Boyle, J., Haan, E., Nelson, J., Turner, G., Baynam, G., Gillessen-Kaesbach, G., Müller, U., Steinberger, D., Budny, B., Badura-Stronka, M., Latos-Bieleńska, A., Ousager, L.B., Wieacker, P., Rodríguez Criado, G., Bondeson, M-L, Annerén, G., Dufke, A., Cohen, M., Van Maldergem, L., Vincent-Delorme, C., Echenne, B., Simon-Bouy, B., Kleefstra, T., Willemsen, M., Fryns, J-P, Devriendt, K., Ullmann, R., Vingron, M., Wrogemann, K., Wienker, T.F., Tzschach, A., van Bokhoven, H., Gecz, J., Jentsch, T.J., Chen, W., Ropers, H-H and Kalscheuer, V.M. (2016) X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes. Molecular Psychiatry, 21 (1). pp. 133-148.

Huang, R-C, Beilin, L.J., Ayonrinde, O., Mori, T.A., Olynyk, J.K., Burrows, S., Hands, B. and Adams, L.A. (2013) Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology, 58 (4). pp. 1306-1314.

Huang, Y., Wang, G., Rowe, D., Wang, Y., Kwok, J.B.J., Xiao, Q., Mastaglia, F., Liu, J., Chen, S-D and Halliday, G. (2015) SNCA Gene, but not MAPT, influences onset age of Parkinson’s Disease in Chinese and Australians. BioMed Research International, 2015 . pp. 1-6.

Huang, Y., Wang, Y., Zhou, Y., Huang, Q., Sun, X., Chen, C., Fang, L., Long, Y., Yang, H., Wang, H., Li, C., Lu, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China. Journal of the Neurological Sciences, 372 . pp. 152-156.

Hull, Russell D., Schellong, S.M, Monreal, M., Samama, M.M., Nicol, P, Vicaut, E, Turpie, A.G., Yusen, R.D. and Baker, R. (2010) Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility. Annals of Internal Medicine, 153 (1). p. 8.

Jing, L., Laing, K.J., Dong, L., Russell, R.M., Barlow, R.S., Haas, J.G., Ramchandani, M.S., Johnston, C., Buus, S., Redwood, A.J., White, K.D., Mallal, S.A., Phillips, E.J., Posavad, C.M., Wald, A. and Koelle, D.M. (2016) Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses. The Journal of Immunology, 196 (5). pp. 2205-2218.

John, M. (2016) Allergen-specific IgE. Medical Forum (WA), August .

John, M. and Gaudieri, S. (2014) Influence of HIV and HCV on T cell antigen presentation and challenges in the development of vaccines. Frontiers in Microbiology, 5 (art. 514). pp. 1-6.

John, M., Heckerman, D., James, I., Park, L.P., Carlson, J.M., Chopra, A., Gaudieri, S., Nolan, D., Haas, D.W., Riddler, S.A., Haubrich, R. and Mallal, S. (2010) Adaptive interactions between HLA and HIV-1: highly divergent selection imposed by HLA class I molecules with common supertype motifs. The Journal of Immunology, 184 (8). pp. 4368-4377.

John, M., Lam, M., Latham, B., Saker, B. and French, M.A.H. (2000) Nephrotic syndrome in a patient with IgA deficiency-associated mesangioproliferative glomerulonephritis. Pathology, 32 (1). pp. 56-58.

Johnson, L., James, I., Rodrigues, J., Stell, R., Thickbroom, G. and Mastaglia, F. (2013) Clinical and posturographic correlates of falling in Parkinson's disease. Movement Disorders, 28 (9). pp. 1250-1256.

Johnson, L., Rodrigues, J., Teo, W-P, Walters, S., Stell, R., Thickbroom, G. and Mastaglia, F. (2015) Interactive effects of GPI stimulation and levodopa on postural control in Parkinson's disease. Gait & Posture, 41 (4). pp. 929-934.

Johnstone, D., Riveros, C., Heidari, M., Graham, R., Trinder, D., Berretta, R., Olynyk, J., Scott, R., Moscato, P. and Milward, E. (2013) Evaluation of different normalization and analysis procedures for illumina gene expression microarray data involving small changes. Microarrays, 2 (2). pp. 131-152.

Jones, A.P., Kermode, A.G., Lucas, R.M., Carroll, W.M., Nolan, D. and Hart, P.H. (2016) Circulating immune cells in multiple sclerosis. Clinical & Experimental Immunology, 187 (2). pp. 193-203.

Jones, A.P., Trend, S., Byrne, S.N., Fabis-Pedrini, M.J., Geldenhuys, S., Nolan, D., Booth, D.R., Carroll, W.M., Lucas, R.M., Kermode, A.G. and Hart, P.H. (2017) Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: Clues to the development of multiple sclerosis. Clinical & Translational Immunology, 6 (5).

Jorgensen, A., O’Leary, P., James, I., Skeaff, S. and Sherriff, J. (2016) Assessment of breast milk iodine concentrations in lactating women in Western Australia. Nutrients, 8 (11). p. 699.

Kamara, D.A., Ryom, L., Ross, M., Kirk, O., Reiss, P., Morlat, P., Moranne, O., Fux, C.A., Mocroft, A., Sabin, C., Lundgren, J.D., Smith, C.J. and Nolan, D. (2014) Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study. BMC Nephrology, 15 (1).

Kanyenda, L.J., Verdile, G., Martins, R., Meloni, B.P., Chieng, J., Mastaglia, F., Laws, S.M., Anderton, R.S. and Boulos, S. (2014) Is cholesterol and Amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated neuroprotection is Reliant on CD147. Journal of Alzheimer's disease : JAD, 39 (3). pp. 545-556.

Karlin, E. and Phillips, E. (2014) Genotyping for severe drug hypersensitivity. Current Allergy and Asthma Reports, 14 (3).

Karnes, J.H., Bastarache, L., Shaffer, C.M., Gaudieri, S., Xu, Y., Glazer, A.M., Mosley, J.D., Zhao, S., Raychaudhuri, S., Mallal, S., Ye, Z., Mayer, J.G., Brilliant, M.H., Hebbring, S.J., Roden, D.M., Phillips, E.J. and Denny, J.C. (2017) Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants. Science Translational Medicine, 9 (389). eaai8708.

Karnes, J.H., Shaffer, C.M., Bastarache, L., Gaudieri, S., Glazer, A.M., Steiner, H.E., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Comparison of HLA allelic imputation programs. PLoS ONE, 12 (2).

Karnes, J.H., Shaffer, C.M., Cronin, R., Bastarache, L., Gaudieri, S., James, I., Pavlos, R., Steiner, H., Mosley, J.D., Mallal, S., Denny, J.C., Phillips, E.J. and Roden, D.M. (2017) Influence of human leukocyte antigen (HLA) alleles and killer cell immunoglobulin-like receptors (KIR) types on heparin-induced thrombocytopenia (HIT). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37 (9). pp. 1164-1171.

Keane, N., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T Cell immunodominance hierarchy in primary HIV infection prior to seroconversion. Retrovirology, 9 (Suppl 2).

Keane, N., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. Retrovirology, 9 (Suppl 2). P243.

Keane, N.M. and John, M. (2011) Biomarkers of natural and vaccine immunity against HIV. Biomarkers in Medicine, 5 (2). pp. 113-116.

Keane, N.M., Pavlos, R.K., McKinnon, E., Lucas, A., Rive, C., Blyth, C.C., Dunn, D., Lucas, M., Mallal, S. and Phillips, E. (2014) HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity. AIDS, 28 (13). pp. 1891-1901.

Keane, N.M., Price, P., Stone, S.F., John, M., Murray, R.J. and French, M.A. (2000) Assessment of Immune Function by Lymphoproliferation Underestimates Lymphocyte Functional Capacity in HIV Patients Treated with Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses, 16 (18). pp. 1991-1996.

Keane, N.M., Roberts, S.G., Almeida, C.M., Krishnan, T., Chopra, A., Demaine, E., Laird, R., Tschochner, M., Carlson, J.M., Mallal, S., Heckerman, D., James, I. and John, M. (2012) High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection. Immunology and Cell Biology, 90 (2). pp. 224-234.

Kesselring, A.M., Wit, F.W., Sabin, C.A., Lundgren, J.D., Gill, M.J., Gatell, J.M., Rauch, A., Montaner, J.S., de Wolf, F., Reiss, P., Mocroft, A. and Phillips, E. (2009) Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS, 23 (13). pp. 1689-1699.

Kim, A.Y., Lauer, G.M., Ouchi, K., Addp, M.M., Lucas, M., Schulze zur Wiesch, J., Timm, J., Boczanowski, M., Duncan, J.E., Wurcel, A.G., Casson, D., Chung, R.T., Draenert, R., Klenerman, P. and Walker, B.D. (2004) The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood, 105 (3). pp. 1170-1178.

Knezevic, B., Sprigg, D., Seet, J., Trevenen, M., Trubiano, J., Smith, W., Jeelall, Y., Vale, S., Loh, R., McLean-Tooke, A. and Lucas, M. (2016) The revolving door: Antibiotic allergy labelling in a tertiary care centre. Internal Medicine Journal, 46 (11). pp. 1276-1283.

Komatsu, H., Inui, A., Sogo, T., Fujisawa, T., Nagasaka, H., Nonoyama, S., Sierro, S., Northfield, J., Lucas, M., Vargas, A. and Klenerman, P. (2006) Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses. Immunity & Ageing, 3 (1). p. 11.

Kongmaroeng, C., Romphruk, A., Puapairoj, C., Leelayuwat, C., Kulski, J.K., Inoko, H., Dunn, D.S. and Romphruk, A.V. (2015) HLA alleles and haplotypes in Burmese (Myanmarese) and Karen in Thailand. Tissue Antigens, 86 (3). pp. 199-204.

Konvinse, K.C., Phillips, E.J., White, K.D. and Trubiano, J.A. (2016) Old dog begging for new tricks: current practices and future directions in the diagnosis of delayed antimicrobial hypersensitivity. Current Opinion in Infectious Diseases, 29 (6). pp. 561-576.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Characterizing immune responses in severe T-cell mediated adverse drug reaction. The Journal of Immunology, 196 (Supp. 1).

Kostenko, L., Kjer-Nielsen, L., Nicholson, I., Hudson, F., Lucas, A., Foley, B., Chen, K., Lynch, K., Nguyen, J., Wu, A.H.B., Tait, B.D., Holdsworth, R., Mallal, S., Rossjohn, J., Bharadwaj, M. and McCluskey, J. (2011) Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity. Tissue Antigens, 78 (1). pp. 11-20.

Kruger, P.C., Leahy, M.F. and Olynyk, J.K. (2012) Assessing iron overload: Are we there yet? Clinical Cancer Research, 18 (23). pp. 6395-6397.

Kung, S., Walters, M., Claes, P., LeSouef, P., Goldblatt, J., Martin, A., Balasubramaniam, S. and Baynam, G. (2015) Monitoring of therapy for mucopolysaccharidosis Type I Using dysmorphometric facial phenotypic signatures. JMID Reports, 22 . pp. 99-106.

Köhn-Gaone, J., Gogoi-Tiwari, J., Ramm, G.A., Olynyk, J.K. and Tirnitz-Parker, J.E.E. (2015) The role of liver progenitor cells during liver regeneration, fibrogenesis and carcinogenesis. American Journal of Physiology: Gastrointestinal and Liver Physiology, 310 (3). G143-G154.

Laird, R., Dawkins, R.L. and Gaudieri, S. (2005) Use of the genomic matching technique to complement multiplex STR profiling reduces DNA profiling costs in high volume crimes and intelligence led screens. Forensic Science International: Genetics, 151 (2-3). pp. 249-257.

Laird, R., Schneider, P.M. and Gaudieri, S. (2007) Forensic STRs as potential disease markers: A study of VWA and von Willebrand's Disease. Forensic Science International: Genetics, 1 (3-4). pp. 253-261.

Lalanne, C., Armstrong, A.R., Herrmann, S., Le Coeur, S., Carrieri, P., Chassany, O. and Duracinsky, M. (2014) Psychometric assessment of health-related quality of life and symptom experience in HIV patients treated with antiretroviral therapy. Quality of Life Research, 24 (6). pp. 1407-1418.

Langan, L.L., D'Orsogna, L.J., Park, L.P., Hughes, T.L., Irish, A., Luxton, G., Witt, C.S. and Christiansen, F.T. (2006) HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study. Clinical Transplants . pp. 219-25.

Lassen, M.R., Gallus, A., Raskob, G.E., Pineo, G., Chen, D., Ramirez, L.M. and Baker, R.I. (2010) Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement. New England Journal of Medicine, 363 (26). pp. 2487-2498.

Lauer, G.M., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A.Y., Day, C.L., Robbins, G.K., Casson, D.R., Reiser, M., Dusheiko, G., Allen, T.M., Chung, R.T., Walker, B.D. and Klenerman, P. (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology, 127 (3). pp. 924-936.

Lauer, G.M., Lucas, M., Timm, J., Ouchi, K., Kim, A.Y., Day, C.L., zur Wiesch, J.S., Paranhos-Baccala, G., Sheridan, I., Casson, D.R., Reiser, M., Gandhi, R.T., Li, B., Allen, T.M., Chung, R.T., Klenerman, P. and Walker, B.D. (2005) Full-breadth analysis of CD8+ T-cell responses in acute Hepatitis C virus infection and early therapy. Journal of Virology, 79 (20). pp. 12979-12988.

Law, M.G., Woolley, I., Templeton, D.J., Roth, N., Chuah, J., Mulhall, B., Canavan, P., McManus, H., Cooper, D.A., Petoumenos, K. and Nolan, D. (2011) Trends in detectable viral load by calendar year in the Australian HIV observational database. Journal of the International AIDS Society, 14 (1). pp. 10-16.

Li, H., Blair, L., Chen, Y., Learn, G., Pfafferott, K., John, M., Bhattacharya, T., Hahn, B.H., Mallal, S., Shaw, G.M. and Bar, K.J. (2013) Molecular mechanisms of HIV Type 1 prophylaxis failure revealed by Single-genome sequencing. Journal of Infectious Diseases, 208 (10). pp. 1598-1603.

Li, R., Sun, X., Shu, Y., Wang, Yuge, Xiao, Li, Wang, Z., Hu, X., Kermode, A.G. and Qiu, W. (2017) Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients. Journal of Neuroimmunology, 313 . pp. 56-60.

Lippert, E., Girodon, F., Hammond, E., Jelinek, J., Reading, N.S., Fehse, B., Hanlon, K., Hermans, M., Richardson, C., Swierczek, S., Ugo, V., Carillo, S., Harrivel, V., Marzac, C., Pietra, D., Sobas, M., Mounier, M., Migeon, M., Ellard, S., Kroger, N., Herrmann, R., Prchal, J.T., Skoda, R.C. and Hermouet, S. (2009) Concordance of assays designed for the quantification of JAK2V617F: a multicenter study. Haematologica, 94 (1). pp. 38-45.

Loh, J.T., Gaddy, J.A., Algood, H.M.S., Gaudieri, S., Mallal, S. and Cover, T.L. (2015) Helicobacter pylori adaptation in vivoin response to a high salt diet. Infection and Immunity .

Longman-Jacobsen, N., Williamson, J.F., Dawkins, R.L. and Gaudieri, S. (2003) In polymorphic genomic regions indels cluster with nucleotide polymorphism: Quantum Genomics. Gene, 312 . pp. 257-261.

Lu, T.T., Dai, Y.Q., Wang, Y.G., Fang, L., Li, R., Kermode, A.G. and Qju, W. (2016) Rapid exacerbation of neuromyelitis optica after rituximab treatment. Multiple Sclerosis Journal, 22 (3). p. 440.

Lucas, A.D., Gaudieri, S., Rauch, A., Nolan, D. and Mallal, S.A. (2005) Cellular tropism of HIV-1 mediated and constrained by co-receptor dependencies. Journal of Viral Entry, 1 (1). pp. 17-27.

Lucas, M., Day, C. L., Wyer, J. R., Cunliffe, S. L., Loughry, A., McMichael, A. J. and Klenerman, P. (2004) Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells. Journal of Virology, 78 (13). pp. 7284-7287.

Lucas, M. and Gaudieri, S. (2012) The interferon family as biomarkers of disease: renaissance of the innate immune system. Biomarkers in Medicine, 6 (2). pp. 133-135.

Lucas, M. and Gaudieri, S. (2013) The role of biomarkers in the prevention of globally important diseases. Biomarkers in Medicine, 7 (3). pp. 331-332.

Lucas, M., Jeelall, Y., Kavanagh, S., Bundell, C., Hew, M., Wood, B.A., Joske, D. and McLean-Tooke, A. (2016) B-cell small lymphocytic lymphoma associated with extremely high total IgE and cutaneous vasculitis. The Journal of Allergy and Clinical Immunology: In Practice, 4 (3). pp. 552-554.

Lucas, M., Vargas-Cuero, A. L., Lauer, G. M., Barnes, E., Willberg, C. B., Semmo, N., Walker, B. D., Phillips, R. and Klenerman, P. (2004) Pervasive Influence of Hepatitis C Virus on the Phenotype of Antiviral CD8+ T Cells. The Journal of Immunology, 172 (3). pp. 1744-1753.

Luo, Y-B and Mastaglia, F.L. (2015) Dermatomyositis, polymyositis and immune-mediated necrotising myopathies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1852 (4). pp. 622-632.

Luo, Y-B, Mastaglia, F.L. and Wilton, S.D. (2014) Normal and aberrant splicing of LMNA. Journal of Medical Genetics, 51 (4). pp. 215-223.

Luo, Y-B, Mitrpant, C., Adams, A.M., Johnsen, R.D., Fletcher, S., Mastaglia, F.L. and Wilton, S.D. (2014) Antisense oligonucleotide induction of progerin in human myogenic cells. PLoS ONE, 9 (6).

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Luquetti, D., Claes, P., Liberton, D.K., Daniels, K., Rosana, K.M., Quillen, E.E., Pearson, L.N., McEvoy, B., Bauchet, M., Zaidi, A.A., Yao, W., Tang, H, Barsh, G.S., Absher, D.M., Puts, D.A., Rocha, J., Beleza, S., Pereira, R.W., Baynam, G., Suetens, P., Vandermeulen, D., Wagner, J.K., Boster, J.S. and Shriver, M.D. (2014) Modeling 3D Facial Shape from DNA. PLoS Genetics, 10 (3). e1004224.

Ma, M.X., John, M. and Forbes, G.M. (2013) Diagnostic dilemmas in celiac disease. Expert Review of Gastroenterology & Hepatology, 7 (7). pp. 643-655.

Magaret, A., Dong, L., John, M., Mallal, S.A., James, I., Warren, T., Gaudieri, S., Koelle, D.M. and Wald, A. (2016) HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesions. Genes and Immunity, 17 (7). pp. 412-418.

Mahurkar, S., Moldovan, M., Suppiah, V., Sorosina, M., Clarelli, F., Liberatore, G., Malhotra, S., Montalban, X., Antigüedad, A., Krupa, M., Jokubaitis, V.G., McKay, F.C., Gatt, P.N., Fabis-Pedrini, M.J., Martinelli, V., Comi, G., Lechner-Scott, J., Kermode, A.G., Slee, M., Taylor, B.V., Vandenbroeck, K., Comabella, M., Boneschi, F.M. and King, C. (2017) Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study. The Pharmacogenomics Journal, 17 (4). pp. 312-318.

Maker, G.L., Siva, B., Batty, K.T, Trengove, R.D., Ferrari, P. and Olynyk, J.K. (2013) Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology, 18 (3). pp. 188-193.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. Journal of the International AIDS Society, 15 (6(Suppl 4)). p. 18119.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Cid, J.F., Hay, P., Nolan, D., Hughes, S., Hughes, A., Ryan, S., Fitch, N., Thorborn, D. and Benbow, A. (2008) HLA-B*5701 screening for hypersensitivity to Abacavir. The New England Journal of Medicine, 358 (6). pp. 568-579.

Martin, A., Amin, J., Cooper, D.A., Carr, A., Kelleher, A.D., Bloch, M., Baker, D., Woolley, I., Emery, S. and Nolan, D. (2010) Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: A randomized clinical trial. AIDS, 24 (17). pp. 2657-2663.

Martin, A. M., Freitas, E. M., Witt, C. S. and Christiansen, F. T. (2000) The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster. Immunogenetics, 51 (4-5). pp. 268-280.

Martin, A.M., Krueger, R., Almeida, C.A., Nolan, D., Phillips, E. and Mallal, S. (2006) A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenetics and Genomics, 16 (5). pp. 353-357.

Martin, J.H., Phillips, E., Thomas, D. and Somogyi, A.A. (2015) Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes. British Journal of Clinical Pharmacology, 80 (5). pp. 929-931.

Martinez-Picado, J., Prado, J.G., Fry, E.E., Pfafferott, K., Leslie, A., Chetty, S., Thobakgale, C., Honeyborne, I., Crawford, H., Matthews, P., Pillay, T., Rousseaux, C., Mullins, J.I., Brander, C., Walker, B.D., Stuart, D.I., Kiepiela, P. and Goulder, P. (2006) Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. Journal of Virology, 80 (7). pp. 3617-3623.

Martínez, E. and Nolan, D. (2008) Long-term management of the HIV-infected patient - Tailoring highly active antiretroviral therapy to optimise therapeutic outcome. European Infectious Diseases, 2 (2). pp. 16-22.

Mastaglia, F.L. and Needham, M. (2015) Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. Journal of Clinical Neuroscience, 22 (1). pp. 6-13.

Mastaglia, F.L., Rojana-udomsart, A., James, I., Needham, M., Day, T.J., Kiers, L., Corbett, J.A., Saunders, A.M., Lutz, M.W. and Roses, A.D. (2013) Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscular Disorders, 23 (12). pp. 969-974.

Maxwell, S., James, I., Dickinson, J.E. and O'Leary, P. (2016) First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21. Australian and New Zealand Journal of Obstetrics and Gynaecology, 56 (1). pp. 29-35.

Mbae, C., Mulinge, E., Guleid, F., Wainaina, J., Waruru, A., Njiru, Z.K. and Kariuki, S. (2016) Molecular characterization of Giardia duodenalis in children in Kenya. BMC Infectious Diseases, 16 (1).

McGettigan, B.D., Hew, M., Phillips, E. and McLean-Tooke, A. (2012) Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. BMJ: Case Reports, 2012 (21 Sept 2012).

McGovern, A.M., Androga, G.O., Knight, D.R., Watson, M.W., Elliott, B., Foster, N.F., Chang, B.J. and Riley, T.V. (2017) Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027. PLoS ONE, 12 (11). e0187658.

McKay, F., Gatt, P.N., Fewings, N., Schibeci, S.D., Parnell, G., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2015) Characterising the Molecular Phenotypes of MS: heredity, gene expression modules, dysregulated immune cell subsets and response to therapy. Multiple Sclerosis Journal, 21 (14). NP1-NP32.

McKay, F.C., Gatt, P.N., Fewings, N., Parnell, G.P., Schibeci, S.D., Basuki, M.A.I., Powell, J.E., Goldinger, A., Fabis-Pedrini, M.J., Kermode, A.G., Burke, T., Vucic, S., Stewart, G.J. and Booth, D.R. (2016) The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies. Clinical Immunology, 163 . pp. 96-107.

McKenzie, E.J., Taylor, P., Stillion, R.J., Lucas, A.D., Harris, J., Gordon, S. and Martinez-Pomares, L. (2007) Mannose receptor expression and function define a new population of murine dendritic cells. Journal of Immunology, 178 (8). pp. 4975-4983.

McKinnon, E., Castley, A., Payne, L., Pummer, S. and Nolan, D. (2016) Determinants of residual viraemia during combination HIV treatment: Impacts of baseline HIV RNA levels and treatment choice. HIV Medicine, 17 (7). pp. 495-504.

McKinnon, E.J., Chua, A.C.G., Oddy, W., Adams, L.A., Ayonrinde, O.T. and Olynyk, J.K. (2014) Evaluation of serum ferritin as a marker of iron status in young Australian adults. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 146.

McKinnon, E.J., Rossi, E., Beilby, J.P., Trinder, D. and Olynyk, J.K. (2014) Factors that affect serum levels of ferritin in Australian adults and implications for Follow-up. Clinical Gastroenterology and Hepatology, 12 (1). pp. 101-108.

McLure, C.A., Dawkins, R.L., Williamson, J.F., Davies, R.A, Berry, J., Longman-Jacobsen, N., Laird, R. and Gaudieri, S. (2004) Amino Acid Patterns Within Short Consensus Repeats Define Conserved Duplicons Shared by Genes of the RCA Complex. Journal of Molecular Evolution, 59 (2). pp. 143-157.

McWhorter, A.R., Smith, L.M., Shellam, G.R. and Redwood, A.J. (2015) Murine cytomegalovirus strains co-replicate at multiple tissue sites and establish co-persistence in salivary glands in the absence of Ly49H-mediated competition. Journal of General Virology, 96 (Pt.5). pp. 1127-1137.

Merani, S., Lucas, M., Deshpande, P., Pfafferott, K., Chopra, A., Cooper, D., Leary, S., Luciani, F. and Gaudieri, S. (2017) Influence of transmitted virus on the host's immune response: A case study. Viral Immunology, 30 (7).

Merani, S., Petrovic, D., James, I., Chopra, A., Cooper, D., Freitas, E., Rauch, A., di Iulio, J., John, M., Lucas, M., Fitzmaurice, K., McKiernan, S., Norris, S., Kelleher, D., Klenerman, P. and Gaudieri, S. (2011) Effect of immune pressure on hepatitis C virus evolution: Insights from a single-source outbreak. Hepatology, 53 (2). pp. 396-405.

Metharom, P., Berndt, M.C., Baker, R.I. and Andrews, R.K. (2015) Current state and novel approaches of antiplatelet therapy. Arteriosclerosis, Thrombosis, and Vascular Biology, 35 (6). pp. 1327-1338.

Metushi, I.G., Wriston, A., Banerjee, P., Gohlke, B.O., English, A.M., Lucas, A., Moore, C., Sidney, J., Buus, S., Ostrov, D.A., Mallal, S., Phillips, E., Shabanowitz, J., Hunt, D.F., Preissner, R. and Peters, B. (2015) Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity. PloS one, 10 (5). e0124878.

Meyer, M., Gaudieri, S., Rhodes, D.A. and Trowsdale, J. (2003) Cluster of TRIM genes in the human MHC class I region sharing the B30.2 domain. Tissue Antigens, 61 (1). pp. 63-71.

Milpied-Homsi, B., Moran, E.M. and Phillips, E.J. (2014) Antiviral Drug Allergy. Immunology and Allergy Clinics of North America, 34 (3). pp. 645-662.

Molster, C.M., Lister, K., Metternick-Jones, S., Baynam, G., Clarke, A.J., Straub, V., Dawkins, H.J.S. and Laing, N. (2017) Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments. Frontiers in Public Health, 5 . Article 25.

Morabito, K.M., Ruckwardt, T.R., Redwood, A.J., Moin, S.M., Price, D.A. and Graham, B.S. (2016) Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung. Mucosal Immunology, 10 . pp. 545-554.

Moran, E.M. and Mastaglia, F.L. (2014) Cytokines in immune-mediated inflammatory myopathies: Cellular sources, multiple actions and therapeutic implications. Clinical & Experimental Immunology, 178 (3). pp. 405-415.

Moran, E.M. and Mastaglia, F.L. (2014) The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscular Disorders, 24 (11). pp. 943-952.

Murphy, A.A., Redwood, A.J. and Jarvis, M.A. (2016) Self-disseminating vaccines for emerging infectious disease. Expert Review of Vaccines, 15 (1). pp. 31-39.

Murphy, N.M., Burton, M., Powell, D.R., Rossello, F.J., Cooper, D., Chopra, A., Hsieh, M.J., Sayer, D.C., Gordon, L., Pertile, M.D., Tait, B.D., Irving, H.R. and Pouton, C.W. (2016) Haplotyping the human leukocyte antigen system from single chromosomes. Scientific Reports, 6 . p. 30381.

Nakano, H., Chua, A.C.G., Klopcic, B.R.S., Ho, D.S., Fu, S.K., Forrest, C.H., Croft, K.D., Olynyk, J.K., Lawrance, I.C. and Trinder, D. (2013) Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PloS one, 8 (11). e78850.

Needham, M. and Mastaglia, F.L. (2017) Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects. Expert Opinion on Orphan Drugs, 5 (5). pp. 431-443.

Needham, M. and Mastaglia, F.L. (2015) Immunotherapies for Immune-Mediated myopathies: A current perspective. Neurotherapeutics, 13 (1). pp. 132-146.

Needham, M. and Mastaglia, F.L. (2016) Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment. Clinical Neurophysiology, 127 (5). pp. 1764-1773.

Needham, M. and Mastaglia, F.L. (2014) Statin myotoxicity: A review of genetic susceptibility factors. Neuromuscular Disorders, 24 (1). pp. 4-15.

Nitschke, K., Barriga, A., Schmidt, J., Timm, J., Viazov, S., Kuntzen, T., Kim, A.Y., Lauer, G.M., Allen, T.M., Gaudieri, S., Rauch, A., Lange, C.M., Sarrazin, C., Eiermann, T., Sidney, J., Sette, A., Thimme, R., López, D. and Neumann-Haefelin, C. (2013) HLA-B∗27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. Journal of Hepatology, 60 (1). pp. 22-29.

Nolan, D., Castley, A., Tschochner, M., James, I., Qiu, W., Sayer, D., Christiansen, F.T., Witt, C., Mastaglia, F., Carroll, W. and Kermode, A. (2012) Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk. Neurology, 79 (6). pp. 538-546.

Nolan, D., John, M. and Mallal, S. (2001) Antiretroviral therapy and the lipodystrophy syndrome. Part 2: Concepts in aetiopathogenesis. Antiviral Therapy, 6 . pp. 145-160.

Nolan, D. and Mallal, S.A. (2001) Effects of sex and race on lipodystrophy pathogenesis. Journal of HIV Therapy, 6 (2). pp. 32-36.

Northfield, J., Lucas, M., Jones, H., Young, N.T. and Klenerman, P. (2005) Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8+ T cells correlates with 'memory inflation' in human cytomegalovirus infection. Immunology and Cell Biology, 83 (2). pp. 182-188.

Northfield, J.W., Harcourt, G., Lucas, M. and Klenerman, P. (2005) Immunology of viral co-infections with HIV. Archivum Immunologiae Et Therapiae Experimentalis, 53 (1). pp. 3-12.

Northfield, J.W., Kasprowicz, V., Lucas, M., Kersting, N., Bengsh, B., Kim, A., Phillips, R.E., Walker, B.D., Thimme, R., Lauer, G. and Klenerman, P. (2008) CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology, 47 (2). pp. 396-406.

Noto, J.M., Chopra, A., Loh, J., Romero-Gallo, J., Piazuelo, M.B., Watson, M.W., Leary, S., Beckett, A., Cover, T., Mallal, S., Israel, D. and Peek, R.M. (2017) Carcinogenic host microenvironments target and modify key pathogenic loci within helicobacter pylori. Gastroenterology, 152 (5). S666.

O'Grady, G.L., Ma, A., Sival, D., Wong, M.T.Y., Peduto, T., Menezes, M.P., Young, H., Waddell, L., Ghaoui, R., Needham, M., Lek, M., North, K.N., MacArthur, D.G., van Ravenswaaij-Arts, C.M.A. and Clarke, N.F. (2016) Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease. European Journal of Human Genetics, 24 (8). pp. 1216-1219.

Oddy, W.H., Herbison, C.E., Jacoby, P., Ambrosini, G.L., O'Sullivan, T.A., Ayonrinde, O.T., Olynyk, J.K., Black, L.J., Beilin, L.J., Mori, T.A., Hands, B.P. and Adams, L.A. (2013) The western dietary pattern is prospectively associated with non-alcoholic fatty liver disease in adolescence. The American Journal of Gastroenterology, 108 (5). pp. 778-785.

Ogasawara, M., Imanishi, T., Moriwaki, K., Gaudieri, S., Tsuda, H., Hashimoto, H., Shiroishi, T., Gojobori, T. and Koide, T. (2005) Length variation of CAG/CAA triplet repeats in 50 genes among 16 inbred mouse strains. Gene, 349 . pp. 107-119.

Oh, D., Huh, J.Y., Chong, S.Y., Kim, I-H, Bang, S-M, Jung, C-W, Lee, J-W, Lee, H.G., Lee, S.M., Kim, Y-K, Park, Y., Jang, S.J., Kim, J-S, Jo, D-Y, Zang, D.Y., Yoon, H-J, Yhim, H-Y, Sohn, S.K., Hong, J., Lee, W-S and Baker, R.I. (2014) Similar levels of complement activation in both patients with thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome: The report from the Korean TTP registry. Blood, 124 (21).

Ostrov, D.A., Grant, B.J., Pompeu, Y.A., Sidney, J., Harndahl, M., Southwood, S., Oseroff, C., Lu, S., Jakoncic, J., de Oliveira, C.A.F., Yang, L., Mei, H., Shi, L., Shabanowitz, J., English, A.M., Wriston, A., Lucas, A., Phillips, E., Mallal, S., Grey, H.M., Sette, A., Hunt, D.F., Buus, S. and Peters, B. (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proceedings of the National Academy of Sciences, 109 (25). pp. 9959-9964.

Pasi, K.J., Fischer, K., Ragni, M., Nolan, B., Perry, D.J., Kulkarni, R., Ozelo, M., Mahlangu, J., Shapiro, A.D., Baker, R.I., Bennett, C.M., Barnes, C., Oldenburg, J., Matsushita, T., Yuan, H., Ramirez-Santiago, A., Pierce, G.F., Allen, G. and Mei, B. (2016) Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B. Thrombosis and Haemostasis, 117 (3). pp. 508-518.

Pavlos, R., Mallal, S., Ostrov, D., Pompeu, Y. and Phillips, E. (2014) Fever, rash, and systemic symptoms: Understanding the role of virus and HLA in severe cutaneous drug allergy. The Journal of Allergy and Clinical Immunology: In Practice, 2 (1). pp. 21-33.

Pavlos, R., Mallal, S. and Phillips, E. (2012) HLA and pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 13 (11). pp. 1285-1306.

Pavlos, R., McKinnon, E.J., Ostrov, D.A., Peters, B., Buus, S., Koelle, D., Chopra, A., Schutte, R., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Kaever, T., Myers, P., Speers, E., Malaker, S.A., Shabanowitz, J., Jing, Y., Gaudieri, S., Hunt, D.F., Carrington, M., Haas, D.W., Mallal, S. and Phillips, E.J. (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Scientific Reports, 7 (1).

Pavlos, R. and Phillips, E.J. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine, 5 (1). pp. 1-17.

Pavlos, R., Redwood, A. and Phillips, E. (2017) AdDRESSing T-cell responses to antituberculous drugs. British Journal of Dermatology, 176 (2). pp. 292-293.

Payne, R.P., Branch, S., Kloverpris, H., Matthews, P.C., Koofhethile, C.K., Strong, T., Adland, E., Leitman, E., Frater, J., Ndung'u, T., Hunter, E., Haubrich, R., Mothe, B., Edwards, A., Riddell, L., Chen, F., Harrigan, P.R., Brumme, Z.L., Mallal, S., John, M., Jooste, J.P., Shapiro, R., Deeks, S.G., Walker, B.D., Brander, C., Landis, C., Carlson, J.M., Prado, J.G. and Goulder, P.J.R. (2014) Differential escape patterns within the dominant HLA-B*57:03-restricted HIV gag epitope reflect distinct Clade-Specific functional constraints. Journal of Virology, 88 (9). pp. 4668-4678.

Pearson, L., Thom, J., Adams, M., Oostryck, R., Krueger, R., Yong, G. and Baker, R. (2009) A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticles. International Journal of Laboratory Hematology, 31 (4). pp. 430-439.

Pedrini, M.J., Cull, G., Augustson, B.M., Walters, S., Crosbie, C., Carroll, W.M. and Kermode, A.G. (2015) Autologous stem cell transplantation in multiple sclerosis: Results from a single centre. Multiple Sclerosis Journal, 21 (6). p. 806.

Pedrini, M.J.F., Seewann, A., Bennett, K.A., Wood, A.J.T., James, I., Burton, J., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2015) Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. Journal of Neurology, Neurosurgery & Psychiatry, 86 (6). pp. 603-607.

Pedrini, S., Gupta, V.B., Hone, E., Doecke, J., O’Bryant, S., James, I., Bush, A.I., Rowe, C.C., Villemagne, V.L., Ames, D., Masters, C.L. and Martins, R.N. (2017) A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports, 7 (1).

Pendyala, G., McManus, H., Petoumenos, K., Franic, T., Kelly, M.D., Watson, J., O’Connor, C.C., Jeanes, M., Hoy, J., Cooper, D.A., Law, M.G. and Nolan, D. (2014) Determinants of suicide and accidental or violent death in the Australian HIV Observational Database. PLoS ONE, 9 (2). e89089.

Pereyra, F., Jia, X., McLaren, P.J., Telenti, A., de Bakker, P.I.W., Walker, B.D., Ripke, S., Brumme, C.J., Pulit, S.L., Carrington, M., Kadie, C.M., Carlson, J.M., Heckerman, D., Graham, R.R., Plenge, R.M., Deeks, S.G., Gianniny, L., Crawford, G., Sullivan, J., Gonzalez, E., Davies, L., Camargo, A., Moore, J.M, Beattie, N., Gupta, S., Crenshaw, A., Burtt, N.P., Guiducci, C., Gupta, N., Gao, X., Qi, Y., Yuki, Y., Piechocka-Trocha, A., Cutrell, E., Rosenberg, R., Moss, K.L., Lemay, P., O'Leary, J., Schaefer, T., Verma, P., Tóth, I., Block, B., Baker, B., Rothchild, A., Lian, J., Proudfoot, J., Alvino, D.M.L., Vine, S., Addo, M.M., Allen, T.M., Altfeld, M., Henn, M.R., Le Gall, S., Streeck, H., Haas, D.W., Kuritzkes, D.R., Robbins, G.K., Shafer, R.W., Gulick, R.M., Shikuma, C.M., Haubrich, R., Riddler, S., Sax, P.E., Daar, E.S., Ribaudo, H.J., Agan, B., Agarwal, S., Ahern, R.L., Allen, B.L., Altidor, S., Altschuler, E.L., Ambardar, S., Anastos, K., Anderson, B., Anderson, V., Andrady, U., Antoniskis, D., Bangsberg, D., Barbaro, D., Barrie, W., Bartczak, J., Barton, S., Basden, P., Basgoz, N., Bazner, S., Bellos, N.C., Benson, A.M., Berger, J., Bernard, N.F., Bernard, A.M., Birch, C., Bodner, S.J., Bolan, R.K., Boudreaux, E.T., Bradley, M., Braun, J.F., Brndjar, J.E., Brown, S.J., Brown, K., Brown, S.T., Burack, J., Bush, L.M., Cafaro, V., Campbell, O., Campbell, J., Carlson, R.H., Carmichael, J.K., Casey, K.K., Cavacuiti, C., Celestin, G., Chambers, S.T., Chez, N., Chirch, L.M., Cimoch, P.J., Cohen, D., Cohn, L.E., Conway, B., Cooper, D.A., Cornelson, B., Cox, D.T., Cristofano, M.V., Cuchural, G., Czartoski, J.L., Dahman, J.M., Daly, J.S., Davis, B.T., Davis, K., Davod, S.M., DeJesus, E., Dietz, C.A., Dunham, E., Dunn, M.E., Ellerin, T.B., Eron, J.J., Fangman, J.J.W., Farel, C.E., Ferlazzo, H., Fidler, S., Fleenor-Ford, A., Frankel, R., Freedberg, K.A., French, N.K., Fuchs, J.D., Fuller, J.D., Gaberman, J., Gallant, J.E., Gandhi, R.T., García, E., Garmon, D., Gathe, J.C., Gaultier, C.R., Gebre, W., Gilman, F.D., Gilson, I., Goepfert, P.A., Gottlieb, M.S., Goulston, C., Groger, R.K., Gurley, T.D., Haber, S., Hardwicke, R., Hardy, W.D., Harrigan, P.R., Hawkins, T.N., Heath, S., Hecht, F.M., Henry, W.K., Hladek, M., Hoffman, R.P., Horton, J.M., Hsu, R.K., Huhn, G.D., Hunt, P., Hupert, M.J., Illeman, M.L., Jaeger, H., Jellinger, R.M., John, M., Johnson, J.A., Johnson, K.L., Johnson, H., Johnson, K., Joly, J., Jordan, W.C., Kauffman, C.A., Khanlou, H., Killian, R.K., Kim, A.Y., Kim, D.D., Kinder, C.A., Kirchner, J.T., Kogelman, L., Kojic, E.M., Korthuis, P.T., Kurisu, W., Kwon, D.S., LaMar, M., Lampiris, H., Lanzafame, M., Lederman, M.M., Lee, D.M., Lee, J.M.L., Lee, M.J., Lee, E.T.Y., Lemoine, J., Levy, J.A., Llibre, J.M., Liguori, M.A., Little, S.J., Liu, A.Y., Lopez, A.J., Loutfy, M.R., Loy, D., Mohammed, D.Y., Man, A., Mansour, M.K., Marconi, V.C., Markowitz, M., Marques, R., Martin, J.N., Martin, H.L., Mayer, K.H., McElrath, M.J., McGhee, T.A., McGovern, B.H., McGowan, K., McIntyre, D., Mcleod, G.X., Menezes, P., Mesa, G., Metroka, C.E., Meyer-Olson, D., Miller, A.O., Montgomery, K., Mounzer, K.C., Nagami, E.H., Nagin, I., Nahass, R.G., Nelson, M.O., Nielsen, C., Norene, D.L., O'Connor, D.H., Ojikutu, B.O., Okulicz, J., Oladehin, O.O., Oldfield, E.C., Olender, S.A., Ostrowski, M., Owen, W.F., Pae, E., Parsonnet, J., Pavlatos, A.M., Perlmutter, A.M., Pierce, M.N., Pincus, J.M., Pisani, L., Price, L.J., Proia, L., Prokesch, R.C., Pujet, H.C., Ramgopal, M., Rathod, A., Rausch, M., Ravishankar, J., Rhame, F.S., Richards, C.S., Richman, D.D., Rodes, B., Rodriguez, M., Rose, R.C., Rosenberg, E.S., Rosenthal, D., Ross, P.E., Rubin, D.S., Rumbaugh, E., Saenz, L., Salvaggio, M.R., Sanchez, W.C., Sanjana, V.M., Santiago, S., Schmidt, W., Schuitemaker, H., Sestak, P.M., Shalit, P., Shay, W., Shirvani, V.N., Silebi, V.I., Sizemore, J.M., Skolnik, P.R., Sokol-Anderson, M., Sosman, J.M., Stabile, P., Stapleton, J.T., Starrett, S., Stein, F., Stellbrink, H-J, Sterman, F.L., Stone, V.E., Stone, D.R., Tambussi, G., Taplitz, R.A., Tedaldi, E.M., Telenti, A., Theisen, W., Torres, R., Tosiello, L., Tremblay, C., Tribble, M.A., Trinh, P.D., Tsao, A., Ueda, P., Vaccaro, A., Valadas, E., Vanig, T.J., Vecino, I., Vega, V.M., Veikley, W., Wade, B.H., Walworth, C., Wanidworanun, C., Ward, D.J., Warner, D.A., Weber, R.D., Webster, D., Weis, S., Wheeler, D.A., White, D.J., Wilkins, E., Winston, A., Wlodaver, C.G., van't Wout, A., Wright, D.P., Yang, O.O., Yurdin, D.L., Zabukovic, B.W., Zachary, K.C., Zeeman, B. and Zhao, M. (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science, 330 (6010). pp. 1551-1557.

Perry, J.R., Julian, J.A., Laperriere, N.J., Geerts, W., Agnelli, G., Rogers, L.R., Malkin, M.G., Sawaya, R., Baker, R., Falanga, A., Parpia, S., Finche, T. and Levine, M.N. (2010) PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. Journal of Thrombosis and Haemostasis, 8 (9). pp. 1959-1965.

Peter, J.G., Lehloenya, R., Dlamini, S., Risma, K., White, K.D., Konvinse, K.C. and Phillips, E.J. (2017) Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 547-563.

Pett, S.L., Wand, H., Law, M.G, Arduino, R., Lopez, J.C., Knysz, B., Pereira, L.C., Pollack, S., Reiss, P., Tambussi, G. and Mallal, S. (2006) Evaluation of subcutaneous proleukin (Interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants. HIV Clinical Trials, 7 (2). pp. 70-85.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., James, I., Heeg, M., Nolan, D., John, M., Rauch, A., Mallal, S., Lucas, A.D., Klenerman, P., Diepolder, H.M. and Lucas, M. (2011) Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity. PLoS ONE, 6 (2). e16797.

Pham, J., Oseroff, C., Hinz, D., Sidney, J., Paul, S., Greenbaum, J., Vita, R., Phillips, E., Mallal, S., Peters, B. and Sette, A. (2016) Sequence conservation predicts T cell reactivity against ragweed allergens. Clinical & Experimental Allergy, 46 (9). pp. 1194-1205.

Phillips, A., Ledergerber, B., Lundgren, J., Hogg, R., D'Arminio Monforte, A., Castelli, F., Wlker, S., Staszewski, S., Dabis, F., Gazzard, B., Saag, M., Petoumenous, K., Johnson, M., Scullard, G., Gill, J., James, I., Fisher, M., Klein, M. and Costagliola, D. (2004) Nucleoside Analogue Use Before and During Highly Active Antiretroviral Therapy and Virus Load Rebound. The Journal of Infectious Diseases, 190 (4). pp. 675-687.

Phillips, E. (2013) Antiretroviral therapy. Internal Medicine Journal, 43 . pp. 11-12.

Phillips, E., Bartlett, J.A., Sanne, I., Lederman, M.M., Hinkle, J., Rousseau, F., Dunn, D., Pavlos, R., James, I., Mallal, S.A. and Haas, D.W. (2013) Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62 (2). e55-e57.

Phillips, E., Hayden, A., Gutiérrez, S., Jahnke, N., Yip, B., Lima, V.D., Hogg, R.S., Harrigan, P.R. and Montaner, J.S.G. (2008) Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: Authorsʼ reply. AIDS, 22 (4). pp. 548-549.

Phillips, E., Nolan, D. and Mallal, S. (2008) The Authors reply - Response to Vandekerckhove et al & Abel et al. New England Journal of Medicine, 358 (23). pp. 2515-2516.

Phillips, E.J. (2016) Classifying ADRs - Does dose matter? British Journal of Clinical Pharmacology, 81 (1). pp. 10-12.

Phillips, E.J., Chung, W-H, Mockenhaupt, M., Roujeau, J-C and Mallal, S. (2011) Drug hypersensitivity: Pharmacogenetics and clinical syndromes. Journal of Allergy and Clinical Immunology, 127 (3). S60-S66.

Phillips, E.J. and Mallal, S. (2007) Drug hypersensitivity in HIV. Current Opinion in Allergy and Clinical Immunology, 7 (4). pp. 324-330.

Phillips, E.J. and Mallal, S. (2009) HLA and drug-induced toxicity. Current Opinion in Molecular Therapeutics, 11 (3). pp. 231-242.

Phillips, E.J. and Mallal, S. (2009) Personalizing antiretroviral therapy: is it a reality? Personalized Medicine, 6 (4). pp. 393-408.

Phillips, E.J. and Mallal, S. (2010) Pharmacogenetics of drug hypersensitivity. Pharmacogenomics, 11 (7). pp. 973-987.

Phillips, E.J. and Mallal, S.A. (2011) HLA-B*1502 Screening and toxic effects of carbamazepine. New England Journal of Medicine, 365 (7). pp. 672-673.

Phillips, E.J. and Mallal, S.A. (2013) HLA-B*5701 and flucloxacillin associated drug-induced liver disease. AIDS, 27 (3). pp. 491-492.

Phillips, E.J. and Mallal, S.A. (2008) Pharmacogenetics and the potential for the individualization of antiretroviral therapy. Current Opinion in Infectious Diseases, 21 (1). pp. 16-24.

Pina-Salazar, E-Z, Urita, K., Hayashi, T., Futamura, R., Vallejos-Burgos, F., Włoch, J., Kowalczyk, P., Wiśniewski, M., Sakai, T., Moriguchi, I., Terzyk, A.P., Osawa, E. and Kaneko, K. (2017) Water adsorption property of hierarchically nanoporous detonation nanodiamonds. Langmuir, 33 (42). pp. 11180-11188.

Plauzolles, A., Lucas, M. and Gaudieri, S. (2013) Hepatitis C virus adaptation to T-cell immune pressure. The Scientific World Journal, 2013 . pp. 1-7.

Pocathikorn, A., Taylor, R.R., James, I. and Mamotte, C.D.S. (2007) LDL-receptor mRNA expression in men is downregulated within an hour of an acute fat load and is influenced by genetic polymorphism. The Journal of Nutrition, 137 (9). pp. 2062-7.

Pompeu, Y.A., Stewart, J.D., Mallal, S., Phillips, E., Peters, B. and Ostrov, D.A. (2012) The structural basis of HLA-associated drug hypersensitivity syndromes. Immunological Reviews, 250 (1). pp. 158-166.

Prakoso, E., Tirnitz-Parker, J.E.E., Clouston, A.D., Kayali, Z., Lee, A., Gan, E.K., Ramm, G.A., Kench, J.G., Bowen, D.G., Olynyk, J.K., McCaughan, G.W. and Shackel, N.A. (2014) Analysis Of The intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence Post-Liver transplantation. Liver Transplantation, 20 (12). pp. 1508-1519.

P’ng, S., Carnley, B., Baker, R.I., Kontorinis, N. and Cheng, W. (2008) Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation. Clinical Gastroenterology and Hepatology, 6 (4). pp. 472-475.

Qiu, W., Kermode, A.G., Li, R., Dai, Y., Wang, Y., Wang, J., Zhong, X., Li, C., Lu, Z. and Hu, X. (2015) Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica. Journal of Clinical Neuroscience, 22 (7). pp. 1178-1182.

Qiu, W., Pham, K., James, I., Nolan, D., Castley, A., Christiansen, F.T., Czarniak, P., Luo, Y., Wu, J., Garlepp, M., Wilton, S., Carroll, W.M., Mastaglia, F.L. and Kermode, A.G. (2013) The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort. Journal of Neuroimmunology, 261 (1-2). pp. 92-97.

Raboud, J., Lesosky, M., Sterling, S., Phillips, E.J., Walmsley, S. and Bayoumi, A. (2007) An Estimate of the proportion of symptoms reported in Self-administered questionnaires that are captured as adverse drug events in an observational database. HIV Clinical Trials, 8 (5). pp. 311-319.

Ranaweera, C.B., Ayonrinde, O.T., Mollison, L., Galhenage, S. and Olynyk, J.K. (2014) Liver ultrasound does not accurately predict transient elastography diagnosed cirrhosis. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). p. 89.

Rath, S.R., Bartley, A., Charles, A., Powers, Neil, Baynam, G., Jones, T., Priest, J.R., Foulkes, W.D. and Choong, C.S.Y. (2014) Multinodular goiter in children: An important pointer to a germline DICER1 mutation. The Journal of Clinical Endocrinology & Metabolism, 99 (6). pp. 1947-1948.

Rauch, A., Gaudieri, S., Evison, J., Nolan, D., Cavassini, M., Weber, R., James, I. and Furrer, H. (2008) Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral Therapy, 13 (3). pp. 455-60.

Rauch, A., Nolan, D., Martin, A., McKinnon, E., Almeida, C. and Mallal, S. (2006) Prospective genetic screening decreases the incidence of Abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clinical Infectious Diseases, 43 (1). pp. 99-102.

Redwood, A., Lloyd, M., Allan, J. and Scalzo, T. (2015) Obituary: Geoff Shellam (1942–2015). Immunology and Cell Biology, 93 (9). pp. 765-766.

Rive, C., Pavlos, R., Ostrov, D., Plasencia, P., Hung, S-L, Chung, W.H., Peters, B., Buus, S., Mallal, S. and Phillips, E. (2014) HLA class I-drug-T-cell receptor interactions in SJS/TEN. Clinical and Translational Allergy, 4 (Suppl. 3). P2.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing delayed drug hypersensitivity. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rive, C.M., Bourke, J. and Phillips, E.J. (2013) Testing for drug hypersensitivity syndromes. Clinical Biochemist Reviews, 34 (1). pp. 15-38.

Rodríguez Cruz, P.M., Luo, Y-B, Miller, J., Junckerstorff, R.C., Mastaglia, F.L. and Fabian, V. (2014) An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies. Neuromuscular Disorders, 24 (12). pp. 1025-1035.

Rodríguez Cruz, P.M., Needham, M., Hollingsworth, P., Mastaglia, F.L. and Hillman, D.R. (2014) Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis. Neuromuscular Disorders, 24 (12). pp. 1036-1041.

Rodríguez-Sáinz, C., Valor, L., Hernández, D.C., Gil, J., Carbone, J., Pascual-Bernaldez, M., Rodríguez-Alcántara, F., Martínez, I., Vicario, J.L., Mallal, S. and Fernández-Cruz, E. (2013) Flow cytometry analysis with a new FITC-Conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1–infected patients. HIV Clinical Trials, 14 (4). pp. 160-164.

Rojana-udomsart, A., Castley, A., James, I., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Martinez, P., Christiansen, F. and Mastaglia, F.L. (2012) G.P.63 High-resolution analysis of HLA-DRB1 alleles and diplotypes in an Australian inclusion body myositis cohort. Neuromuscular Disorders, 22 (9-10). pp. 853-854.

Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., Martinez, P., Christiansen, F. and Mastaglia, F. (2012) High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250 (1-2). pp. 77-82.

Rueter, K., Ta, B., Bear, N., Lucas, M. and Prescott, S. (2016) Physician training programs significantly improve diagnosis in cases coded as anaphylaxis over time: A major factor compounding time-trend data? The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Saag, M., Balu, R., Phillips, E.J., Brachman, P., Martorell, C., Burman, W., Stancil, B., Mosteller, M., Brothers, C., Wannamaker, P., Hughes, A., Sutherland‐Phillips, D., Mallal, S. and Shaefer, M. (2008) High sensitivity of human leukocyte antigen–B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. Clinical Infectious Diseases, 46 (7). pp. 1111-1118.

Sabin, C., D'Arminio Monforte, A., Friis-Moller, N., Weber, R., El-Sadr, W., Reiss, P., Kirk, O., Mercie, P., Law, M., De Wit, S., Pradier, C., Phillips, A., Lundgren, J. and Mallal, S. (2008) Changes over time in risk factors for cardiovascular disease and use of Lipid‐lowering drugs in HIV‐Infected individuals and impact on myocardial infarction. Clinical Infectious Diseases, 46 (7). pp. 1101-1110.

Sabin, C., Worm, S., Weber, R., Reiss, P., El-Sadr, W., Dabis, F., De Wit, S., Law, M., D'Arminio Monforte, A., Friis-Moller, N., Kirk, O., Pradier, C., Weller, I., Phillips, A., Lundgren, J. and Mallal, S. (2008) Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. The Lancet, 371 (9622). pp. 1417-1426.

Saito, Y., Stamp, L.K., Caudle, K.E., Hershfield, M.S., McDonagh, E.M., Callaghan, J.T., Tassaneeyakul, W., Mushiroda, T., Kamatani, N., Goldspiel, B.R., Phillips, E.J., Klein, T.E. and Lee, M.T.M. (2015) Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clinical Pharmacology & Therapeutics, 99 (1). pp. 36-37.

Schlub, T.E., Grimm, A.J., Smyth, R.P., Cromer, D., Chopra, A., Mallal, S., Venturi, V., Waugh, C., Mak, J. and Davenport, M.P. (2014) Fifteen to Twenty Percent of HIV substitution mutations are associated with recombination. Journal of Virology, 88 (7). pp. 3837-3849.

Schulman, S., Kearon, C., Kakkar, A.K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., Goldhaber, S.Z. and Baker, R.I. (2009) Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine, 361 (24). pp. 2342-2352.

Schulte, B.M., Gielen, P.R., Kers-Rebel, E.D., Prosser, A.C., Lind, K., Flodström-Tullberg, M., Tack, C.J., Elving, L.D. and Adema, G.J. (2016) Enterovirus exposure uniquely discriminates type 1 diabetes patients with a homozygous from a heterozygous melanoma differentiation-associated protein 5/interferon induced with helicase C domain 1A946T genotype. Viral Immunology, 29 (7). pp. 389-397.

Scriba, T.J., Zhang, H.-T., Brown, H.L., Oxenius, A., Tamm, N., Fidler, S., Fox, J., Weber, J.N., Klenerman, P., Day, C.L., Lucas, M. and Phillips, R.E. (2005) HIV-1–specific CD4+ T lymphocyte turnover and activation increase upon viral rebound. Journal of Clinical Investigation, 115 (2). pp. 443-450.

Secombe, C.J., Tan, R.H.H., Perera, D.I., Byrne, D.P., Watts, S.P. and Wearn, J.G. (2017) The Effect of Geographic Location on Circannual Adrenocorticotropic Hormone Plasma Concentrations in Horses in Australia. Journal of Veterinary Internal Medicine, 31 (5). pp. 1533-1540.

Semmo, N., Day, C.L., Ward, S.M., Lucas, M., Harcourt, G., Loughry, A. and Klenerman, P. (2005) Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology, 41 (5). pp. 1019-1028.

Semmo, N., Lucas, M., Krashias, G., Lauer, G., Chapel, H. and Klenerman, P. (2006) Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy. Blood, 107 (11). pp. 4570-4571.

Shear, N.H., Milpied, B., Bruynzeel, D.P. and Phillips, E.J. (2008) A review of drug patch testing and implications for HIV clinicians. AIDS, 22 (9). pp. 999-1007.

Shin, E-C, Pfafferott, K., Deshpande, P., McKinnon, E., Merani, S., Lucas, A., Heckerman, D., Mallal, S., John, M., Gaudieri, S. and Lucas, M. (2015) Anti-Hepatitis C virus T-Cell immunity in the context of multiple exposures to the virus. PloS one, 10 (6). e0130420.

Shoukry, N.H., Lucas, A., Lucas, M., Strhyn, A., Keane, N.M., McKinnon, E., Pavlos, R., Moran, E.M., Meyer-Pannwitt, V., Gaudieri, S., D’Orsogna, L., Kalams, S., Ostrov, D.A., Buus, S., Peters, B., Mallal, S. and Phillips, E. (2015) Abacavir-Reactive memory T Cells are present in drug naïve individuals. PLoS ONE, 10 (2). e0117160.

Shu, Y., Li, R., Qiu, W., Chang, Y., Sun, X., Fang, L., Chen, C., Yang, Y., Lu, Z., Hu, X. and Kermode, A.G. (2017) Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis. Multiple Sclerosis and Related Disorders, 18 . pp. 65-70.

Silbert, B.I., Heaton, A.E., Cash, R.F.H., James, I., Dunne, J.W., Lawn, N.D., Silbert, P.L., Mastaglia, F.L. and Thickbroom, G.W. (2015) Evidence for an excitatory GABAA response in human motor cortex in idiopathic generalised epilepsy. Seizure, 26 . pp. 36-42.

Simeoni, I., Stephens, J.C., Hu, F., Deevi, S.V.V., Megy, K., Bariana, T.K., Lentaigne, C., Schulman, S., Sivapalaratnam, S., Vries, M.J.A., Westbury, S.K., Greene, D., Papadia, S., Alessi, M-C, Attwood, A.P., Ballmaier, M., Baynam, G., Bermejo, E., Bertoli, M., Bray, P.F., Bury, L., Cattaneo, M., Collins, P., Daugherty, L.C., Favier, R., French, D.L., Furie, B., Gattens, M., Germeshausen, M., Ghevaert, C., Goodeve, A.C., Guerrero, J.A., Hampshire, D.J., Hart, D.P., Heemskerk, J.W.M., Henskens, Y.M.C., Hill, M., Hogg, N., Jolley, J.D., Kahr, W.H., Kelly, A.M., Kerr, R., Kostadima, M., Kunishima, S., Lambert, M.P., Liesner, R., Lopez, J.A., Mapeta, R.P., Mathias, M., Millar, C.M., Nathwani, A., Neerman-Arbez, M., Nurden, A.T., Nurden, P., Othman, M., Peerlinck, K., Perry, D.J., Poudel, P., Reitsma, P., Rondina, M.T., Smethurst, P.A., Stevenson, W., Szkotak, A., Tuna, S., van Geet, C., Whitehorn, D., Wilcox, D.A., Zhang, B., Revel-Vilk, S., Gresele, P., Bellissimo, D.B., Penkett, C.J., Laffan, M.A., Mumford, A.D., Rendon, A., Gomez, K., Freson, K., Ouwehand, W.H. and Turro, E. (2016) A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders. Blood, 127 (23). pp. 2791-2803.

Simes, John, Becattini, Cecilia, Agnelli, Giancarlo, Eikelboom, John W., Kirby, Adrienne C., Mister, Rebecca, Prandoni, Paolo, Brighton, Timothy A. and Baker, R.I. (2014) Aspirin for the prevention of recurrent venous thromboembolism: The INSPIRE Collaboration. Circulation, 130 (13). pp. 1062-1071.

Smith, R.C., Smith, S.F., Wilson, J., Pearce, C., Wray, N., Vo, R., Chen, J., Ooi, C.Y., Oliver, M., Katz, T., Turner, R., Nikfarjam, M., Rayner, C., Horowitz, M., Holtmann, G., Talley, N., Windsor, J., Pirola, R. and Neale, R. (2015) Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology . In Press.

Smyth, R.P., Schlub, T.E., Grimm, A.J., Waugh, C., Ellenberg, P., Chopra, A., Mallal, S., Cromer, D., Mak, J., Davenport, M.P. and Hahn, B.H. (2014) Identifying Recombination Hot Spots in the HIV-1 Genome. Journal of Virology, 88 (5). pp. 2891-2902.

Sohrabi, H.R., Bates, K.A., Weinborn, M., Bucks, R.S., Rainey-Smith, S.R., Rodrigues, M.A., Bird, S.M., Brown, B.M., Beilby, J., Howard, M., Criddle, A., Wraith, M., Taddei, K., Martins, G., Paton, A., Shah, T., Dhaliwal, S.S., Mehta, P.D., Foster, J.K., Martins, I.J., Lautenschlager, N.T., Mastaglia, F., Laws, S.M. and Martins, R.N. (2015) Bone mineral density, adiposity, and cognitive functions. Frontiers in Aging Neuroscience, 7 .

Somogyi, A.A. and Phillips, E. (2017) Genomic testing as a tool to optimise drug therapy. Australian Prescriber, 40 (3). pp. 101-104.

St Pierre, T.G., House, M.J., Bangma, S.J., Pang, W., Bathgate, A., Gan, E.K., Ayonrinde, O.T., Bhathal, P.S., Clouston, A., Olynyk, J.K. and Adams, L.A. (2016) Stereological analysis of liver biopsy histology sections as a reference standard for validating Non-Invasive liver fat fraction measurements by MRI. PLoS ONE, 11 (8). e0160789.

Sterling, T.R., Moro, R.N., Borisov, A.S., Phillips, E., Shepherd, G., Adkinson, N.F., Weis, S., Ho, C. and Villarino, M.E. (2015) Flu-like and other systemic drug reactions among persons receiving weekly rifapentine plus isoniazid or daily isoniazid for treatment of latent tuberculosis infection in the PREVENT tuberculosis study. Clinical Infectious Diseases, 61 (4). pp. 527-535.

Stewart, T., Spelman, T., Havrdova, E., Horakova, D., Trojano, M., Izquierdo, G., Duquette, P., Girard, M., Prat, A., Lugaresi, A., Grand’Maison, F., Grammond, P., Sola, P., Shaygannejad, V., Hupperts, R., Alroughani, R., Oreja-Guevara, C., Pucci, E., Boz, C., Lechner-Scott, J., Bergamaschi, R., van Pesch, V., Iuliano, G., Ramo, C., Taylor, B., Slee, M., Spitaleri, D., Granella, F., Verheul, F., McCombe, P., Hodgkinson, S., Amato, M.P., Vucic, S., Gray, O., Cristiano, E., Barnett, M., Sanchez Menoyo, J.L., van Munster, E., Saladino, M.L., Olascoaga, J., Prevost, J., Deri, N., Shaw, C., Singhal, B., Moore, F., Rózsa, C., Shuey, N., Skibina, O., Kister, I., Petkovska-Boskova, T., Ampapa, R., Kermode, A., Butzkueven, H., Jokubaitis, V. and Kalincik, T. (2017) Contribution of different relapse phenotypes to disability in multiple sclerosis. Multiple Sclerosis Journal, 23 (2). pp. 266-276.

Stone, C.A., Hemler, J.A., Commins, S.P., Schuyler, A.J., Phillips, E.J., Peebles, R.S. and Fahrenholz, J.M. (2016) Anaphylaxis after zoster vaccine: Implicating alpha-gal allergy as a possible mechanism. Journal of Allergy and Clinical Immunology, 139 (5). pp. 1710-1713.

Stone, S.F., Phillips, E.J., Wiese, M.D., Heddle, R.J. and Brown, S.G.A (2014) Immediate-type hypersensitivity drug reactions. British Journal of Clinical Pharmacology, 78 (1). pp. 1-13.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D., Pedrini, M., Kermode, A., Carroll, W. and Nolan, D. (2014) Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risks. Multiple Sclerosis Journal, 20 (3). pp. 286-294.

Strock, S.B., Gaudieri, S., Mallal, S., Yu, C., Mitchell, D., Cogan, J., Mason, W., Crowe, D. and Loyd, J.E. (2015) Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 − a case control study. BMC Infectious Diseases, 15 (1).

Styles, C.E., Seed, C.R., Hoad, V.C., Gaudieri, S. and Keller, A.J. (2017) Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia. Vox Sanguinis, 112 (8). pp. 723-732.

Subramaniam, K., Spilsbury, K., Ayonrinde, O.T., Latchmiah, F., Mukhtar, A., Semmens, J., Leahy, M.F. and Olynyk, J.K. (2014) Blood transfusion is associated with increased mortality rate in upper gastrointestinal bleeding. Journal of Gastroenterology and Hepatology, 29 (Supp. 2). pp. 52-53.

Sulzer, D., Alcalay, R.N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W.H., Mao, X., Dawson, V.L., Dawson, T.M., Oseroff, C., Pham, J., Sidney, J., Dillon, M.B., Carpenter, C., Weiskopf, D., Phillips, E., Mallal, S., Peters, B., Frazier, A., Lindestam Arlehamn, C.S. and Sette, A. (2017) T cells from patients with Parkinson’s disease recognize α-synuclein peptides. Nature, 546 (7660). pp. 656-661.

Suppiah, V., Gaudieri, S., Armstrong, N.J., O'Connor, K.S., Berg, T., Weltman, M., Abate, M.L., Spengler, U., Bassendine, M., Dore, G.J., Irving, W.L., Powell, E., Hellard, M., Riordan, S., Matthews, G., Sheridan, D., Nattermann, J., Smedile, A., Müller, T., Hammond, E., Dunn, D.S., Negro, F., Bochud, P-Y, Mallal, S., Ahlenstiel, G., Stewart, G.J., George, J. and Booth, D.R. (2011) IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic Hepatitis C virus infection in a European cohort: A cross-sectional study. PLoS Medicine, 8 (9). e1001092.

Symons, J., Chopra, A., Malantinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Abana, C.O., Rhodes, A., Rezaei, S.D., Vandekerckhove, L., Mallal, S., Lewin, S.R. and Cameron, P.U. (2017) HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retrovirology, 14 (1).

Symons, J., Chopra, A., Malatinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Abana, C.O., Rhodes, A., Rezaei, S.D., Vandekerckhove, L., Mallal, S., Lewin, S.R. and Cameron, P.U. (2017) Erratum to: HIV integration sites in latently infected cell lines: evidence of ongoing replication. Retrovirology, 14 (1).

Taruscio, D., Groft, S.C., Cederroth, H., Melegh, B., Lasko, P., Kosaki, K., Baynam, G., McCray, A. and Gahl, W.A. (2015) Undiagnosed Diseases Network International (UDNI): White paper for global actions to meet patient needs. Molecular Genetics and Metabolism, 116 (4). pp. 223-225.

Tay, J. W., James, I., Hughes, Q.W., Tiao, J.Y. and Baker, R.I. (2017) Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy. BMC Research Notes, 10 (1).

Teo, W-P, Rodrigues, J.P., Mastaglia, F.L. and Thickbroom, G.W. (2014) Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson’s disease and is reversed by levodopa. Clinical Neurophysiology, 125 (3). pp. 562-568.

Thin, L.W.Y., Lawrance, I.C., Spilsbury, K., Kava, J. and Olynyk, J.K. (2014) Detection of liver injury in IBD using transient elastography. Journal of Crohn's and Colitis, 8 (7). pp. 671-677.

Thomas, M., Hopkins, C., Duffy, E., Lee, D., Loulergue, P., Ripamonti, D., Ostrov, D.A. and Phillips, E. (2017) Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir. Clinical Infectious Diseases, 64 (9). pp. 1198-1203.

Thompson, G., John, M. and Chopra, A. (2016) Triple threats: Tracking antigen-specific T cells in a case of concurrent autoimmunity, infectious disease and possible malignancy. Pathology, 48 (Supp. 1). S44.

Timm, J., Lauer, G.M., Kavanagh, D.G., Sheridan, I., Kim, A.Y., Lucas, M., Pillay, T., Ouchi, K., Reyor, L.L., zur Wiesch, J.S., Gandhi, R. T., Chung, R.T., Bhardwaj, N., Klenerman, P., Walker, B.D. and Allen, T.M. (2004) CD8 Epitope Escape and Reversion in Acute HCV Infection. The Journal of Experimental Medicine, 200 (12). pp. 1593-1604.

Tirnitz-Parker, J., Glanfield, A., Olynyk, J. and Ramm, G. (2013) Iron and hepatic carcinogenesis. Critical Reviews in Oncogenesis, 18 (5). pp. 391-407.

Tirnitz-Parker, J.E.E., Olynyk, J.K. and Ramm, G.A. (2014) Role of TWEAK in coregulating liver progenitor cell and fibrogenic responses. Hepatology, 59 (3). pp. 1198-1201.

Trend, S., Jones, A., Geldenhuys, S., Byrne, S., Fabis-Pedrini, M., Nolan, D., Booth, D., Carroll, W., Lucas, R., Kermode, A.G. and Hart, P. (2017) Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI. International Journal of Molecular Sciences, 18 (6). p. 1277.

Trubiano, J. and Phillips, E. (2013) Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling'. Current Opinion in Infectious Diseases, 26 (6). pp. 526-537.

Trubiano, J.A., Adkinson, N.F. and Phillips, E.J. (2017) Penicillin allergy is not necessarily forever. JAMA, 318 (1). p. 82.

Trubiano, J.A., Beekmann, S.E., Polgren, P.M., Worth, L.J., Grayson, M.L. and Phillips, E.J. (2016) Antibiotic allergy De-Labeling: Teaching an old dog new tricks. Journal of Allergy and Clinical Immunology, 137 (2). AB398.

Trubiano, J.A., Beekmann, S.E., Worth, L.J., Polgreen, P.M., Thursky, K.A., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2016) Improving antimicrobial stewardship by antibiotic allergy delabeling: Evaluation of knowledge, attitude, and practices throughout the emerging infections network. Open Forum Infectious Diseases, 3 (3).

Trubiano, J.A., Redwood, A., Strautins, K., Pavlos, R., Woolnough, E., Chang, C.C. and Phillips, E. (2016) Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis. The Journal of Allergy and Clinical Immunology: In Practice, 5 (3). pp. 823-826.

Trubiano, J.A., Stone, C.A., Grayson, M.L., Urbancic, K., Slavin, M.A., Thursky, K.A. and Phillips, E.J. (2017) The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration. The Journal of Allergy and Clinical Immunology: In Practice . In Press.

Trubiano, J.A., Thursky, K.A., Stewardson, A.J., Urbancic, K., Worth, L.J., Jackson, C., Stevenson, W., Sutherland, M., Slavin, M.A., Grayson, M.L. and Phillips, E.J. (2017) Impact of an Integrated Antibiotic Allergy Testing Program on Antimicrobial Stewardship: A Multicenter Evaluation. Clinical Infectious Diseases, 65 (1). pp. 166-174.

Trubiano, J.A., Worth, L.J., Urbancic, K., Brown, T.M., Paterson, D.L., Lucas, M. and Phillips, E. (2016) Return to Sender: The need to re-address patient antibiotic allergy labels in Australia and New Zealand. Internal Medicine Journal, 46 (11). pp. 1311-1317.

Tschochner, M., Leary, S., Cooper, D., Strautins, K., Chopra, A., Clark, H., Choo, L., Dunn, D., James, I., Carroll, W.M., Kermode, A.G. and Nolan, D. (2016) Identifying Patient-Specific Epstein-Barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PloS one, 11 (2).

Tseng, A., Hughes, C.A., Wu, J., Seet, J. and Phillips, E.J. (2017) Cobicistat Versus Ritonavir: Similar pharmacokinetic enhancers but some important differences. Annals of Pharmacotherapy, 51 (11). pp. 1008-1022.

Tseng, A., Seet, J. and Phillips, E.J. (2015) The evolution of three decades of antiretroviral therapy: Challenges, triumphs and the promise of the future. British Journal of Clinical Pharmacology, 79 (2). pp. 182-194.

Ulsenheimer, A., Lucas, M., Seth, N.P., Tilman Gerlach, J., Gruener, N.H., Loughry, A., Pape, G.R., Wucherpfennig, K.W., Diepolder, H.M. and Klenerman, P. (2006) Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. Journal of Viral Hepatitis, 13 (10). pp. 708-714.

Walker, C.E., Mahede, T., Davis, G., Miller, L.J., Girschik, J., Brameld, K., Sun, W., Rathod, A., Ayme, S., Zubrick, S.R., Baynam, G.S., Molster, C., Dawkins, H.J.S. and Weeramanthri, T.S. (2017) The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort. Genetics in Medicine, 19 (5). pp. 546-552.

Ward, S.M., Jonsson, J.R., Sierro, S., Clouston, A.D., Lucas, M., Vargas, A.L., Powell, E.E. and Klenerman, P. (2004) Virus-specific CD8+ T lymphocytes within the normal human liver. European Journal of Immunology, 34 (6). pp. 1526-1531.

Waugh, C., Cromer, D., Grimm, A., Chopra, A., Mallal, S., Davenport, M. and Mak, J. (2015) A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library. Virology Journal, 12 (1).

Weiskopf, D., Angelo, M.A., Grifoni, A., O'Rourke, P.H., Sidney, J., Paul, S., De Silva, A.D., Phillips, E., Mallal, S., Premawansa, S., Premawansa, G., Wijewickrama, A., Peters, B. and Sette, A. (2016) HLA-DRB1 alleles are associated with different magnitudes of dengue Virus–Specific CD4+T-Cell responses. Journal of Infectious Diseases, 214 (7). pp. 1117-1124.

Wheatley, L.M., Plaut, M., Schwaninger, J.M., Banerji, A., Castells, M., Finkelman, F.D., Gleich, G.J., Guttman-Yassky, E., Mallal, S.A.K., Naisbitt, D.J., Ostrov, D.A., Phillips, E.J., Pichler, W.J., Platts-Mills, T.A.E., Roujeau, J-C, Schwartz, L.B. and Trepanier, L.A. (2015) Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. Journal of Allergy and Clinical Immunology, 136 (2). 262-271.e2.

White, K.D., Chung, W-H, Hung, S-L, Mallal, S. and Phillips, E.J. (2015) Evolving models of the immunopathogenesis of T cell–mediated drug allergy: The role of host, pathogens, and drug response. Journal of Allergy and Clinical Immunology, 136 (2). pp. 219-234.

Witt, C.S., Martin, A. and Christiansen, F.T. (2000) Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens, 56 (3). pp. 248-257.

Witt, C.S., Whiteway, J.M., Warren, H.S., Barden, A., Rogers, M., Martin, A., Beilin, L.J. and Christiansen, F.T. (2002) Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. European Journal of Immunology, 32 (1). pp. 18-29.

Worm, S.W., Bower, M., Reiss, P., Bonnet, F., Law, M., Fätkenheuer, G., d’Arminio Monforte, A., Abrams, D.I., Grulich, A., Fontas, E., Kirk, O., Furrer, H., De Wit, S., Phillips, A., Lundgren, J.D., Sabin, C.A. and Nolan, D. (2013) Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study. BMC Infectious Diseases, 13 (1).

Xu, W., li, R., Dai, Y., Wu, A., Wang, H., Cheng, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., Kermode, A.G. and Hu, X. (2013) IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of Neuroimmunology, 261 (1-2). pp. 87-91.

Yagita, Y., Kuse, N., Kuroki, K., Gatanaga, H., Carlson, J. M., Chikata, T., Brumme, Z. L., Murakoshi, H., Akahoshi, T., Pfeifer, N., Mallal, S., John, M., Ose, T., Matsubara, H., Kanda, R., Fukunaga, Y., Honda, K., Kawashima, Y., Ariumi, Y., Oka, S., Maenaka, K. and Takiguchi, M. (2013) Distinct HIV-1 Escape Patterns Selected by Cytotoxic T Cells with Identical Epitope Specificity. Journal of Virology, 87 (4). pp. 2253-2263.

Yeap, B.B., Divitini, M.L., Gunton, J.E., Olynyk, J.K., Beilby, J.P., McQuillan, B., Hung, J. and Knuiman, M.W. (2014) Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clinical Endocrinology, 82 (4). pp. 525-532.

Yu, X. G., Lichterfeld, M., Chetty, S., Williams, K.L., Mui, S.K., Miura, T., Frahm, N., Feeney, M.E., Tang, Y., Pereyra, F., LaBute, M.X., Pfafferott, K., Leslie, A., Crawford, H., Allgaier, R., Hildebrand, W., Kaslow, R., Brander, C., Allen, T.M., Rosenberg, E.S., Kiepiela, P., Vajpayee, M., Goepfert, P.A., Altfeld, M., Goulder, P.J.R. and Walker, B.D. (2007) Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes. Journal of Virology, 81 (4). pp. 1619-1631.

Zhong, X., Zhou, Y., Lu, T., Wang, Z., Fang, L., Peng, L., Kermode, A.G. and Qiu, W. (2017) Infections in neuromyelitis optica spectrum disorder. Journal of Clinical Neuroscience . In Press.

Zhou, Y., Huang, Q., Lu, T., Sun, X., Fang, L., Lu, Z., Hu, X., Kermode, A. and Qiu, W. (2017) Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG. Journal of Clinical Neuroscience, 38 . pp. 71-73.

da Silva Antunes, R., Paul, S., Sidney, J., Weiskopf, D., Dan, J.M., Phillips, E., Mallal, S., Crotty, S., Sette, A. and Lindestam Arlehamn, C.S. (2017) Definition of human epitopes recognized in tetanus toxoid and development of an assay strategy to detect Ex Vivo tetanus CD4+ T cell responses. PLoS ONE, 12 (1).

von Delft, A., Humphreys, I.S., Brown, A., Pfafferott, K., Lucas, M., Klenerman, P., Lauer, G.M., Cox, A.L., Gaudieri, S. and Barnes, E. (2016) The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut, 65 (1). pp. 112-123.

Conference Paper

Brumme, Z.L., Brumme, C.J., Streeck, H., Carlson, J., Markowitz, M., Jessen, H., Kelleher, A., John, M., Hekerman, D. and Walker, B. Sequential order of escape within HLA-restricted CTL epitopes in the first year of HIV infection is consistent with early immunodominant CTL response patters. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, Massachusetts, USA

Chopra, A. (2016) Analysis and visualization tools for NGS sequence data. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia

Chopra, A., Cooper, D., Sharma, L., Plauzolles, A., Watson, M., Rauch, A., Gaudieri, S. and Mallal, S. (2013) KIR Genotyping using a real time assay and FLX 454. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth

Cooper, D., Chopra, A., Blinco, J., Sharma, L., Dunn, D., Watson, M. and Mallal, S. (2014) HLA typing from second generation sequencing data – where are we headed? In: Asia Pacific Histocompatibility & Immunogenetics Association Conference, 15 - 19 November 2014, Peter Doherty Institute, Melbourne

John, M., Moore, C.B., James, I.R., Christiansen, F.T., Witt, C.S. and Mallal, S.A. (2002) Putative immune escape mutations in HIV-1 sequence: The influence of HLA Class I and II alleles in a host population on viral evolution. In: 13th International HLA Congress, 14-18 May 2002, Seattle, Washington, USA.

Keane, N.M., Almeida, C., Chopra, A., Leary, S., McKinnon, E., Cooper, D., Mallal, S. and John, M. (2014) Viral adaptation in autologous viral sequences of patients with acute and early HIV infection prior to full seroconversion. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia

Keane, N.M., Pfafferott, K., Cooper, D., Roberts, S.G., Chopra, A., Demaine, E., Krishnan, T., Mallal, S. and John, M. (2010) HIV-1 adaptation to early HLA restricted immune responses in acute heterosexual transmission. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Lalanne, C., Goujard, C., Herrmann, S., Cheung-Lung, C., Schwartz, Y., Armstrong, A., Chassany, O. and Duracinsky, M. (2014) Analysis of response .me in electronic PRO instrument: How could it be used to refine the analysis of health-­‐related quality of life data? In: Medicine 2.0 Conference, 9 - 10 October 2014, Malaga, Spain

Lucas, A., Meyer-Pannwitt, V., McKinnon, E., Burrows, S., Rist, M., Leary, S., Lucas, M., Mallal, S. and Phillips, E. (2013) Abacavir impairs an HLA-B*5701-restricted CD8+ T Cell response to an immunodominant Epstein-Barr virus epitope. In: 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013), 3 - 6 March 2013, Atlanta, Georgia

Mallal, S. (2004) HIV, Now a chronic disease. In: 29th Australian & New Zealand Intensive Care Society Annual Scientific Meeting on Intensive Care, 7 - 10 October 2004, Melbourne, VIC

Mallal, S. and Nolan, D. (2004) Complications of HIV infection and its treatment. In: XV World AIDS Conference 2004, July 11-16, 2004, Bangkok, Thailand

Phillips, E., Nolan, D., Thornborn, D., Schaefer, M., Laird, R., Rauch, A., Montaner, J., Hughes, A., James, I. and Mallal, S. Genetic factors predicting Abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals: combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, Massachusetts, USA

Tschochner, M., Rohrbach, J., Cooper, D., Merani, S., Chopra, A., Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S., Rauch, A. and Gaudieri, S. (2010) Characterisation of hepatitis C virus evolution in HIV/HCV coinfected individuals using deep sequencing technology: Relevance for new antiviral drugs and disease outcome. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia

Conference Item

Allan, J., Qui, S., Clark, H., Hofmann, K., Watson, M. and Trinder, D. (2013) Does HCV alter the iron status of infected cells? In: 20th International Symposium on Hepatitis C Virus and Related Viruses, 6-10 October 2013, Melbourne, Australia.

Almeida, C., Bronke, C., Roberts, S., Cooper, D., Corkery, M., McKinnon, E., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M. and Heckerman, D. (2009) Identification of multiple novel HIV-specific T-cell epitopes using HLA-associated HIV polymorphisms. In: 39th Annual Scientific Meeting of the Australasian Society for Immunology 2009, 6 - 10 December 2009, Gold Coast, QLD.

Almeida, C., Bronke, C., Roberts, S., McKinnon, E., Keane, N., Chopra, A., Kadie, C., Carlson, J., Haas, D., Riddler, S., Haubrich, R., Heckerman, D., Mallal, S. and John, M. (2010) HIV-1 adaptation leads to inflation of the HIV-specific CD8 T-cell response against HLA-adapted variant epitopes. In: Annual Meeting. Australasian Society for Immunology 2010, 5 - 9 December 2010, Perth, Western Australia.

Almeida, C., Bronke, C., Roberts, S.G., Ahmad, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2009) Identification of multiple novel HIV-specific T-cell epitopes using HLA-associated HIV polymorphisms. In: AIDS Vaccine 2009, 19 - 22 October 2009, Paris, France.

Almeida, C., Martin, A., Nolan, D., James, I., Cameron, P. and Mallal, S. (2004) Increase in inflammatory cytokine levels in abacavir stimulated mono-nuclear cells from HIV infected patients with abacavir hypersensitivity. In: 16th Annual Conference of the Australasian Society for HIV Medicine, 2 - 4 September 2004, Canberra, Australia.

Almeida, C., Martin, A.M., Nolan, D., James, I. and Mallal, S. (2005) Abacavir stimulated IFN-g production in HLA-B*5701+ abacavir hypersensitive, and naive HIV-infected individuals. In: Australian Society for Medical Research (ASMR), June, 2005, Perth, Western Australia.

Almeida, C.M., Bronke, C., Roberts, S.G., Ahmed, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2012) Exploiting HLA in investigating T cell immunity in HIV-1 infection. In: 9th International Summer School (APHIA) 2012, 11 - 13 November 2013, Adelaide, SA.

Almeida, C.M., Bronke, C., Roberts, S.G., Ahmed, I., Keane, N.M., Chopra, A., James, I., Mallal, S., Heckerman, D. and John, M. (2012) T cell immunity in HIV-1 infection and vaccine design. In: APHIA, 13 November 2013, Adelaide, SA.

Almeida, C.M., Martin, A.M., Nolan, D., James, I. and Mallal, S. (2005) Abacavir stimulated production of inflammatory and T1 cytokines in abacavir hypersensitive and tolerant HIV-infected individuals. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

Almeida, C.M., Olney, A., Claas, F., Witt, C., John, M. and D'Orsogna, L.J. (2013) Cross-reactive HIV Specific TCR Clonotypes identified from an HIV-1 infected patient expressing the Protective HLA-B*27:05 Allele: Implications for Protective HIV Immunity? In: Australian Society of Immunology (ASI) Conference, 2 - 4 December 2013, Wellington, NZ.

Apps, R., Qi, Y., Carlson, J.M., Chen, H., Gao, X., Thomas, R., Yuki, Y., Del Prete, G.Q., Goulder, P., Brumme, Z.L., Brumme, C.J., John, M., Mallal, S., Nelson, G. and Bosch, R. (2013) Opposing effects of HLA-C expression level in viral versus inflammatory disease. In: Keystone conference; Immune Activation in HIV Infection: Basic Mechanisms and Clinical Implications (D2), 3 - 8 April 2013, Breckenridge, Colorado.

Armstrong, A., Duracinsky, M., Lalanne, C., de Silva, M., Jamal, L., Herrmann, S., Carrieri, P., Davril, J. and Chassany, O. (2011) A new framework for understanding the impact of hepatitis C and its treatment on quality of life. In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Bernard, R., Chopra, A., James, I., Cooper, D., Blinco, J., Watson, M., Jabara, C., Lemon, S., Mallal, S. and Gaudieri, S. (2015) Ultra-deep sequencing reveals dynamics of drug Resistance-Associated variants in Hepatitis C viruses: Relevance to treatment outcome and resistance screening. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Bourke, J., Pavlos, R., Hollingsworth, P., McLean-Tooke, A., Horimoto, N., O'Brien, V., Edward, E. and Phillips, E. (2012) Penicillin de-labelling in tertiary clinics: Safe and efficacious but incomplete effectiveness. In: ASCIA 23rd Annual Scientific Meeting, 5 - 8 September 2012, Wellington, New Zealand.

Brumme, C.J., Chan, B., Markle, T., Carlson, J., Martin, E., Le, Q.A., Penney, K., Rahman, M., Kuang, T., Nassab, P., Chopera, D.R., Markowitz, M., John, M., Mallal, S., Walker, B.D., Koblin, B., Mayer, K., Brockman, M.A., Poon Art, F.Y. and Brumme, Z.L. (2011) Molecular and functional consequences of immune-mediated evolution in HIV-1 Nef during the North American epidemic. In: AIDS Vaccine 2011, 12–15 September, 2011, Bangkok, Thailand.

Carlson, J.M., Pfeifer, N., Schaefer, M., Brumme, C., Kreimer, A., DeZiel, C., Tan, V., John, M., Mallal, S., Ndung'u, T., Gilmour, J., Price, M., Lakhi, S., Harrigan, R., Miura, T., Goulder, P., Brumme, Z., Heckerman, D. and Hunter, E. (2013) Adaptation to HLA-I is a primary correlate of HIV-1 disease progression. In: AIDS Vaccine 2013, 7 - 10 October 2013, Barcelona, Spain.

Castley, A. (2013) Monitoring HIV-1 subtype diversity and mobility in the Western Australia HIV cohort - Where are HIV infections coming from and are there forward transmissions? In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Castley, A., Gaudieri, S., Gizzarelli, L., Guelfi, G., John, M. and Nolan, D. (2013) The changing face of HIV-1 diversity in Western Australia - a 12 year analysis. In: 25th Annual Conference of the Australasian Society for HIV Medicine (ASHM) 2013, 21 - 23 October 2013, Darwin, Australia.

Castley, A., Gizzarelli, L., John, M. and Nolan, D. (2014) Monitoring HIV-1 drug resistance mutations among newly diagnosed Western Australian HIV patients. In: 10th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research (ACH²), 4 - 6 June 2014, Lorne, NSW.

Castley, A., Tschochner, M., James, I., Kermode, A., Carroll, W., Sayer, D., Christiansen, F., Witt, C. and Nolan, D. (2011) Investigation of promoter HLA-DRB1 polymorphism in relation to a putative VDRE motif: HLA-DRB1 allele associations and influence on risk of multiple sclerosis. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 19 – 22 October 2011, Amsterdam, Netherlands.

Chan, B., Masters, L., Mitrovic, M., Jonijic, S., Rwandamuriye, F., Shellam, G., Smith, L. and Redwood, A.J. (2015) Acute interactions between the MCMV m15 locus and asialo-GM1+ cells determines viral dissemination to and replication in the salivary glands. In: 8th Australasian Virology Meeting (AVS) 2015, 6 - 9 December 2015, Hunter Valley, NSW.

Chan, B., Mitrovic, M., Masters, L., Jonjic, S., Shellam, G., Smith, L. and Redwood, A. (2016) The m15 locus of murine cytomegalovirus modulates natural killer cell responses and promotes dissemination to the salivary glands. In: International Congress of Immunology, 21 - 26 August 2016, Melbourne, VIC.

Cherry, C., Rosenow, A., Wesselingh, S., James, I., French, M., McArthur, J., Lal, L. and Price, P. (2006) Cytokine genotypes establish a role for inflammation in antiretroviral toxic neuropathy (ATN) and predict and individual's ATN risk. In: 13th Conference on Retroviruses and Opportunistic Infections, 5 - 9 February 2006, Denver, Colorado, USA.

Chikata, T., Carlson, J.M., Tamura, Y., Borghan, M.A., Naruto, T., Hashimoto, M., Murakoshi, H., Mallal, S., John, M., Gatanaga, H., Oka, S., Brumme, Z.L. and Takiguchi, M. (2013) HIV-1 polymorphisms associated with 4-Digit HLA alleles in Japanese individuals chronically infected with the Clade B virus. In: AIDS Vaccine 2013, 7 - 10 October 2013, Barcelona, Spain.

Chikata, T., Carlson, J.M., Tamura, Y., Brumme, Z.L., Naruto, T., Hashimoto, M., Borghan, M.A., John, M., Mallal, S., Gatanaga, H., Oka, S. and Takiguchi, M. (2012) HLA-associated viral polymorphism in chronically HIV-1-Infected Japanese cohort: Analysis of four-digit HLA allele level. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Chopra, A. (2016) Core Laboratory Activity at IIID. In: Immunology Seminar. Fiona Stanley Hospital, Murdoch, W.A.

Chopra, A. (2013) High throughput HLA sequence-based typing using next generation sequencing. In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Chopra, A., Clark, H., Blinco, J., John, M., Watson, M. and Mallal, S. (2015) Identification of clonal TCR expansion using Next Generation Sequencing. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Chopra, A., Cooper, D., Sharma, L., Choo, L., Blinco, J., Dunn, D., Leary, S., Watson, M. and Mallal, S. (2012) High throughput HLA sequence-based typing using Next Generation Sequencing. In: 22nd Annual Combined Biological Sciences Meeting, 24 August 2012, University of Western Australia, Perth.

Chopra, A., Cooper, D., Sharma, L., Plauzolles, A., Watson, M.W., Rauch, A., Gaudieri, S. and Mallal, S. (2013) KIR genotyping using a real time assay and FLX454. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Chopra, A., Deganaar, J., Rushton, B., Maiden, T., Keller, J., Park, P.L., Gaudieri, S., John, M. and Mallal, S. (2007) High throughput sequencing of full length HIV-1 genomes. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Chopra, A., Gaudieri, S., Clark, H., Blinco, J., Cooper, D., Leary, S., Watson, M. and Mallal, S. (2015) Cutting edge tools for Phenotyping and characterising T-Cell subsets. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Chopra, A., Gaudieri, S., Pilkington, M., Blinco, J., Leary, S., Cooper, D., Abana, C., Watson, M., Kalams, S. and Mallal, S. (2016) Cutting edge tools for phenotyping and characterising T-Cell subsets. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Chopra, A., Mpunga, T. and Gaudieri, S. (2015) Differential gene expression profiling of NK cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Chopra, A., Watson, M., Cooper, D., Leary, S., John, M. and Mallal, S. (2009) High throughput long amplicon sequencing, assembly and reference mapping of HIV genome using the GS FLX sequencer. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Christiansen, F.T., Langan, L., Park, L.P., Luxton, G., Witt, C.S. and Irish., A. (2007) Soluble CD30 and HLA antibodies independently and additively predict subsequent kidney graft outcome. In: 25th Annual Scientific Meeting of the TSANZ, 28 - 30 March 2007, Canberra, ACT, Australia..

Christiansen, F.T., Langen, L., Park, L.P., Luxton, G., Witt, C. and Irish, A. (2006) Soluble CD30 and HLA antibodies have an independent and additive effect on post transplant kidney graft outcome. In: American Society of Histocompatibility and Immunogenetics (ASHI) 32nd Annual Meeting, 16 - 20 October 2006, San Diego, USA.

Cooper, D., Chopra, A., Blinco, J., Jabara, C., Lemon, S., Barnard, R., Gaudieri, S., Watson, M. and Mallal, S. (2012) Accurate identification of HCV sequence variants using deep sequencing with a primer ID. In: 22nd Annual Combined Biological Sciences Meeting, 24 August 2012, University of Western Australia, Perth.

Cooper, D., Chopra, A., Blinco, J., Leary, S., Watson, M. and Mallal, S. (2015) Hybridization based enrichment for genotyping HLA and KIR genes using Next Generation Sequencing. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Cooper, D., Chopra, A., Blinco, J., Watson, M., Gaudieri, S. and Mallal, S. (2013) Forensic analysis of mitochondrial DNA mixtures by 454 FLX sequencing. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Cooper, D., Patsopoulos, N., Chopra, A., Watson, M., de Bakker, P. and Mallal, S. (2011) HLA Class I typing based on FLX 454 sequencing. In: 21st Annual Combined Biological Sciences Meeting, 26 August 2011, Perth, Western Australia.

Cotton, L., Chopera, D., Penney, K., Carlson, J., Martin, E., Le, A., Kuang, T., Walker, B., Fuchs, J., Buchbinder, S., Wagner, T., John, M., Mallal, S., Koblin, B., Mayer, K., Poon, A., Brockman, M. and Brumme, Z. (2012) Limited evidence for alterations in Gag-mediated HIV replication capacity over the course of the North American epidemic (1979-Present). In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

D'Orsogna, L.J. (2016) Stimulation of HIV-specific T cell responses using allogeneic HLA. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Deshpande, P., Lucas, M., Brunt, S., Goulding, M., Hollingsworth, P. and Bundell, C. (2013) Low level autoantibodies are common in a general Australian population. In: Australasian Society of Clinical Immunology and Allergy (ASCIA) 24th Annual Scientific Meeting, 11 - 13 September 2013, Perth, Australia.

Deshpande, P., Pfafferott, K., Lucas, M. and Gaudieri, S. (2013) Cross-genotype immunity in individuals with High-risk HCV exposure. In: 20th International Symposium on Hepatitis C Virus and Related Viruses, 6 - 10 October 2013, Melbourne, VIC.

Duracinsky, M., Armstrong, A., Herrmann, S., Lalanne, C., Fofana, D.A., Galano, E., Da Silva, M.H., Carrieri, P.M. and Chassany, O. (2016) Validation of health-related quality of life (HRQL) of a new questionnaire specific to Viral hepatitis C: PROQOL-HCV. In: 51st European Association of the Study of Liver Disease Annual Meeting (EASL), 13 - 17 April 2016, Barcelona, Spain.

Fernandez, S., Price, P., McKinnon, E.J., Nolan, R.C. and French, M.A. (2005) Low CD4+ T-cell counts in immunodeficient HIV patients receiving stable antiretroviral therapy are associated with CD4+ T-cell activation and senescence but no with low interferon-g responses. In: 35th Annual Meeting of the Australasian Society for Immunology, 4 - 8 December 2005, Melbourne, Australia.

French, M.A., Keane, N.M., Phung, S., McKinnon, E. and Price, P. Immune reconstitution in severely immunodeficient HIV patients is biased towards type 2 immune responses. In: 3rd IAS Conference on HIV Pathogenesis and Treatment, 25 - 27 August 2005, Rio de Janeiro, Brazil.

Galvão, V.R., Pavlos, R., McKinnon, E. and Guitart, M.C.C. (2016) Overrepresentation of a Class II HLA haplotype in severe hypersensitivity Type I reactions To carboplatin. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Factors affecting liver elastography in community-based young adults in the Raine study. In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gan, E.K., Olynyk, J.K., Marsh, J.A., Ayonrinde, O.T., Mori, T.A., Beilin, L.J. and Adams, L. (2012) Liver stiffness as a novel marker of metabolic syndrome? In: The Liver Meeting 2012: American Association for the Study of Liver Diseases (AASLD) 63rd Annual Meeting, 9 - 13 November 2013, Boston, MA.

Gaudieri, S. (2007) Evidence of viral adaptation to host immune pressure in hepatitis C virus infection. In: 31st Annual Scientific Meeting of the Australasian and South East Asian Tissue Typing Association (ASEATTA) 2007, 14 - 16 November 2007, Fremantle, WA.

Gaudieri, S. (2006) Host interaction in hepatitis C infection. In: 14th International HLA and Immunogenetics Workshop, 29 November - 3 December 2005, Melbourne, Australia.

Gaudieri, S. (2016) T cells: TCR sequencing, transcriptomics and transfectomas. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Gaudieri, S. (2007) Viral adaptation to the host’s immune responses to HIV and Hepatitis C. In: Annual Scientific Meeting of the Australian Society of Microbiology., 9 - 13 July 2007, Adelaide, South Australia.

Gaudieri, S., Chopra, A., Leary, S., Clark, H., Mallal, S., Baraki, B., Brockman, M., Brumme, Z.L. and John, M. (2016) Identifying sites of “Deep Conservation" in HIV-1 for vaccine immunogen design. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Baker, R., Cheng, W., McCaughan, G., Shackel, N., Jeffrey, G., Mollinson, L., Mallal, S., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Nolan, D., John, M. and Lucas, M. (2009) Co-localisation of hepatitis C virus drug-resistant mutations and immune-driven adaptations: Relevance to therapy outcome. In: 19th Annual Combined Biological Sciences Meeting 2009, 28 August 2009, Perth, Western Australia.

Gaudieri, S., Rauch, A., James, I., Pfafferott, K., Cheng, W., McCaughan, G., Jeffrey, G., Mollison, L., Furrer, H., Günthard, H., Hirschel, B., Klenerman, P., Mallal, S., Nolan, D., John, M. and Lucas, M. (2009) Divergent adaptation of Hepatitis C virus genotypes to HLA-restricted immune pressure: relevance to HCV infection and vaccine design. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October 2009, Nice, France.

Gaudieri, S., Rauch, A., Pfafferott, K., Park, L. and Mallal, S. (2007) Limited overlap in HLA-associated viral diversity between hepatitis C virus genotypes 1 and 3. In: 4th Australian Virology Group Meeting, 9 - 13 December 2007, Fraser Island, Queensland.

Gaudieri, S., Tschochner, M., Cooper, D., Chopra, A., Merani, S., Witteck, A., Battegay, M., Günthard, H., Furrer, H., Rohrbach, J. and Rauch, A. (2010) Identification of HCV minority species in HIV/HCV coinfected individuals using deep sequencing technology: relevance for new anti-HCV drugs and host immune responses to HCV. In: The 17th International Meeting on Hepatitis C Virus and Related Diseases., 10 - 14 September 2010, Yokohama, Japan.

Gaylard, E., Lucas, A., Deshpande, P., Lucas, M. and Gaudieri, S. (2014) Identification of new CD4+ T Cell Hepatitis C Virus Targets: Relevance to Infection Outcome. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Graham, R., Delima, R.D., Johnstone, D., Milward, E.A., Olynyk, J.K. and Trinder, D. (2013) Changes in gene expression of cholesterol metabolism pathways in mouse models of haemochromatosis. In: BioIron 2013, 14 - 18 April 2013, University College, London.

Hammond, E., Almeida, C., Mamotte, C., Nolan, D., Phillips, E., Schollaardt, T., Gill, M.J., Angel, J.B., Neurath, D., Li, J., Giulivi, T., McIntyre, C., Koultchitski, G., Wong, B., Reis, M., Rachlis, A., Cole, D.E., Chew, C.B., Neifer, S. and Mallal, S. (2007) Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Hammond, E., Shaw, K., Carnley, B., James, I., Png, S. and Herrmann, R. (2006) TaqMan quantitation of JAK2 V617F mutational load: a sensitive diagnostic tool that reflects clonal proliferation. In: Annual Combined Haematology Society of Australian and New Zealand, 16 October 2006, Hobart, Tasmania.

Harari, A., Cellerai, C., Kostler, J., Gaudieri, S., James, I., John, M., Wagner, R., Mallal, S. and Pantaleo, G. (2007) Relationship between HLA Genotype and the functional profile of Antigen-specific CD8 T cells. In: 14th Conference on Retroviruses and Opportunistic Infections, 25 - 28 February 2007, Los Angeles, U.S.A.

Herrmann, S., Duracinsky, M., Lalanne, C., Acquadro, C., Mallal, S. and Nolan, D. (2009) Health-related quality of life in the WA HIV Cohort: 2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Antiretroviral issues in temporary visa holders in Western Australia: A qualitative report on access, attitude and adherence. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., John, M., Wardrop, J. and Nolan, D. (2011) Experiences of people on temporary visas who are diagnosed with HIV in Western Australia. In: 23rd Annual Australasian Society for HIV Medicine Conference, 26 - 28 September, Canberra, Australia.

Herrmann, S., Lucas, M., John, M. and Nolan, D. (2011) Implementing medication adherence interventions into HIV clinical care: Implications for current research and other blood borne viruses. In: WA SiREN Research Symposium - Found or Lost in Translation, 6 May, Perth, Western Australia.

Herrmann, S., McKinnon, E., Grace, A., Locke, V., Correia, H., Byrnes, M., Chaney, R., Mastaglia, F. and Mallal, S. (2016) A snapshot of neuropsychological health in a “50-Something Aged” cohort of people living with chronic HIV infection. In: Australasian Sexual Health Conference (ASHM) 2016, 14 - 16 November 2016, Adelaide, Australia.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2009) Substance use in the WA HIV Cohort: 2002-2008. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Herrmann, S., Williams, L., McKinnon, E. and Nolan, D. (2010) Vulnerable populations: Substance use in the WA HIV Cohort Study. In: 17th Western Australian Drug and Alcohol Symposium, 30 August - 1 September, Fremantle, Western Australia.

Herrmann, S.E., Grace, A., McKinnon, E., Skinner, M.J., Locke, V., Correia, H., Byrnes, M., Chaney, R. and Mastaglia, F.L. (2016) Moving into the 50+ age demographic: A snapshot of neuropsychological health in a cohort of people living with chronic HIV infection. In: Australasian HIV AIDS Conference 2016, 16 - 18 November 2016, Adelaide, SA.

Hertz, T., Nolan, D., James, I., John, M., Gaudieri, S., Phillips, E., Huang, J., Riadi, G., Mallal, S. and Jojic, N. (2011) HLA class I binding and its relationship with evolutionary conservation in human proteins and viral proteomes. In: Keystone HIV Evolution Genomics & Pathogenesis, 20 - 25 March 2011, Whistler, British Columbia, Canada.

James, I. (2014) Assessment of positivity in ELISPOT assays based on FDR-type and mixture procedures. In: 35th Annual Conference of the International Society for Clinical Biostatistics (ISCB 2014), 24 - 28 August 2014, Vienna, Austria.

James, I. (2007) Estimation of natural disease progression with unknown or uncertain dates of infection. In: 2007 Australian & New Zealand Industrial and Mathematics (ANZIAM) Conference, January, 2007, Fremantle, WA.

James, I. (2007) Missingness in the T1DGC MHC fine mapping data. In: Type I Missingness in the T1DGC MHC fine mapping data, 27 - 28 August 2007, Washington, USA.

James, I. (2008) Statistical issues in large-scale viral-host genetic association studies. In: 29th Conference of the International Society for Clinical Biostatistics, 17 - 21 August 2008, Copenhagen, Denmark.

James, I., Hepworth, A. and KcKinnon, E. (2010) Correlation estimation with bivariate censored data. In: Annual Conference of the International Society of Clinical Biostatistics., 30 August – 2 September 2010, Montpellier, France..

James, I. and McKinnon, E. (2009) Estimation of natural HIV disease progression incorporating unknown infection dates. In: 30th Conference of the International Society for Clinical Biostatistics, 23 - 27 August 2009, Prague, Czech Republic.

James, I. and McKinnon, E. (2007) Estimation of natural disease progression when seroconversion dates are unknown or uncertain. In: 11th International Workshop on HIV Observational Databases, 22 - 25 March, Monte Carlo.

James, I. and McKinnon, E. (2013) Viral diversity attributable to host genotype. In: 34th Annual Conference of the International Society for Clinical Biostatistics (ISCB) 2013, 25 - 29 August 2013, Munich, Germany.

James, I., McKinnon, E. and Morahan, G. (2007) Contrasting results from different approaches to T1DGC SNP analyses. In: Type I Diabetes Genetics Consortium: MHC Fine Mapping Results Workshop, 27 - 28 August 2007, Washington, USA.

James, I., McKinnon, E. and Morahan, G. (2008) Identifying potential MHC markers of T1D susceptibility via clustering. In: Type 1 Diabetes Genetics Consortium: Analytic Results Meeting, 21 - 23 October 2008, Washington DC, USA.

James, I., Rauch, A., McKinnon, E., Telenti, A. and Furrer, H. (2006) Post-HAART immunologic and virologic trends and carriage of HLA-Bw4: A comparison of the Western Australian and the Swiss HIV Cohort Studies. In: 10th International Workshop on HIV Observational Databases, 23 – 26 March 2006., Madrid, Spain.

John, M. (2015) ANA and immune periodicity. In: WA ASCIA Research day, 20 June 2015, The Zoo, South Perth, WA.

John, M. (2008) Applications of MHC-HIV co-evolution for HIV vaccine design. In: Applications of MHC-HIV co-evolution for HIV vaccine design. 3rd Annual CAVD Meeting , Collaboration for AIDS Vaccine Discovery (CAVD) Conference, 3 - 5 December 2008, Seattle, Washington, USA.

John, M. (2015) Celiac Disease: New food for thought, Celiac disease and advances in T cell diagnostics. In: ASCIA Educational Seminars, 13 October 2015, Perth, WA.

John, M. (2015) Drug hypersensitivity and abacavir. In: The art of ART meeting, 11 April 2015, Brisbane, Australia.

John, M. (2008) Genetic factors in HIV and HCV disease. In: ASHM “Meet the Expert” – Basic Science. 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September 2008,, Perth, Australia.

John, M. (2009) HIV immunogen design. In: PTVDC Plenary Meeting, 23 - 25 April 2009, Vienna, Austria.

John, M. (2016) Host-pathogen adaptation and evolutionary analyses. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

John, M. (2015) Immune deficiency and autoimmunity updates. In: Rural Health West WEBCAST, 16 October 2015, Perth, WA.

John, M. (2005) Using the most powerful tools of our time to combat the HIV pandemic and other infectious diseases. In: Australian Society for Medical Research (ASMR) Medical Research Week, June 2005, Perth, Western Australia.

John, M., Gaudieri, S., Chopra, A., Leary, S., Jorritsma, J., Mallal, S., Baraki, B., Brockman, M. and Brumme, Z. (2015) Strong functional constraint at residues in HIV-1 Gag are predicted by measures of evolutionary rather than population-level genetic conservation. In: 8th AIS Conference on HIV Pathogenesis, Treatment & Prevention, 19 - 22 July 2015, Vancouver, Canada.

John, M., Gaudieri, S., Chopra, A., Leary, S., Jorritsma, J., Mallal, S., Baraki, B., Brockman, M.A. and Brumme, Z.L. (2016) HIV-1 residues under strong functional constraint are predicted by measures of evolutionary rather than population-level genetic conservation. In: 25th Conference of the Canadian Association for HIV Research (CAHR) 2016, 12-15 May 2016, Winnipeg, Manitoba, Canada.

John, M., Heckerman, D., Park, L., Gaudieri, S., James, I., Nolan, D., Chopra, A., Riddler, S., Haubrich, R. and Mallal, S. (2007) Strong genome-wide HLA associated selection in HIV-1. In: 31st Annual Scientific Meeting of the Australasian and South East Asian Tissue Typing Association (ASEATTA) 2007, 14 - 16 November 2007, Fremantle, WA.

John, M. and Keane, N.M. (2008) Immune escape variants. In: 3rd Annual CAVD Meeting, Collaboration for AIDS Vaccine Discovery Conference, 3 - 5 December 2008, Seattle, Washington, USA..

Jorritsma, J., Keane, N., Ma, M., Forbes, G. and John, M. (2013) Optimisation of a Novel Assay to Detect Gliadin-Specific T-cells in Celiac Disease. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Jorritsma, J., Tay, J., Hughes, Q. and Baker, R. (2015) In silico prediction of microRNA binding sites in haemostatic factors. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

KcKinnon, E., James, I., Nolan, D., Gaudieri, S. and Morahan, G. (2007) Application of survival techniques to assessment of Type I Diabetes susceptibility regions across the MHC. In: Type I Diabetes Genetics Consortium: MHC Fine Mapping Results Workshop, 27 - 28 August 2007, Washington, USA.

Keane, N., Almeida, C., Chopra, A., Leary, S., Cooper, D., McKinnon, E., Mallal, S. and John, M. (2013) Analysis of HLA-restricted HIV-specific CD8 T cell responses and viral adaptation in patients with acute HIV infection prior to full seroconversion. In: 9th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research, (ACH²), 5 - 7 June 2013, Katoomba, NSW.

Keane, N., Almeida, C.M., Chopra, A., Cooper, D., Mallal, S. and John, M. (2013) Analysis of HLA-restricted HIV-specific CD8 T cell responses and viral adaptation in patients with acute HIV infection prior to full seroconversion. In: Towards an HIV Cure Symposium IAS Conference, 30 June - 3 July 2013, Kuala Lumpur, Malaysia.

Keane, N., Lucas, A., Netto, J., Almeida, C., Martin, A., Marriott, D., Kelleher, A., Phillips, E., Nolan, D. and Mallal, S. (2007) Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Keane, N.M., Almeida, C., Chopra, A., Cooper, D., Demaine, E., Mallal, S. and John, M. (2012) Early changes in the CD8 T cell immunodominance hierarchy in primary HIV infection prior to seroconversion. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Keane, N.M., Almeida, C., Roberts, S., Ahmad, I., Mallal, S. and John, M. (2012) Evaluation of the dual IFNγ/IL-2 Fluorospot-assay with flow cytometry for detection of HLA-restricted HIV-specific T-cell responses in HIV controllers. In: AIDS Vaccine 2012, 9 - 12 September 2012, Boston, U.S.A.

Keane, N.M., Lucas, A.D., Almeida, C.M., Martin, A.M., Netto, J.D., Nolan, D. and Mallal, S. (2006) HIV-1 patients 3 years or more post a nevirapine hypersensitivity reaction show no detectable lymphoproliferative responses to nevirapine (5-20µg/ml). In: 18th Annual Conference Australasian Society for HIV Medicine, 11 – 14 October 2006, Melbourne, Australia.

Keane, N.M., Ma, M.X., Jorritsma, J., Forbes, G. and John, M. (2015) Development of a Novel T cell based assay to aid diagnoses of coeliac disease. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Keane, N.M., Pfafferott, K., Cooper, D., Chopra, A., Roberts, S.G., Sterrett, S., Leary, S., Demaine, E., Krishnan, T., Mallal, S., Bar, K., Shaw, G. and John, M. (2011) Limited acute CTL escape among three founder viruses in a case of acute heterosexual transmission of HIV-1 infections. In: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention., 17 - 20 July, 2011, Rome, Italy.

Keane, N.M., Pfafferott, K., Cooper, D., Roberts, S.G., Chopra, A., Demaine, E., Krishan, T., Mallal, S. and John, M. (2010) FLX 454 deep sequencing of HLA-restricted viral epitope sequences in acute HIV infection identifies sites of selection. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5 - 9 December 2010, Perth, Australia.

Kermode, A. (2013) Current understanding of pathogenic mechanisms for MS and a novel therapeutic approach. In: Multiple Sclerosis for Healthcare Professionals conference, 14 - 15 September 2013, Sydney, NSW.

Kermode, A. (2016) Early treatment of MS. In: 15th Asian and Oceanian Congress of Neurology (AOCN), 18 - 21 August 2016, Kuala Lumpur, Malaysia.

Kermode, A. (2016) Is there such a thing as benign MS? In: Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting, 24 - 27 May 2016, Perth, WA.

Kermode, A., Pedrini, M., Seewann, A., Bennet, K., Marshall, B. and Carroll, W. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark.

Konvinse, K.C., White, K., Pavlos, R., Redwood, A., Trubiano, J., Ergen, E., Mallal, S.A. and Phillips, E.J. (2016) Allergic Mechanisms: Characterizing immune responses in severe T-cell mediated adverse drug reaction. In: American Association of Immunologists Conference, (AAI) 2016, 13 - 17 May 2016, Seattle, USA.

Kostenko, L., Lucas, A., Kjer-Nielsen, L., Foley, B., Nicholson, I., Tait, B., Holdsworth, R., Rossjohn, J., Mallal, S. and McCluskey, J. (2007) A rapid and sensitive flow-based screening test for detection of HLA-B57 to avoid abacavir hypersensitivity. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Laird, R., Almeida, C., Roberts, S., Lucas, A., Keane, N., Turley, J., Chopra, A., Rushton, B., Pfafferott, K., Mallal, S. and John, M. (2007) An Automated high-throughput method for ELISpot testing of antigen specific T-cell responses. In: Annual Scientific Meeting. Australasian Society for Immunology, 7 - 11 December 2007, Canberra, A.C.T.

Lalanne, C., Armstrong, A.R., Herrmann, S., Chassany, O. and Duracinsky, M. (2011) How does health-related quality Of life relate to symptoms experienced in HIV patients treated with highly-active antiretroviral therapy? In: ISPOR 14th Annual European Congress, 5 - 8 November, Madrid, Spain.

Lalanne, C., Herrmann, S., Armstrong, A., Lecoeur, S., Goujard, C., Chassany, O. and Duracinsky, M. (2014) Joint analysis of reported symptoms and health-related quality of life endpoints in HIV patients: A way to improve health care. In: IXème Congrès de Physiologie, Pharmacologie et de Thérapeutique (P2T) 2014, 22 - 24 April 2014, Poitiers, France.

Lalanne, C., Herrmann, S., Armstrong, A.R., Cheung-Lung, C., Schwartz, Y., Chassany, O. and Duracinsky, M. (2013) Paper-based and electronic assessment of health-related quality of life specific to HIV disease: A reliability study with the Proqol-HIV questionnaire. In: International Society for Pharmacoeconomics and Outcomes Research, 16th Annual European Congress, 2 - 6 November, Dublin, Ireland.

Lange, J., Brinkman, K., John, M., Kakuda, T., Moyle, G., Galli, M. and Saint Marc, T. (2000) Mitochondrial toxicities and metabolic complications in antiretroviral therapy. In: World Health CME, September, 2000, 41 Madison Ave, New York, New York.

Leary, S., Cooper, D., Chopra, A., Watson, M. and Mallal, S. (2016) Analysis and visualisation tools for NGS sequence data. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Leary, S., Cooper, D., Chopra, A., Watson, M. and Mallal, S. (2013) IIID VGAS - A visual genome analysis studio incorporating high performance next generation sequence analysis. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Leary, S., Cooper, D., Chopra, A., Watson, M. and Mallal, S. (2013) IIID VGAS: A visual genome analysis studio incorporating high performance next generation sequence analysis. In: Great Lakes Bioinformatics Conference (GLBIO) 2013, 14 - 16 May 2013, Pittsburgh, PA.

Lee, M.H., Anderson, J., Stocker, S.L., Williams, K.M., Graham, G.G., Phillips, E.J., Nolan, D. and Day, R.O. (2009) A tale of two brothers: A familial study of risk factors to allopurinol-induced Stevens-Johnson Syndrome. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Li, H., Bar, K.J., Chen, Y., Hahn, B.H., Pfafferott, K., John, M., Mallal, S. and Shaw, G.M. (2010) Molecular identification of transmitted/founder viruses by single genome amplification following percutaneous occupational exposure to HIV-1. In: AIDS Vaccine Conference, 28 September – 1 October 2010, Altanta, USA..

Lim, A., Price, P., Kamarulzaman, A., James, I. and French, M. (2006) Regulatory T cell populations accumulate as HIV disease progresses and decline as patients respond to combination antiretroviral therapy. In: Australasian Society for Immunology, 3 - 7 December 2006, New Zealand..

Lo, G., Herrmann, S., Cheng, W., Kontorinis, N., Nolan, D. and Lucas, M. (2008) HIV/Hepatitis co-infection in the WA HIV cohort: a clinical audit. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Lucas, A., Lucas, M., Mallal, S. and Phillips, E. (2010) Antigen specific CD8+T cells in abacavir hypersensitiviy can become oligoclonal, CD43Io+/-CD127hi. In: 40th Australasian Society of Immunology Annual Scientific Meeting, 5 - 9 December 2010, Perth, W.A.

Lucas, A., Lucas, M., Pavlos, R., Mallal, S. and Phillips, E. (2012) Abacavir reactive HLA-B*5701 restricted memory CD8+ T cells are present in abacavir unexposed donors. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Lucas, A.D., Lucas, M., Mallal, S. and Phillips, E.J. (2010) Antigen specific CD8+ T-cells in abacavir hypersensitivity are oligoclonal and CD34lo. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Lucas, M., Northfield, J., Young, N., Lauer, G., Walker, B. and Klenerman, P. (2004) HCV specific CD8+ T-cells display a novel pattern of expression of NK inhibitory molecules. In: 11th International Symposium on Hepatitis C and Related Diseases, 3 - 7 October 2004, Heidelberg, Germany.

Lucas, M., Pfafferott, K., Baker, R., Baccala, M., Herrmann, S. and Gaudieri, S. (2009) HCV-specific T-cell responses reflect Hepatitis C infection outcome following multiple exposures to the virus. In: Australian Centre for HIV & Hepatitis Virology Research (ACH2) 5th National Workshop, 3 - 5 June, Terrigal, NSW, Australia.

Lucas, M., Pfafferott, K., Baker, R., Cheng, W., Mollison, L., Baccala, M., Miczkova, S., Nazareth, S., Herrmann, S., Rauch, A. and Gaudieri, S. (2009) Correlates of infection outcome following multiple exposures to the Hepatitis C virus. In: 16th International Symposium on Hepatitis C Virus & Related Viruses, 3 - 7 October, Nice, France.

Lucas, M., Ulsenheimer, A., Pape, G., Diepolder, H. and Klenerman, P. Rapid loss of virus-specific CD4+ T cells as after acute hepatitis C virus infection. In: . 2nd National Scientific Workshop 2005, Australian Centre for Hepatitis Virology & HIV Virology Interest Group, 4 - 6 May 2005, Terrigal, NSW.

Lui, W., Tay, J., Hughes, Q., Tiao, J. and Baker, R. (2015) MicroRNA-494 promotes thrombosis by targeting multiple coagulation factors. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26 - 27 November 2015, Murdoch University, Perth.

Mallal, S. (2005) Adaptations of HIV to the immune system. In: 15th Challenge in Virology, Swiss Academic Foundation for Education in Infectious Diseases, 14 January 2005, Saanen-Gstaad, Switzerland.

Mallal, S. (2011) Are the best ART regimens for induction the best regimes for maintenance? In: Merck Satellite meeting ASHM, 27 September, 2011, Canberra, ACT, Australia.

Mallal, S. (2011) Co-evolution of HLA and viruses. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Mallal, S. (2010) Co-evolution of HLA and viruses. In: Seminar presentation, 29 October 2010, Marshall Centre, University of Western Australia, Perth, Australia..

Mallal, S. Co-evolution of HLA and viruses. In: Forefront Lecture, British Columbia Centre for Excellence in HIV/AIDS, 4 March, 2011, Vancouver, Canada..

Mallal, S. (2010) Drivers of excellence in clinical care. In: Leadership WA Conference, 16 June 2010, Perth, Australia..

Mallal, S. (2006) Drug hypersensitivity in the setting of HIV: pathogenesis and management. In: 8th International Congress on Drug Therapy in HIV Infection, 12 - 16 November 2006, Glasgow, UK.

Mallal, S. (2011) Evolution of HIV therapy. In: HIV Treatment Updates. Body Positive New Zealand, 26 August, 2011, Pullman Hotel, Auckland, NZ.

Mallal, S. (2010) Further insights into the genetic predisposition to abacavir hypersensitivity. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Mallal, S. (2004) HIV and Hepatitis C Adaptation to HLA-Restricted Immune Responses. In: 16th Annual Conference of the Australasian Society for HIV Medicine, 2 - 4 September 2004, Canberra, ACT, Australia.

Mallal, S. (2009) HLA-B*5701 screening for abacavir hypersensitivity: Immunopathogenesis and Laboratory implementation. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute, 23 June 2009, Moscow, Russia.

Mallal, S. (2014) Heterologous immunity: Parallels between transplant rejection and drug hypersensitivitiy. In: Renal Medicine Seminar, 12 December 2014, Vanderbilt University, Nashville.

Mallal, S. (2011) Lipoatrophy: forgotten but never forgiving. In: HIV Treatment Updates, Body Positive New Zealand, 26 August, 2011, Pullman Hotel, Auckland, NZ.

Mallal, S. (2000) Long-term complications of antiretroviral therapy. In: HIV Treatment 2000: Clinical Management Issues, 30 November – 3 December, 2000., Tucson, Arizona, USA.

Mallal, S. Organizer: The Evolution of HIV Care over the last three decades. Train the trainer. In: HIV Clinical Leaders from Asia-Pacific region at the Institute of Immunology and Infectious Diseases, 19 - 20 January, 2011, Perth, Western Australia.

Mallal, S. (2009) Pharmacogenetic testing for predicting at risk patients: Genotyping and flow cytometry of HLA-B. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Mallal, S. (2010) Pharmacogenomics and adverse reactions. In: 16th World Congress of Basic and Clinical Pharmacology, 17 - 23 July 2010, Copenhagen, Denmark..

Mallal, S. (2011) Potential role of Heterologous Immunity in drug hypersensitivity. In: UWA School of Pathology & Laboratory Medicine, 17 June, 2011, Perth, Western Australia.

Mallal, S. (2016) Putting together core technologies for your AdVANTAGE. In: PMI Research Retreat, 30 January 2016, Student Life Center, Vanderbuilt University, Nashville.

Mallal, S. (2000) Resistance and other factors involved in therapy failure. In: GlaxoSmithKline Symposium at the 5th International Congress on Drug Therapy in HIV Infection, 22-26 October 2000, Glasgow, United Kingdom.

Mallal, S. (2011) Role of Heterologous Immunity in Transplantation Rejection and Drug Hypersensitivity. In: Merck Sharp & Dohme, May 6, 2011, West Point, NY, USA.

Mallal, S. (2016) Role of heterologous immunity in transplant rejection and other experiments of man. In: Division of Hematology/Oncology Hematology Grand Rounds, 30 March 2016, Vanderbilt University, Nashville.

Mallal, S. (2016) T Cells behaving badly: Evolution to population to single cells. In: ID Grand Rounds, 10 March 2016, Vanderbilt University, Nashville.

Mallal, S. (2010) Translation of Personalized Medicine into the Clinic: Difficult but not Impossible. In: Seminar presentation, 27 October 2010, Sir Charles Gairdner Hospital, Perth, Australia..

Mallal, S. (2010) Translation of personalized medicine into the clinic: Difficult but not impossible. In: Univation, 4 November, 2010., Royal Perth Hospital, Perth, Western Australia.

Mallal, S. (2011) Translational Pharmacogenetics: Pharmacogenomics of HIV/Antiretroviral Therapy at Institute of Immunology and Infectious Diseases. In: Satellite workshop in conjunction with ASCEPT conference, 4 December, 2011, Perth, Western Australia.

Mallal, S. (2010) The pharmacogenetics of drug hypersensitivity. In: 16th World Congress of Basic and Clinical Pharmacology, 17 - 23 July 2010, Copenhagen, Denmark.

Mallal, S., Hertz, T., John, M., Gaudieri, S. and James, I. (2008) Co-evolution of viruses and their human host: What it might teach us? In: Perth Immunology Group Meeting, 9 - 10 October 2008, Perth Western Australia.

Mallal, S., Hertz, T., John, M., Gaudieri, S., James, I., Phillips, E., Nolan, D. and Jojic, N. (2008) Co-evolution of HLA and viruses: implications and applications. In: Australasian Society for Immunology Meeting, 7 - 11 December 2008, Canberra, ACT, Australia.

Mallal, S., John, M., Gaudieri, S., Phillips, E. and Nolan, D. (2008) How might understanding of the co-evolution of HLA and viruses inform contemporary clinical issues. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Mallal, S. and Nolan, D. (2004) Metabolic complications of HIV infection and its treatment. In: 11th Conference on Retroviruses and Opportunistic Infections (CROI), February 2004, Washington, USA.

Mallal, S. and Phillips, E. (2012) Abacavir and the altered peptide repertoire model: Clinical implications. In: 11th International Congress on Drug Therapy in HIV Infection, 11 - 15 November 2012, Glasgow, Scotland.

Mallal, S. and Phillips, E. (2015) Personalizing immunology: The immunopathogenesis of severe T-cell mediated drug hypersensitivity. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Mallal, S., Phillips, E., Carosi, G., Molina, J-M, Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kozyrev, O., Flores, C.J., Hay, P., Nolan, D., Hughes, S., Hughes, A., Thorborn, D. and Benbow, A. (2007) PREDICT-1: a novel randomised prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Mallal, S., Phillips, E., Carosi, G., Molina, J.M., Workman, C., Tomazic, J., Jagel-Guedes, E., Rugina, S., Kosyrey, O., Flores, C.J., Hay, P., Nolan, D., Thorborn, D. and Benbow, A. (2007) PREDICT-1: A novel randomized prospective study to determine the clinical utility of HLA-B*5701 screening to reduce abacavir hypersensitivity in HIV-1 infected subjects. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Mallon, P., Sedwell, R., Rogers, G., Nolan, D., Unemore, P., Wand, H., Samaras, K., Kelleher, A., Emery, S., Cooper, D. and Carr, A. (2005) The effect of rosiglitazone on PPAR gamma expression in human adipose tissue is limited by continued exposure to thymidine NRTI. In: 12th Conference on Retroviruses and Opportunistic Infections, 22 - 25 February 2005, Hynes Convention Center, Boston, MA.

Martin, A., Nolan, D., Rauch, A., Almeida, C., McKinnon, E. and Mallal, S. (2005) Genetic screening for Abacavir hypersensitivity (ABC-HSR) in the Western Australian cohort: Prospective data and novel diagnostic approaches. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

Martin, A.M., Almeida, C., Nolan, D., Cameron, P., Purcell, A., Chessman, D., McCluskey, J., Phillips, E. and Mallal, S. (2005) Involvement of metabolic and immune responses in the pathogenesis of Abacavir hypersensitivity reaction. In: 17th Annual Conference of the Australasian Society for HIV Medicine (ASHM 2005), 24 - 27 August 2005, Hobart, Tasmania.

McCluskey, J., Chessman, D., Lethborg, T., Kostenko, L., Purcell, A.W., Kjer-Nielsen, L., Mifsud, N.A., Tait, B.D., Holdsworth, R., Almeida, C., Nolan, D., Mallal, S., Bharadwaj, M. and Rossjohn, J. (2007) Abacavir hypersensitivity in HLA-B57-positive individuals with HIV infection is dependent upon the conventional MHC-I Ag presentation pathway. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

McGettigan, B.D., McKinnon, E., Mallal, S., French, M., Hammond, E., Nolan, D. and Phillips, E.J. (2010) Association between low 25(OH) vitamin D levels, antiretroviral therapy and metabolic profile in a cohort of treated ahd therapy naive HIV positive patients in Western Australia. In: 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

McKinnon, E. (2013) Exploring informative diversity in SPN-based association studies. In: International Biometric Society – Australasian Region Conference, “Biometrics by the Canals”, 1 - 5 December 2013, Mandurah, WA.

McKinnon, E. and James, I. (2009) Retrospective matching analysis of induction/maintenance HIV treatment strategies. In: 30th Conference of the International Society for Clinical Biostatistics, 23 - 27 August 2009, Prague, Czech Republic.

McKinnon, E., James, I. and John, M. (2006) Analysis of 3-NRTI maintenance regimens via a retrospective matching approach. In: 10th International Workshop on HIV Observational Databases, 23 – 26 March 2006, Madrid, Spain.

McKinnon, E., James, I. and John, M. Regression modelling of mean responses with censored data. In: 12th International workshop on HIV observational databases, 27 - 30 March 2008, Malaga, Spain.

McKinnon, E., James, I. and Nolan, D. (2013) Analysis of censored duration intervals overlapping a fixed time point where censoring and survival times are correlated. In: 34th Annual Conference of the International Society for Clinical Biostatistics (ISCB) 2013, 25 - 29 August 2013, Munich, Germany.

Merani, S., Freitas, E., Gaudieri, S., Klenerman, P. and Petrovic, D. (2008) Human Leukocyte Antigen (HLA) associated viral polymorphisms in individuals infected by a single HCV source. In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

Miura, T., Brumme, C., Brockman, M.A., Peryra, F., Block, B., Trocha, A., Brumme, Z., John, M., Mallal, S., Harrigan, R. and Walker, B. (2008) HLA-associated mutations occur less frequently in HIV elite controllers than in chronically infected individuals. In: AIDS Vaccine 2008, 13 - 16 October 2008, Cape Town, South Africa.

Morahan, G., Mehta, M., McKinnon, E. and James, I. Effect of linkage status of affected sib-pairs on the search for Type I diabetes susceptibility genes in the HLA complex. In: Type I Diabetes Genetics Consortium: MHC Fine Mapping Results Workshop, 27 - 28 August 2007, Washington, USA.

Moyle, G., Carr, A. and John, M. (2001) Morphological and Metabolic complications of antiretroviral therapy (ART). In: Lipodystrophy workshop (BMS), January 2001, Clivedon, UK.

Needham, M., Scott, A., James, I., Day, T., Kiers, L., Corbett, A., Witt, C., Garlepp, M., Allcock, R., Laing, N., Christiansen, F. and Mastaglia, F. (2009) Epistatic interactions between alleles at the DRB1 locus influence both susceptibility to sIBM and clinical phenotype. In: World Muscle Society Congress, 9 - 12 September 2009, Geneva, Switzerland.

Nolan, D. (2015) HIV Treatment revision: As simple as old versus new. In: Australasian HIV & AIDS (ASHM) Conference 2015, 16 - 18 September 2015, Brisbane, QLD.

Nolan, D. (2008) HIV infection and healthy ageing: is there a need for HIV-specific management guidelines for the protection of hearts, bones, minds and more? In: 20th Annual Australasian Society for HIV Medicine Conference - GSK Meet the Speakers Session, 17 - 20 September 2008, Perth, Australia.

Nolan, D. (2013) How safe is contemporary ART? In: 25th Annual Conference of the Australasian Society for HIV Medicine (ASHM) 2013, 21 - 23 October 2013, Darwin, Australia.

Nolan, D. (2016) New tools to investigate Multiple Sclerosis. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Nolan, D. (2008) Prevention and management strategies for metabolic syndrome and cardiovascular risk in patients taking antiretroviral therapy. In: 20th Annual Australasian Society for HIV Medicine Conference, 17 - 20 September, Perth, Western Australia.

Nolan, D. and Mallal, S. (2009) EBV and MS: Lessons from hepatitis and HIV. In: 10th Biennial Scientific Conferene on "Progress on MS Research" - MSRA Conference 2009, 15 - 17 October 2009, Sydney, Australia.

Nolan, D., Thorborn, D., Shaefer, M., Laird, R., Montaner, M., Hughes, A., James, I., Mallal, S. and Phillips, E. (2008) Genetic factors predicting abacavir hypersensitivty and tolerance in HLA-B*5701 positive individuals: Combined analysis from PREDICT-1, SHAPE and a multinational study. In: 15th Conference on Retroviruses and Opportunistic Infections (CROI), 3 - 6 February 2008, Boston, U.S.A.

Olney, A., Almeida, C.M., Berry, C., John, M., Witt, C. and D'Orsogna, L. (2013) Stimulating HIV memory CD8+ T cells with allogeneic cell immunotherapy. In: ASMR WA Scientific Symposium, 5th June 2013, Perth, WA.

Pavlos, R. (2014) Mechanistic basis of Antiretroviral HLA - Associated drug hypersensitivities: Nevirapine. In: 10th Annual Scientific Workshop Australian Centre for HIV and Hepatitis Virology Research (ACH²), 4 - 6 June 2014, Lorne, NSW.

Pavlos, R., McKinnon, E., Ostrov, D., Peters, B., Buus, S., Koelle, D., Chopra, A., Rive, C., Redwood, A., Restrepo, S., Bracey, A., Yuan, J., Gaudieri, S., Carrington, M., Haas, D., Mallal, S. and Phillips, E. (2016) Specific binding characteristics Of HLA Alleles associated with nevirapine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E. (2014) Specific binding characteristics of HLA alleles associate with Nevirapine hypersensitivity. In: Conference on Retroviruses and Opportunistic Infections (CROI) 2014, 3 - 6 March 2014, Boston, MA.

Pavlos, R., Rive, C., McKinnon, E., Ostrov, D., Plascensia, P.C., Peters, B., Yuan, J., Gaudieri, S., Haas, D., Mallal, S. and Phillips, E.J. (2015) Specific binding characteristics of HLA alleles associate with nevirapine hypersensitivity. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Pavlos, R., Strautins, K., James, I., Mallal, S., Redwood, A.J. and Phillips, E. (2016) Variation in EraP Influencees Risk for HLA-B*57:01 positive abacavir hypersensitivity. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI) 2016, 22 - 25 February 2016, Boston, MA.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Asymptomatic course and resolution of PML during Natalizumab therapy with pre-emptive treatment for IRIS. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Seewann, A., Bennett, K.A., Marshall, B.J., Carroll, W.M. and Kermode, A.G. (2013) Helicobacter pylori infection as a protective factor against multiple sclerosis development in Western Australians. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pedrini, M.J., Xu, W., Xu, Z., Carroll, W.M. and Kermode, A.G. (2013) Benign multiple sclerosis: A longitudinal follow-up study of large Western Australian cohort. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Pfafferott, K., Gaudieri, S., Ulsenheimer, A., John, M., James, I., Heeg, M., Nolan, D., Rauch, A., Lucas, A., Klenerman, P., Diepolder, H.M. and Lucas, M. (2009) Divergent pattern of viral evolution and escape dynamics in acute and early HCV and HIV infection. In: Australasian Virology Group Meeting, 13 - 17 December 2009, Mantra Erskine Resort, Lorne, VIC.

Pfafferott, K., Merani, S., Rauch, A., Baccala, M., Mallal, S., Baker, R., Gaudieri, S. and Lucas, M. (2010) One step closer to a CTL-based HCV vaccine. In: The Australian Centre for HIV and Hepatitis Virology Research (ACH2) 6th National Workshop, 23 - 25 June 2010, Yarra Valley, Australia.

Pfafferott, K., Ulsenheimer, A., Naidoo, K., Rauch, A., Gaudieri, S., Mallal, S., Diepolder, H. and Lucas, M. (2007) Longitudinal analysis of HLA Class I -driven adaptation of HCV: New insights into HCV escape dynamics. In: 4th Australian Virology Group Meeting, 9 - 13 December 2007, Fraser Island, Queensland.

Pfafferott, K., Ulsenheimer, A., Naidoo, K., Rauch, A., Gaudieri, S., Mallal, S., Diepolder, H.M. and Lucas, M. (2007) Genetic analysis of Hepatitis C (HCV) in acutely infected patients-evidence of limited HLA class II-driven selection pressure. In: 3rd Australian Centre for HIV & Hepatitis Research (ACH2) Workshop, 8 - 10 October 2007, Melbourne, Australia.

Pfafferott, K., Ulsenheimer, A., Naidoo, V., Gaudieri, S., Rauch, A., Diepolder, H. and Lucas, M. (2006) HLA-driven HCV evolution in acutely infected patients. In: 13th International Meeting on Hepatitis C Virus & Related Viruses, 27 - 31 August, Cairns, Australia.

Phillips, E. (2014) Advances in antibiotic allergy. In: Infectious Diseases Grand Rounds, 24 July 2014, University of Melbourne (Austin Health).

Phillips, E. (2009) Avoiding catastrophic drug toxicities: ‘Drugs that cause hypersensitivity reactions'. In: 2009 Annual Meeting of the American Association of Clinical Chemistry, 22 July 2009, Chicago, Illinois, USA.

Phillips, E. (2015) Current science and translational opportunities in the prediction and prevention of immunologically-mediated adverse drug reactions. In: 54th Annual Meeting Society of Toxicology (SOT) and ToxExpo, 22 - 26 March 2015, San Diego, CA.

Phillips, E. (2015) Defining and prioritizing unmet research needs for a deadly disease. In: Research Directions in Genetically-mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), 3 - 4 March 2015, Rockville, Maryland.

Phillips, E. (2015) HLA and SCARs: What’s new and What’s next? In: 9th International Congress on Cutaneous Adverse Drug Reactions, 8 June 2015, Vancouver, BC, Canada.

Phillips, E. (2009) Human Genes and Adverse Drug Reactions: when genetics meets practical medicine needs: Pharmacogenetics and ADRs: a practical perspective. In: Pharmacogenetics workshop at the Russian Central Scientific Epidemiology Institute., 23 June 2009, Moscow, Russia.

Phillips, E. (2011) Immunogenetics and immunopathology of drug hypersensitivity. In: Joint Forefront Lecture by Dr. Simon Mallal and Dr. Elizabeth Phillips, 4 March 2011, St. Paul's Hospital, Vancouver, British Columbia.

Phillips, E. (2016) Improving phenotypic precision & using pharmacogenomics to understand mechanisms of drug hypersensitivity reactions. In: Science on the Swan Post Conference Workshop: Cutting Edge tools: from populations to signal cell., 6 May 2016, Perth, WA.

Phillips, E. (2016) Improving the prediction of drug action. In: ASCPT, 8 - 12 March 2016, San Diego, USA.

Phillips, E. (2014) Models for prevention of drug hypersensitivity. In: 6th Drug Hypersensitivity Meeting (DHM6), 11 April 2014, Bern, Switzerland.

Phillips, E. (2015) Personalized approaches to severe immunologically mediated drug reactions: Abacavir hypersensitivity and HLA-B*57:01 as a roadmap for science and translation. In: Advances in Personalized Medicine Workshop, 20 April 2015, Institute for Immunology & Infectious Diseases, Murdoch.

Phillips, E. (2015) Personalized approaches to severe immunologically-mediated drug reactions. In: Future Directions in Personalized Medicine, 5 February 2015, Vanderbilt University, Nashville, Tennessee.

Phillips, E. (2016) Pharmacogenomics in drug hypersensitivity practice. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Phillips, E. (2013) Pharmacogenomics of drug hypersensitivity in HIV: Evolution of knowledge. In: 8th iSCAR Meeting, 16 - 18 November 2013, Taipei, Taiwan.

Phillips, E. (2015) Pharmacogenomics of severe adverse reactions to antituberculous medications. In: NIAID Host Response to TB-HIV Infections, 13 - 14 January 2015, Rockville, Maryland.

Phillips, E. (2014) Strategy and policy cohesion: "The one health agenda: will it deliver". In: Anti-microbial resistance: addressing the one health security agenda, Centre on Global Health Security at Chatham House, 9 December 2014, Murdoch University, Perth.

Phillips, E. (2016) TPS 10 Anaphylaxis in drug hypersensitivity and LB TPS 9 Drug Allergy II. In: European Academy of Allergy and Clinical Immunology Congress (EAACI), 11 - 15 June 2016, Vienna, Austria.

Phillips, E. (2016) Translational drug safety: Predicting and preventing severe immunologically-mediated drug reactions. In: Drug Safety Gordon Research Conference 2016, 26 June - 1 July 2016, Stonehill College, Easton, Massachussetts.

Phillips, E. (2015) Translational opportunities in the prediction and prevention of drug hypersensitivity. In: Telethon Kids Research Retreat, 29 - 30 October 2015, Rottnest Island, Perth.

Phillips, E. (2015) Understanding and preventing HLA-associated drug reactions. In: PGRN Retreat, 3 - 4 November 2015, San Francisco, USA.

Phillips, E. (2009) Using pharmacogenetics to prevent adverse drug reactions. In: Australian Pharmacogenomics Summit (invited Plenary), 31 July 2009, Sydney, Australia.

Phillips, E. (2016) Utility of HLA in Pharmacogenomic testing. In: IGNITE Meeting, 27 January 2016, Nashville, Tennessee.

Phillips, E. (2010) The pharmacogenetics of drug hypersensitivity. In: WorldPharma 2010 – Bridging Basic and Clinical Pharmacology (16th World Congress of Basic & Clinical Pharmacology), 17 - 23 July 2010, Copenhagen, Denmark.

Phillips, E. (2009) The pharmacogenetics of drug hypersensitivity: personalizing medicine and predicting the unpredictable? In: WAMSG Medication Safety Symposium, 14 July 2009, Perth, Australia.

Phillips, E., Keane, N., Blyth, C., Lucas, A., Pavlos, R., Lucas, M., McKinnon, E. and Mallal, S. (2011) Both HLA Class I restricted CD8+ and Class II restricted CD4+T Cells are implicated in the pathogenesis of nevirapine hypersensitivity. In: 51st Interscience Conference of Antimicrobial Agents and Chemotherapy, 17 - 20 September 2011, Chicago, IL.

Phillips, E., Lucas, M., Keane, N., Lucas, A., McKinnon, E. and Mallal, S. (2010) HLA-B*35 is associated with nevirapine hypersensitivity in the contemporary Western Australian HIV cohort study. In: 4th International Drug Hypersensitivity Meeting, 22 - 25 April 2010, Rome, Italy.

Phillips, E. and Mallal, S. (2006) Predisposition to Drug Hypersensitivity in Patients with HIV. In: 2nd International Drug Hypersensitivity Conference, 18 - 21 April 2006, Liverpool, England.

Phillips, E., Nolan, D., Thorborn, D., Schaefer, M., Laird, R., Rauch, A., Rachlis, A., Shear, N., Knowles, S., Hughes, A., Montaner, J., James, I. and Mallal, S. (2008) Genetic factors predicting abacavir hypersensitivity and tolerance in HLA-B*5701 positive individuals. In: 3rd International Drug Hypersensitivity Conference, 11 - 13 April 2008, Paris, France.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Knowles, S., Shear, N., Cavassini, M., Harrigan, R., Montaner, J., Keane, N., Laird, R., Lucas, A. and Mallal, S. (2007) Genetic characterization of patients with MHC class I mediated abacavir hypersensitivity reaction. In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Phillips, E., Rauch, A., Nolan, D., Martin, A., Almeida, C., Laird, R., Montaner, J., Shear, N., Lucas, A. and Mallal, S. (2007) Genetic characterization of patch test negative patients reporting symptoms after initiation after abacavir. In: 8th International Workshop on Clinical Pharmacology of HIV Therapy, 16 - 18 April 2007, Budapest, Hungary.

Phillips, E., Stasezewski, S., Arribas, J., Fitch, N. and Givens, N. (2007) Characteristics of abacavir hypersensitivity diagnoses according to HLA-B*5701 status and subsequent abacavir patch test result. In: 11th European AIDS Conference, 24 - 27 October 2007, Madrid, Spain.

Phillips, E.J. (2009) Drugs that cause hypersensitivity reactions: Personalising medicine & Predicting the unpredictable. In: Annual Meeting of the American Association of Clinical Chemistry (AACC) 2009, 19 - 23 July 2009, Chicago, IL.

Phillips, E.J. (2009) Overcoming the barrier of clinical translation: The Abacavir example. In: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Conference 2009, 29 November - 2 December 2009, Sydney Convention Centre, Sydney.

Phillips, E.J. and Mallal, S. (2010) Immunology of drug hypersensitivity reactions. In: 40th Annual Scientific Meeting for the Australasian Society for Immunology, 5-9 December 2010, Perth, Australia.

Price, P., James, I., Fernandez, S. and French, M. Alleles of the gene encoding interleukin-1a may predict control of plasma viremia in HIV-1 patients on HAART. In: 16th Annual Conference of the Australasian Society for HIV Medicine, 2 - 4 September, Canberra, Australia.

Price, P., James, I., Fernandez, S. and French, M.A. (2006) SNP in immune related genes define cytokines critical to the outcome of anti-retroviral therapy in HIV-1 patients. In: 14th International HLA and Immunogenetics Workshop, 29 November - 3 December 2005,, Melbourne, Australia.

Prosser, A., Pfafferott, K., Deshpande, P., Eule, U., McKinnon, E., Chopra, A., Lucas, A., Gaudieri, S. and Lucas, M. (2015) Using a population based reverse genomics approach to predict HCV vaccine T cell responses. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Rauch, A., Furrer, H., Nolan, D., McKinnon, E., Telenti, A. and James, I. (2007) Carriage of HLA-Bw4 is associated with lower CD4 cell counts after starting HAART: Consistent findings in the Western Australian HIV Cohort Study (WAHIV) and the Swiss HIV Cohort Study (SHCS). In: 14th Conference on Retroviruses and Opportunistic Infections, 25 - 28 February 2007, Los Angeles, U.S.A.

Rauch, A., Gaudieri, S., Cavassini, M., Wever, R., Nolan, D., James, I. and Hurrer, H. (2007) Low CD4 cell counts are associated with higher hepatitis C viral loads in the Swiss HIV Cohort Study (SHCS). In: 14th Conference on Retroviruses and Opportunistic Infections, 25 - 28 February 2007, Los Angeles, U.S.A.

Rauch, A., Thurnheer, C., Fux, C., Nolan, D., Cavassini, M., Chave, J-P, Opravil, M., Phillips, E., Mallal, S. and Furrer, H. (2008) Genetic testing and structured clinical assessment reveal over diagnosis of abacavir hypersensitivity reactions in the Swiss HIV Cohort Study. In: 12th International Workshop on HIV Observational Databases, 27 - 30 March 2008, Malaga, Spain.

Redwood, A. (2015) In search of a virotope: Identification of herpesvirus specific CD8 T cells. In: 11th Annual Scientific Workshop, 9 - 11 December 2015, Hunter Valley, NSW.

Redwood, A., Jing, L., Tran, T., White, K., Mallal, S., Koelle, D. and Phillips, E. (2015) In search of a virotope: Identification of herpesvirus specific CD8T cells. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Redwood, A., White, K., Strautins, K., Chopra, A., Konvinse, K., Leary, S., Pavlos, R., Mallal, S. and Phillips, E. (2016) Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Redwood, A.J., Trubiano, J.A., Pavlos, R., Woolnough, E., Strautins, K., Chang, C. and Phillips, E. (2016) Enzyme linked Immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials. In: 7th Drug Hypersensitivity Meeting (DHM) 2016, 21 - 23 April 2016, Malaga, Spain.

Rive, C., Watson, M., Chopra, A., Cooper, D., Demaine, E. and Mallal, S. (2011) Development of a low bias target enrichment method to estimate viral variation using 454 sequencing. In: 21st Annual Combined Biological Sciences Meeting, 26 August 2011, Perth, Western Australia.

Roberts, S., Almeida, C., Bronke, C., Ahmad, I., Keane, N., Chopra, A., Mallal, S., John, M., Heckerman, D. and Mallal, S. (2009) Screening for HIV responses using optimal epitopes predicted by HLA-viral sequence polymorphism associations. In: 21st Annual Conference of the Australasian Society for HIV Medicine (ASHM), 9 - 11 September, Brisbane, Australia.

Saag, M., Balu, R., Brachman, P., Brothers, C., Stancil, B., Mosteller, M., Wannamaker, P., Sutherland‐Phillips, D., Phillips, E., Mallal, S. and Shaefer, M. (2007) High sensitivity of HLA-B*5701 in Whites and Blacks in immunologically-confirmed cases of abacavir hypersensitivity (ABC HSR). In: 4th International AIDS Conference on HIV Pathogenesis, Treatment and Prevention, 22 - 25 July, Sydney, Australia.

Seet, J.M., Ingram, P.R., Lie, K., Phillips, E.J. and Murray, R.J. (2012) Using antibiotics better: The healthy antimicrobial prescribing initiative (HAPI). In: Australian Society for Antimicrobials 13th Annual Scientific Meeting, 23 - 25 February 2012, Brisbane Convention & Exhibition Centre, Brisbane.

Shahid, A., Cotton, L., Jessen, H., Markowitz, M., Walker, B.D., Harrigan, P.R., Mallal, S. and John, M. (2014) Impact of HLA-B*13-associated polymorphisms in HIV-1 Gag and Pol on viral replication capacity. In: Keystone conference, 2014, Banff, Alberta.

Shasha, D., Meseret, Y., Chopra, A., Cooper, D., James, I., Herrmann, S., Wolday, D., Maayan, S., Mallal, S. and John, M. (2012) Unique footprints of HLA class I on clade C HIV-1 in a cohort of Ethiopian patients. In: 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), 5 - 8 March, Seattle, Washington, USA.

Snowball, F., Watson, M. and Chopra, A. (2014) Methods for reducing sequence resampling and improving sample enrichment for Human Virome Sequencing. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Stiel, H. and John, M. (2013) Going Viral. Finalist in Best of Grand Rounds. In: Royal Australasian College of Physicians (RACP) Future Directions in Health Congress 2013, 26 - 29 May 2013, Perth, WA.

Strautins, K. (2014) Adaptive immune responses against Epstein-Barr Virus influencing Multiple Sclerosis risk. In: 24th Annual Combined Biological Sciences Meeting 2014, 29 August 2014, University of Western Australia, Perth.

Strautins, K., Tschochner, M., Berry, C. and Nolan, D. (2012) Development of an anti-Epstein-Barr Virus nuclear antigen-1 ELISA and investigation of B-cell-epitope specific antibodies in Multiple Sclerosis patients. In: Murdoch University Postgraduate Student Association (MUPSA) Multidisciplinary Conference, 27 September 2012, Murdoch University, Murdoch.

Strautins, K., Tschochner, M., James, I., Berry, C. and Nolan, D. (2013) Influence of gender, genetic factors and Epstein-Barr Virus antibody profiles, on Multiple Sclerosis risk. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Strautins, K., Tschochner, M., James, I., Berry, C.M. and Nolan, D. (2012) Epstein-Barr virus (EBV) - specific antibodies in multiple sclerosis patients, including targeted investigation of a candidate EBV nuclear antigen-1 (EBNA-1) B cell epitope. In: 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), 10 - 13 October, Lyon, France.

Strautins, K., Tschochner, M., James, I., Choo, L., Dunn, D.S., Pedrini, M. and Kermode, A. (2013) Combining genetic risk factors, gender And Anti-Epstein Barr Virus (EBV) antibody profiles, sing A Novel Anti-EBV Nuclear Antigen-1 (EBNA-1) B Cell Epitope ELISA, to stratify multiple sclerosis risk. In: PACTRIMS 2013, 6 - 8 November 2013, Kyoto, Japan.

Strautins, K., Tschochner, M., James, I., Leary, S., Choo, L., Walters, S., Pedrini, M., Dunn, D., Berry, C., Clark, H., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2015) Investigating the role of EBV infection in multiple sclerosis pathogenesis. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Strautins, K., Tschochner, M., Nolan, D. and Berry, C. (2012) Investigating Epstein-Barr virus (EBV) antibodies in Multiple Sclerosis patients, and development of an anti-EBV nuclear antigen-1 B cell epitope ELISA. In: ASMR Medical Research Week, 7 June 2012, Perth, Western Australia.

Symons, J., Chopra, A., Malantinkova, E., De Spiegelaere, W. and Leary, S. (2016) Integration analysis of latently infected cell lines: Evidence of ongoing replication. In: 23rd Conference on Retroviruses and Opportunistic Infections (CROI), 20-25 February 2016, Boston, MA.

Symons, J., Lewin, S., Chopra, A., Malatinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Vandekerckhove, L., Mallal, S. and Cameron, P. (2015) Integration site analysis of latently infected cell lines: evidence of ongoing replication. In: 7th International workshop on HIV Persistence during Therapy, 8 - 11 December 2015, Miami, FL.

Symons, J., Lewin, S.R., Chopra, A., Malantinkova, E., De Spiegelaere, W., Leary, S., Cooper, D., Vandekerckhove, L., Mallal, S. and Cameron, P. (2016) Integration site analysis of latently infected cell lines: evidence of ongoing replication. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Tay, J., James, I., Hughes, Q. and Baker, R.I. (2015) Identification of oestrogen responsive miRNAs associated with regulating coagulation and increased thrombotic risk in pregnant women. In: International Society on Thrombosis and Haemostasis (ISTH) 2015, 20-25 June 2015, Toronto, Canada.

Tay, J., Jorritsma, J., Hughes, Q. and Baker, R. (2015) Probing miR-494 function in coagulation. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Tay, J., Jorritsma, J., Hughes, Q. and Baker, R.I. (2015) In silico Prediction of microRNA Binding Sites in Haemostatic factors. In: International Society on Thrombosis and Haemostasis (ISTH) 2015, 20 - 25 June 2015, Toronto, Canada.

Tay, J., Jorritsma, J., Hughes, Q., Tiao, J. and Baker, R.I. (2015) Platelet activation releases mature miR-494 in microparticles. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26 - 27 November 2015, Murdoch University, Perth.

Tay, J., Lui, W., Tian, J., Hughes, Q., Tiao, J. and Baker, R. (2017) Evidence for direct and indirect modulation of haemostatic factors by miR-494. In: International Society on Thrombosis and Haemostasis 2017, 8 - 13 July 2017, Berlin, Germany.

Tian, J., Tay, J., Hughes, Q., Tiao, J. and Baker, R.I. (2015) Oestrogen sensitive miR-365a-3p, a new player in regulating tissue factor expression during pregnancy. In: 1st International Symposium on Functional Nucleic Acids: From Laboratory to Targeted Molecular Therapy, 26 - 27 November 2015, Murdoch University, Perth.

Tiao, J. and Baker, R. (2015) APMAT, A Multi-Centre observational study of patients with microangiopathic thrombocytopenia. In: Science on the Swan, 21 - 23 April 2015, Perth, Western Australia.

Tschochner, M., James, I., Almeida, C., Keane, N.M., Roberts, S., Bronke, C., Chopra, A., Maiden, T., Ahmed, I.F., Gaudieri, S., Furrer, H., Günthard, H.F., Mallal, S., Rauch, A. and John, M. (2009) Effects of HIV-1 immune selection on susceptibility to integrase inhibitor resistance. In: 12th European AIDS Conference (EACS), 11 - 14 November 2009, Cologne, Germany.

Tschochner, M., James, I., Almeida, C., Keane, N., Roberts, S., Bronke, C., Chopra, A., Maiden, T., Ahmad, I., Gaudieri, S., Mallal, S., Rauch, A., John, M., Furrer, H. and Günthard, H. (2009) Effects of HIV-1 immune selection on susceptability to integrase inhibitor resistance. In: 12th European AIDS Conference (EACS) 2009, 11 - 14 November 2009, Cologne, Germany.

Tschochner, M., Leary, S. and Nolan, D. (2011) Identifying potential targets for Epstein-Barr virus-associated molecular mimicry in T cell-mediated autoimmunity of multiple sclerosis. In: 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis, 19 – 22 October 2011, Amsterdam, Netherlands.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Identifying Epstein-Barr virus EBNA-1 sequence variation using 454 FLX technology in Multiple Sclerosis patient samples. In: Keystone Symposia on Molecular and Cellular Biology: Multiple Sclerosis, 11 - 16 January 2013, Big Sky, Montana USA.

Tschochner, M., Leary, S., Strautins, K., Clark, H., Cooper, D., Chopra, A., Choo, L., Carroll, W., Kermode, A. and Nolan, D. (2013) Multiple Sclerosis Patient Sequence Variation In Epstein-Barr Virus Nuclear Antigen 1. In: Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) 2013, 6 - 8 November 2013, Kyoto, Japan.

Tschochner, M., Strautins, K., James, I., Leary, S., Choo, L., Clark, H., Dunn, D., Chopra, A., Cooper, D., Kermode, A., Carroll, W. and Nolan, D. (2016) Contribution of EBV infection to Multiple Sclerosis Pathogenesis: Human leukocyte antigen restricted, EBV epitope-specific T cell responses in Multiple Sclerosis. In: Science on the Swan 2016, 2 - 5 May 2016, Perth, Western Australia.

Tschochner, M., rohrbach, J., Cooper, D., Merani, S., Chopra, A., Witteck, A., Battegay, M., Furrer, H., Günthard, H., Mallal, S., Rauch, A. and Gaudieri, S. (2010) Characterization of hepatitis C virus evolution in HIV-HCV coinfected individuals using deep sequencing technology: relevance for new antiviral drugs and disease outcome. In: Australasian HIV/AIDS Conference 2010 – 22nd Annual Conference of the Australasian Society for HIV Medicine, 20 - 22 October 2010, Sydney, Australia.

Vaezeslami, S., Tao, J., Blinco, J., Yu, F., Sinha, R., Heo, S-J, Miller, D., Watson, M., Pitcher, D., Boffelli, D., Quake, S., Weissman, I. and Jenkins, J. (2015) Methods for reduced cost and lower sample prep volumes for genetic analysis applications. In: American Society of Human Genetics (ASHG) 2015 Annual Meeting, 6 - 10 October 2015, Baltimore, MD.

Van Trigt, J., Clark, H., Watson, M. and Allan, J. (2013) Optimisation of a reporter cell line for assessing neutralising antibody titres to hepatitis C virus. In: 23rd Annual Combined Biological Sciences Meeting (CBSM) 2013, 30 August 2013, University of Western Australia, Perth.

Villarino, M.E., Moro, R., Borisov, A., Adkinson, N.F., Phillips, E., Shepherd, G., Ho, C., Weis, S.E. and Sterling, T.R. (2013) Hypersensitivity reactions among persons receiving a 3 month regimen of rifapentine plus isoniazid for treatment of latent tuberculosis infection (LTBI). In: 20th Conference on Retroviruses and Opportunistic Infections (CROI) 2013, 3 - 6 March 2013, Atlanta, Georgia.

Watson, M. (2013) Accurate identification of HCV sequence variants using deep sequencing with a primer ID. In: Australian Centre for HIV and Hepatitis Virology Research (ACH2) 4th Annual Workshop, 4 - 6 June 2008, Novotel Barossa Valley Resort, South Australia.

White, K., Redwood, A., Jing, L., Konvinse, K., Pavlos, R., Koelle, D., Mallal, S. and Phillips, E. (2016) Isolation of activated CD8+ T cells following drug stimulation: A first step toward evaluating the heterologous immunity model for pure T-cell mediated adverse drug reactions. In: American Society for Clinical Investigation (ASCI) Meeting, 15 - 17 April 2016, Chicago, IL.

White, K.D., Konvinse, K., Pilkington, M., Barnett, L., Gangula, R., Redwood, A., Pavlos, R., Chopra, A., Mallal, S. and Phillips, E. (2016) Characterization of TCR repertoire diversity and tissue distribution of drug-specific T cells in DRESS. In: 16th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS) 2016, 22 - 26 June 2016, Boston, MA.

Wilson, G.F.V., Chopra, A., Watson, M. and Mallal, S. (2010) Front end modification of library preparation for GS FLX to minimize cost, sample loss and labour. In: Combined Biological Sciences Meeting., 28 August 2010, UWA Perth, Western Australia.

Wu, J., Qui, W., James, I., Joseph, J., Carroll, W., Christiansen, F., Mastaglia, F. and Kermode, A. (2009) Frequency of HLA-DRB1 alleles and disease-modifying effects in a large West Australian multiple sclerosis cohort. In: Australian & New Zealand Association of Neurologists Annual Scientific Meeting, 18 - 21 May 2009, Christchurch, New Zealand.

Book Chapter

Gaudieri, S. and John, M. (2017) Evolution of the Human Leukocyte Antigen System. In: Tibayrenc, M. and Ayala, F.J., (eds.) On Human Nature. Elsevier Inc., pp. 211-219.

Herrmann, S. and Skinner, M. (2016) HIV and ageing. In: Baker, D. and Bloch, M., (eds.) ASHM HIV management in Australasia. ASHM.

John, M., Gaudieri, S. and Mallal, S. (2017) Immunogenetics and vaccination. In: Modjarrad, K. and Koff, W.C., (eds.) Human Vaccines: Emerging Technologies in Design and Development. Academic Press.

John, M., Nolan, D. and Mallal, S.A. (2001) Lipodystrophy syndrome in the Western Australian cohort. In: Jäger, Hans and Mauss, Stefan, (eds.) AIDS.Lipodystrophie. Pathophysiologische Grundlagen und Klinisches Management, (AIDS Lipodystrophy Pathophysiological Basis and Clinical Management). Thieme Verlag, Stuttgart, Germany, pp. 28-35.

Mallal, S. (2017) What HIV has taught about the interactions between biology, culture, and other evolving systems. In: Tibayrenc, M. and Ayala, F.J., (eds.) On Human Nature. Elsevier Inc., pp. 771-776.

Martin, A.M., Gaudieri, S., Witt, C., Sayer, D., Castley, A., Mamotte, C., Nolan, D., James, I., Christiansen, F. and Mallal, S. (2004) Association of tumour necrosis factor promoter polymorphisms with abacavir hypersensitivity. In: Hansen, John A. and Dupont, Bo, (eds.) HLA 2004: Immunobiology of the human MHC : proceedings of the 13th International Hisotcompatibility Workshop and Conference and the XIII International Congress of Histocompatibility and Immunogenetics. International Histocompatibility Working Group Press : Fred Hutchinson Cancer Research Center.

Martinez, O.P., John, M., Nolan, D. and Mallal, S.A. (2002) Patagenia de la redistirbucion de grasa corporal y alteraciones metabólicas (Pathogenesis of body fat redistribution and metabolic alterations) (Spanish). In: Polo-Rodriguez, Rosa, (ed.) Manuel de Nutricion y SIDA. NILO Industria Grafica, Madrid, Spain, pp. 404-451.

Nolan, D. (2005) Involvement of Apoptosis in complications of HIV and its treatment. In: Badley, Andrew D., (ed.) Cell Death During HIV Infection. CRC Press (Taylor & Francis), Boca Raton FL, USA, pp. 405-420.

Nolan, D., Almeida, C. and Phillips, E. (2007) Abacavir hypersensitivity. In: Pichler, Werner J., (ed.) Drug Hypersensitivity. S.Karger AG, Basel, Switzerland.

Nolan, D., Almeida, C., Phillips, E. and Mallal, S. (2007) Abacavir hypersensitivity. In: Pichler, W.J., (ed.) Drug Hypersensitivity. S. Karger AG, Basel, Switzerland, pp. 95-104.

Nolan, D. and Mallal, S. (2007) Lactic acidosis and other mitochondrial disorders associated with HIV therapy. In: Dolin, Raphael, Masur, Henry and Saag, Michael, (eds.) AIDS Therapy. Churchill Livingstone, London, UK, pp. 1300-1310.

Nolan, D., Mallal, S. and Reiss, P. (2012) Complications resulting from antiretroviral therapy for HIV infection. In: Volberding, P., Greene, W., Lange, J.M.A., Gallant, J.E. and Sewankambo, N., (eds.) Sande's HIV/AIDS Medicine: Medical Management of AIDS 2013. Elsevier Inc., pp. 177-191.

O’Connor, K.D.J. and Mastaglia, F.L. (2014) Drug-Induced disorders of the nervous system. In: Aminoff, M.J. and Josephson, S.A., (eds.) Aminoff's Neurology and General Medicine. Academic Press, pp. 685-711.

Phillips, E.J. and Mallal, S.A. (2010) Abacavir. In: Wu, A.H.B. and Kiang-Teck, J.Y., (eds.) Pharmacogenomic Testing in Current Clinical Practice. Humana Press, New York, U.S.A, pp. 201-212.

Phillips, E.J. and Mallal, S.A. (2010) HLA and drug reactions. In: Mehra, N.K., Kaur, G., McCluskey, J., Christiansen, F.T. and Claas, F.H.J., (eds.) The HLA Complex in Biology and Medicine: A Resource Book. Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 332-349.

Thesis

Cooper, Donald (2015) High resolution HLA typing from second generation sequencing data. PhD thesis, Murdoch University.

Herrmann, Susan (2013) By virtue of circumstance: HIV/AIDS in mobile and rural populations in Western Australia, an ethnographic study. PhD thesis, Murdoch University.

Reeves, Karyn (2013) Founder effects and related issues in Host-viral association studies. PhD thesis, Murdoch University.

Rive, Craig (2016) The immunopathogenesis of drug hypersensitivity. PhD thesis, Murdoch University.

This list was generated on Tue Nov 21 09:41:43 2017 UTC.